P07504457A03
A/DT MAP/NN kinase/NN activator/NN recently/RB purified/VBN and/CC cloned/VBN has/VBZ been/VBN shown/VBN to/TO be/VB a/DT protein/NN kinase/NN (/( MAP/NN kinase/NN kinase/NN )/) that/WDT is/VBZ able/JJ to/TO induce/VB the/DT dual/JJ phosphorylation/NN of/IN MAP/NN kinase/NN on/IN both/CC the/DT regulatory/JJ tyrosine/NN and/CC threonine/NN sites/NNS in/FW vitro/FW ./.
P07535768A04
Here/RB we/PRP report/VBP the/DT cloning/NN and/CC characterization/NN of/IN a/DT novel/JJ dual/JJ specific/JJ phosphatase/NN ,/, HVH2/NN ,/, which/WDT may/MD function/VBP in/FW vivo/FW as/IN a/DT MAP/NN kinase/NN phosphatase/NN ./.
P07535770A05
Here/RB ,/, we/PRP demonstrate/VBP that/IN p38/NN ,/, like/IN JNK/NN ,/, is/VBZ activated/VBN by/IN treatment/NN of/IN cells/NNS with/IN pro-inflammatory/JJ cytokines/NNS and/CC environmental/JJ stress/NN ./.
P07600582A03
These/DT proteins/NNS also/RB activate/VBP MAP/NN kinase/NN (/( MAPK/NN )/) cascades/NNS that/WDT regulate/VBP gene/NN expression/NN ./.
P07629120A03
Whether/IN a/DT similar/JJ antagonism/NN may/MD account/VBP for/IN the/DT late/JJ inhibitory/JJ effect/NN of/IN cAMP/NN in/IN T/NN cell/NN was/VBD examined/VBN ./.
P07644477A07
Further/RB ,/, PD/NN 098059/CD is/VBZ an/DT invaluable/JJ tool/NN that/WDT will/MD help/VBP elucidate/VB the/DT role/NN of/IN the/DT MAPK/NN cascade/NN in/IN a/DT variety/NN of/IN biological/JJ settings/NNS ./.
P07716521A05
JNKK/NN also/RB activated/VBD another/DT MAPK/NN ,/, p38/NN (/( Mpk2/NN ;/: the/DT mammalian/JJ homolog/NN of/IN HOG1/NN from/IN yeast/NN )/) ,/, whose/WDT activity/NN is/VBZ regulated/VBN similarly/RB to/TO that/PRP of/IN the/DT JNKs/NNS ./.
P07797573A02
This/DT activation/NN of/IN MAPKs/NNS coincides/VBZ with/IN the/DT formation/NN of/IN superoxide/NN anion/NN ,/, which/WDT occurs/VBZ through/IN the/DT activation/NN of/IN a/DT multiple-component/NN NADPH/NN oxidase/NN pathway/NN ./.
P07838428A07
The/DT protein/NN expression/NN profiles/NNS were/VBD almost/RB equivalent/JJ ,/, but/CC the/DT MEK/NN expression/NN was/VBD slightly/RB advanced/VBN ,/, suggesting/VBG that/IN the/DT observed/JJ up-regulation/NN of/IN MEK/NN was/VBD not/RB due/JJ to/TO that/PRP of/IN ERK/NN ./.
P07839144A03
Two/CD human/NN MAP/NN kinase/NN kinases/NNS (/( MKK3/NN and/CC MKK4/NN )/) were/VBD cloned/VBN that/WDT phosphorylate/VBP and/CC activate/VBP p38/NN MAP/NN kinase/NN ./.
P07867573A01
We/PRP have/VBP examined/VBN porcine/JJ granulosa/NN cells/NNS (/( pGCs/NNS )/) for/IN the/DT presence/NN of/IN immunodetectable/JJ mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinases/NNS (/( extracellular/JJ signal-regulated/JJ kinases/NNS ,/, ERK/NN )/) and/CC have/VBP further/RB studied/VBN the/DT effects/NNS of/IN epidermal/JJ growth/NN factor/NN (/( EGF/NN )/) on/IN the/DT activation/NN of/IN these/DT kinases/NNS ./.
P07935387A05
Despite/IN these/DT reports/NNS ,/, we/PRP find/VBP that/IN unlike/IN the/DT JNKs/NNS ,/, ERK1/NN and/CC ERK2/NN do/VBP not/RB phosphorylate/VBP the/DT N-terminal/JJ sites/NNS of/IN c-Jun/NN in/FW vitro/FW ;/: instead/RB they/PRP phosphorylate/VBP an/DT inhibitory/JJ C-terminal/JJ site/NN ./.
P07935449A01
Independent/JJ of/IN its/PRP$ ability/NN to/TO block/VB translation/NN ,/, anisomycin/NN intrinsically/RB initiates/VBZ intracellular/JJ signals/NNS and/CC immediate-early/JJ gene/NN induction/NN [/( L./NNP C./NNP Mahadevan/NNP and/CC D./NNP R./NNP Edwards/NNP ,/, Nature/NN (/( London/NNP )/) 349/CD :/: 747-749/CD ,/, 1991/CD ]/) ./.
P08381539A03
We/PRP separated/VBD two/CD protein/NN factors/NNS from/IN the/DT cytosol/NN fraction/NN of/IN Xenopus/NN oocytes/NNS by/IN column/NN chromatography/NN :/: one/CD was/VBD the/DT inactive/JJ form/NN of/IN MAP/NN kinase/NN kinase/NN and/CC the/DT other/PRP was/VBD a/DT factor/NN tentatively/RB named/VBN ras/NN p21-dependent/JJ ERK-kinase/NN stimulator/NN (/( REKS/NN )/) ./.
P08394352A06
These/DT cell-selective/JJ differences/NNS in/IN MEK/NN activation/NN parallel/VBP constitutive/JJ MAPK/NN activation/NN in/IN these/DT cell/NN lines/NNS ./.
P08529671A10
The/DT potential/JJ activator/NN of/IN MAP/NN kinase/NN ,/, RAF-1/NN ,/, was/VBD hyperphosphorylated/VBN in/IN erythropoietin-stimulated/JJ cells/NNS and/CC its/PRP$ autophosphorylation/NN activity/NN was/VBD strongly/RB increased/VBN ./.
P08530360A04
In-gel/NN JNK/NN assays/NNS confirmed/VBD activation/NN of/IN two/CD renaturable/JJ JNKs/NNS of/IN 46/CD and/CC 55/CD kDa/NN (/( JNK-46/NN and/CC JNK-55/NN ,/, respectively/RB )/) ./.
P08567974A03
Herein/RB we/PRP provide/VBP evidence/NN that/IN two/CD distinct/JJ classes/NNS of/IN MAP/NN kinases/NNS ,/, the/DT extracellular/JJ signal-regulated/JJ kinases/NNS (/( ERK/NN )/) and/CC the/DT c-Jun/NN NH2-terminal/JJ kinases/NNS (/( JNK/NN )/) ,/, are/VBP transiently/RB activated/VBN in/IN rat/NN arteries/NNS (/( aorta/NN ,/, carotid/JJ and/CC femoral/JJ arteries/NNS )/) in/IN response/NN to/TO an/DT acute/JJ elevation/NN in/IN blood/NN pressure/NN induced/VBN by/IN either/CC restraint/NN or/CC administration/NN of/IN hypertensive/JJ agents/NNS (/( i.e./IN ,/, phenylephrine/NN and/CC angiotensin/NN II/CD )/) ./.
P08576169A05
Insulin/NN did/VBD not/RB enhance/VBP activation/NN of/IN phospholipase/NN D/NN in/IN response/NN to/TO phorbol/NN ester/NN ./.
P08598210A02
CD40/NN signaling/NN activates/VBZ downstream/JJ effectors/NNS ,/, including/VBG the/DT tyrosine/NN protein/NN kinase/NN ,/, Lyn/NN ,/, the/DT phosphatidylinositol-3-kinase/NN (/( PI-3/NN kinase/NN )/) ,/, and/CC the/DT transcription/NN factor/NN ,/, NF-kappa/NN B/NN ./.
P08607977A08
Three/CD MAP/NN kinase/NN homologs/NNS have/VBP been/VBN identified/VBN in/IN the/DT rat/NN :/: Erk1/NN ,/, Erk2/NN ,/, and/CC Erk3/NN ./.
P08626699A03
A/DT novel/JJ mitogen-activated/JJ protein/NN kinase/NN kinase/NN ,/, MEK6/NN ,/, was/VBD cloned/VBN and/CC characterized/VBN ./.
P08626724A01
Stimulation/NN of/IN a/DT variety/NN of/IN cell/NN surface/NN receptors/NNS enhances/VBZ the/DT enzymatic/JJ activity/NN of/IN mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) ./.
P08631968A02
In/IN particular/NN ,/, epidermal/JJ growth/NN factor/NN (/( EGF/NN )/) -stimulated/JJ DNA/NN synthesis/NN is/VBZ reduced/VBN in/IN hepatocytes/NNS from/IN aged/JJ rats/NNS relative/JJ to/TO young/JJ rats/NNS ./.
P08645177A02
In/IN each/DT case/NN ,/, there/EX is/VBZ a/DT conditional/JJ requirement/NN for/IN GTP-Gs/NNS alpha/NN ./.
P08645177A13
Sphingosine/NN phosphate-stimulated/JJ ERK-2/NN activity/NN is/VBZ also/RB abolished/VBN by/IN pertussis/NN toxin/NN ,/, indicating/VBG that/IN c-Raf-1/NN kinase/NN is/VBZ activated/VBN via/IN a/DT Gi-dependent/JJ mechanism/NN ./.
P08645194A06
Moreover/RB ,/, ceramide/NN can/MD suppress/VBP growth/NN factor-/NN or/CC sphingosine-induced/JJ ERK/NN activation/NN as/RB well/RB as/IN proliferation/NN ./.
P08647130A10
From/IN these/DT studies/NNS ,/, it/PRP is/VBZ evident/JJ that/IN sphingosine/NN phosphate/NN displays/VBZ a/DT signalling/JJ profile/NN that/WDT is/VBZ consistent/JJ with/IN it/PRP mediating/NN part/NN of/IN the/DT action/NN of/IN platelet-derived/JJ growth/NN factor/NN ./.
P08648136A01
Stimulation/NN of/IN human/NN neutrophils/NNS by/IN LPS/NN is/VBZ central/JJ to/TO the/DT pathogenesis/NN of/IN sepsis/NN and/CC the/DT adult/NN respiratory/JJ distress/NN syndrome/NN ./.
P08663242A05
Most/RBS importantly/RB ,/, treatment/NN of/IN aortic/JJ SMC/NN with/IN PD/NN 98059/CD potently/RB inhibited/VBD AII-stimulated/JJ protein/NN synthesis/NN with/IN a/DT half-maximal/JJ inhibitory/JJ concentration/NN of/IN 4.3/CD microM/NN ./.
P08668180A09
These/DT findings/NNS suggest/VBP that/IN the/DT high-affinity/NN and/CC active/JJ site-independent/JJ binding/NN observed/VBN in/FW vitro/FW facilitates/VBZ signal/NN transduction/NN in/FW vivo/FW and/CC suggest/VBP further/RB that/IN MEK-MAPK/NN interactions/NNS may/MD utilize/VBP a/DT double-selection/NN mechanism/NN to/TO ensure/VB fidelity/NN in/IN signal/NN transmission/NN and/CC to/TO insulate/VB one/CD signaling/JJ pathway/NN from/IN another/PRP ./.
P08668187A04
Rat/NN MAP/NN //SYM ERK/NN kinase/NN kinase/NN 1/CD can/MD stimulate/VBP the/DT activity/NN of/IN each/PRP of/IN these/DT MAP/NN kinases/NNS ./.
P08702674A02
Previous/JJ work/NN in/IN this/DT laboratory/NN has/VBZ focused/VBN on/IN elucidating/NN the/DT mechanism/NN of/IN NOx/NN signaling/NN in/IN cells/NNS ./.
P08703041A07
Therefore/RB ,/, inhibition/NN of/IN PTP/NN activity/NN is/VBZ sufficient/JJ per/FW se/FW to/TO initiate/VB a/DT complete/JJ MAP/NN kinase/NN activation/NN program/NN ./.
P08755992A04
Using/VBG the/DT isolated/JJ perfused/JJ rat/NN heart/NN ,/, we/PRP show/VBP that/IN global/JJ ischemia/NN does/VBZ not/RB activate/VBP the/DT 42-/CD and/CC 44-kD/NN extracellular/JJ signal-regulated/JJ (/( protein/NN )/) kinase/NN (/( ERK/NN )/) subfamily/NN of/IN MAPKs/NNS but/CC rather/RB stimulates/VBZ a/DT 38-kD/NN activator/NN of/IN MAPK-activated/JJ protein/NN kinase-2/NN (/( MAPKAPK2/NN )/) ./.
P08757935A03
One/CD pathway/NN converges/VBZ on/IN the/DT ERK/NN subfamily/NN known/VBN as/IN the/DT "/`` stress/NN activated/JJ '/'' protein/NN kinases/NNS (/( SAPKs/NNS ,/, also/RB termed/VBN Jun/NN N-terminal/JJ kinases/NNS ,/, JNKs/NNS )/) ,/, whereas/IN the/DT second/JJ pathway/NN recruits/VBZ the/DT p38/NN kinases/NNS ./.
P08758915A05
Indeed/RB ,/, 4-CD3-BHTOOH/NN ,/, an/DT analogue/NN that/WDT generates/VBZ less/PRP of/IN the/DT metabolite/NN BHT-quinone/NN methide/NN (/( 2/CD ,/, 6-di-tert-butyl-4-methylene-2/NN ,/, 5-cyclohexadienone/NN )/) and/CC fewer/JJR tumors/NNS in/FW vivo/FW ,/, accordingly/RB exhibited/VBD diminished/JJ potency/NN for/IN activating/NN ERK/NN ./.
P08759724A03
In/IN this/DT study/NN ,/, we/PRP have/VBP examined/VBN signal/NN transduction/NN events/NNS mediated/VBN by/IN CD40/NN cross-linking/NN in/IN resting/JJ murine/JJ splenic/JJ B/NN cells/NNS ./.
P08759733A02
These/DT pathways/NNS are/VBP disrupted/VBN by/IN agonists/NNS that/WDT utilize/VBP adenylate/NN cyclase/NN and/CC cAMP-dependent/JJ protein/NN kinase/NN A/NN (/( PKA/NN )/) ./.
P08761479A09
Secondly/RB ,/, a/DT 27/CD kDa/NN protein/NN that/WDT aligns/VBZ with/IN a/DT protein/NN recognized/VBN by/IN anti-hsp27/NN antibody/NN is/VBZ phosphorylated/VBN upon/IN LPS/NN stimulation/NN of/IN intact/JJ human/NN neutrophils/NNS prelabelled/VBN with/IN radioactive/JJ phosphate/NN ./.
P08766546A07
Furthermore/RB ,/, similar/JJ features/NNS of/IN differential/JJ activation/NN of/IN ERK/NN isoforms/NNS were/VBD observed/VBN in/IN normal/JJ resting/JJ B/NN cells/NNS in/IN CD40/NN and/CC sIgM/NN signaling/NN ./.
P08808707A05
Ha-RasV12/NN and/CC activated/JJ proteins/NNS in/IN both/CC the/DT extra-cellular/JJ regulated/JJ kinase/NN (/( ERK/NN )/) and/CC the/DT stress-activated/JJ protein/NN kinase/NN (/( SAPK/NN )/) or/CC Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) cascades/NNS independently/RB stimulated/VBD PEA3-mediated/JJ gene/NN expression/NN ./.
P08824287A09
However/WRB ,/, the/DT combined/JJ treatment/NN with/IN PDTC/NN and/CC PMA/NN ,/, two/CD agents/NNS that/WDT synergize/VBP on/IN AP-1/NN activation/NN ,/, resulted/VBD in/IN the/DT persistent/JJ phosphorylation/NN of/IN ERK-2/NN ./.
P08836113A08
Important/JJ concepts/NNS are/VBP that/IN signal/NN transmission/NN often/RB entails/VBZ the/DT targeted/JJ relocation/NN of/IN specific/JJ proteins/NNS in/IN the/DT cell/NN ,/, and/CC the/DT reversible/JJ formation/NN of/IN protein/NN complexes/NNS by/IN means/NNS of/IN regulated/JJ protein/NN phosphorylation/NN ./.
P08855261A07
In/IN the/DT case/NN of/IN the/DT Jun-dependent/JJ transcription/NN ,/, this/DT effect/NN was/VBD not/RB due/JJ to/TO direct/JJ phosphorylation/NN of/IN c-Jun/NN by/IN activated/JJ CaM-KIV/NN ,/, since/IN transcription/NN was/VBD blocked/VBN by/IN a/DT dominant-negative/JJ JNK/NN and/CC by/IN two/CD MAP/NN kinase/NN phosphatases/NNS ./.
P08855340A07
In/IN addition/NN ,/, activators/NNS of/IN protein/NN kinase/NN A/NN ,/, including/VBG forskolin/NN and/CC 8-Br-cAMP/NN ,/, which/WDT are/VBP known/VBN to/TO inhibit/VB ERK-mediated/JJ events/NNS ,/, also/RB inhibited/VBD urea-inducible/JJ Egr-1/NN transcription/NN ./.
P08877106A02
We/PRP have/VBP compared/VBN the/DT regulation/NN and/CC ,/, indirectly/RB ,/, the/DT role/NN of/IN these/DT two/CD pathways/NNS in/IN hepatic/JJ development/NN during/IN late/JJ gestation/NN in/IN the/DT rat/NN ./.
P08910292A10
Taken/VBN together/RB ,/, these/DT findings/NNS strongly/RB suggest/VBP that/IN members/NNS of/IN the/DT novel/JJ MLK/NN family/NN of/IN highly/RB related/JJ kinases/NNS link/VBP small/JJ GTP-binding/JJ proteins/NNS to/TO the/DT JNK/NN signaling/JJ pathway/NN ./.
P08940179A05
The/DT putative/JJ catalytic/JJ domain/NN of/IN MAPKKK5/NN shows/VBZ significant/JJ sequence/NN homology/NN to/TO the/DT kinase/NN domains/NNS of/IN the/DT MAPKKK/NN //SYM MEKK/NN level/NN protein/NN kinases/NNS from/IN mouse/NN MEKK2/NN and/CC -3/CD ,/, Drosophila/NN melanogaster/NN PK92B/NN ,/, Saccharomyces/NN cerevisiae/NN STE11/NN ,/, and/CC Schizosaccharomyces/NN pombe/NN BYR2/NN ./.
P08943238A07
Co-treatment/NN with/IN a/DT tyrosine/NN phosphatase/NN inhibitor/NN (/( sodium/NN orthovanadate/NN )/) and/CC T-cell/NN activation/NN signals/NNS (/( phorbol/NN 12-myristate/NN 13-acetate/NN plus/CC ionomycin/NN )/) prolonged/VBD JNK/NN induction/NN ,/, followed/VBN by/IN T-cell/NN apoptosis/NN ./.
P08987738A06
PD98059/NN ,/, an/DT inhibitor/NN of/IN MEK/NN (/( MAP/NN kinase/NN kinase/NN )/) ,/, completely/RB abolished/VBD the/DT antiapoptotic/JJ effect/NN of/IN PACAP-38/NN ,/, suggesting/VBG that/IN MAP/NN kinase/NN pathway/NN activation/NN is/VBZ necessary/JJ for/IN PACAP-38/NN action/NN ./.
P08995450A06
Also/RB ,/, PTx/NN had/VBD no/DT effect/NN on/IN shear-dependent/JJ activation/NN of/IN JNK/NN ./.
P08999807A02
TGF-beta/NN exerts/VBZ its/PRP$ effects/NNS through/IN a/DT heteromeric/JJ complex/NN between/IN two/CD transmembrane/JJ serine/NN //SYM threonine/NN kinase/NN receptors/NNS ,/, the/DT type/NN I/CD and/CC type/NN II/CD receptors/NNS ./.
P08999940A07
Dominant-negative/JJ SAPK/NN or/CC ERK/NN kinase-1/NN was/VBD used/VBN to/TO demonstrate/VB that/IN JNK/NN //SYM SAPK/NN activation/NN is/VBZ necessary/JJ for/IN induction/NN of/IN DSE-/NN and/CC TRE-dependent/JJ transcription/NN by/IN IL-5/NN ,/, whereas/IN extracellular/JJ signal-regulated/JJ kinase/NN 2/CD was/VBD not/RB essential/JJ for/IN TRE-/NN and/CC DSE-dependent/JJ transcription/NN ./.
P09006914A05
TNFalpha/NN stimulation/NN of/IN endothelial/JJ cells/NNS induces/VBZ transient/JJ phosphorylation/NN of/IN both/CC ATF-2/NN and/CC c-JUN/NN and/CC induces/VBZ marked/JJ activation/NN of/IN the/DT c-JUN/NN N-terminal/JJ kinase/NN (/( JNK1/NN )/) and/CC p38/NN but/CC not/RB extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK1/NN )/) ./.
P09012803A08
These/DT data/NNS indicate/VBP that/IN in/IN addition/NN to/TO functioning/NN as/IN a/DT positive/JJ effector/NN of/IN growth/NN ,/, stimulation/NN of/IN the/DT MEK/NN //SYM MAPK/NN pathway/NN can/MD result/VBP in/IN an/DT inhibition/NN of/IN CDK/NN activity/NN and/CC cell/NN cycle/NN arrest/NN ./.
P09013447A09
This/DT study/NN suggests/VBZ a/DT potential/JJ mechanism/NN to/TO regulate/VB ERK/NN activity/NN through/IN feedback/NN inhibition/NN by/IN demonstrating/NN the/DT ERK/NN cascade/NN 's/POS induction/NN of/IN the/DT dual-specificity/NN PTPases/NNS CL100/NN ,/, PAC1/NN ,/, and/CC B23/NN ./.
P09015364A04
We/PRP demonstrate/VBP that/IN IL-1/NN activates/VBZ three/CD MAPKs/NNS ,/, ERK/NN ,/, JNK/NN and/CC p38/NN ,/, in/IN a/DT time/NN and/CC dose-dependent/JJ manner/NN ./.
P09020184A02
Like/IN other/JJ MAP/NN kinases/NNS ,/, JNKs/NNS are/VBP activated/VBN via/IN phosphorylation/NN on/IN adjacent/JJ threonine/NN and/CC tyrosine/NN residues/NNS and/CC can/MD be/VBP inactivated/VBN by/IN a/DT unique/JJ family/NN of/IN dual/JJ specificity/NN phosphatases/NNS ,/, called/VBN MAP/NN kinase/NN phosphatases/NNS (/( MKPs/NNS )/) ./.
P09024981A05
Jurkat/NN ,/, but/CC not/RB EL4/NN ,/, expresses/VBZ a/DT 120-kDa/NN protein/NN recognized/VBN by/IN an/DT anti-PLD/NN antibody/NN ./.
P09030549A09
Also/RB ,/, the/DT dominant/JJ negative/JJ forms/NNS of/IN Ras/NN ,/, MAPK/NN ,/, and/CC JNK/NN strongly/RB inhibited/VBD Galpha12/NN (/( R203C/NN )/) -induced/JJ stimulation/NN of/IN cyclin/NN A/NN promoter/NN activity/NN ./.
P09038212A01
Invasive/JJ and/CC metastatic/JJ cells/NNS require/VBP protease/NN expression/NN for/IN migration/NN through/IN the/DT extracellular/JJ matrix/NN ./.
P09044838A05
The/DT ERK2/NN isoform/NN was/VBD activated/VBN by/IN 6-fold/NN within/IN 10/CD min/NN of/IN TGF-beta3/NN addition/NN to/TO the/DT TGF-beta-sensitive/JJ BCC/NN line/NN Hs578T/NN ./.
P09045626A04
However/WRB ,/, a/DT kinase/NN other/JJ than/IN Raf/NN appears/VBZ responsible/JJ for/IN angII-mediated/JJ signal/NN transduction/NN because/IN we/PRP showed/VBD previously/RB that/IN treatment/NN with/IN 1/CD microM/NN phorbol/NN 12/CD ,/, 13-dibutyrate/NN (/( PDBU/NN )/) for/IN 24/CD h/NN completely/RB blocked/VBD Raf-Ras/NN association/NN in/IN VSMC/NN but/CC did/VBD not/RB inhibit/VBP activation/NN of/IN MEK/NN and/CC ERK1/NN //SYM 2/CD by/IN angII/NN ./.
P09048659A03
In/IN the/DT present/JJ study/NN ,/, we/PRP observed/VBD that/IN H2O2/NN in/IN concentrations/NNS that/WDT induced/VBD severe/JJ fragmentation/NN of/IN F-actin/NN in/IN fibroblasts/NNS rather/RB induced/VBD a/DT reorganization/NN of/IN F-actin/NN in/IN primary/JJ cultures/NNS of/IN human/NN umbilical/JJ vein/NN endothelial/JJ cells/NNS (/( HUVECs/NNS )/) that/WDT was/VBD characterized/VBN by/IN the/DT accumulation/NN of/IN stress/NN fibers/NNS ,/, the/DT recruitment/NN of/IN vinculin/NN to/TO focal/JJ adhesions/NNS ,/, and/CC the/DT loss/NN of/IN membrane/NN ruffles/NNS ,/, H2O2/NN also/RB induced/VBD in/IN these/DT cells/NNS a/DT strong/JJ (/( 10-/CD to/TO 14-fold/NN )/) activation/NN of/IN the/DT p38/NN mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN ,/, which/WDT resulted/VBD in/IN activation/NN of/IN MAP/NN kinase-activated/JJ protein/NN kinase-2/NN //SYM 3/CD and/CC phosphorylation/NN of/IN the/DT F-actin/NN polymerization/NN modulator/NN ,/, heat/NN shock/NN protein/NN 27/CD (/( HSP27/NN )/) ./.
P09067893A04
To/TO clarify/VB this/DT point/NN ,/, we/PRP examined/VBD whether/IN ET-1/NN could/MD activate/VBP JNK/NN and/CC the/DT mechanism/NN of/IN activation/NN in/IN cultured/JJ mesangial/JJ cells/NNS ./.
P09090707A05
CONCLUSIONS/NNS :/: These/DT studies/NNS show/VBP that/IN TAM/NN activates/VBZ the/DT signal/NN transduction/NN kinases/NNS ,/, JNK1/NN and/CC ERK2/NN ,/, which/WDT may/MD play/VBP important/JJ roles/NNS in/IN the/DT regulation/NN of/IN gene/NN expression/NN by/IN TAM/NN ./.
P09096313A06
Activation/NN of/IN p38/NN MAPK/NN and/CC the/DT resulting/JJ induction/NN of/IN apoptosis/NN may/MD be/VBP important/JJ in/IN the/DT demonstrated/JJ antineoplastic/JJ actions/NNS of/IN nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS ./.
P09096344A07
Therefore/RB ,/, regulation/NN of/IN neutrophil/NN migration/NN appears/VBZ to/TO be/VB largely/RB independent/JJ of/IN the/DT activation/NN of/IN the/DT mitogen-activated/JJ protein/NN kinases/NNS ./.
P09099744A10
These/DT data/NNS indicate/VBP that/IN IL-1beta/NN activates/VBZ ERK2/NN through/IN an/DT oxidation-dependent/JJ pathway/NN ./.
P09111071A06
Transient/JJ transfection/NN experiments/NNS confirmed/VBD that/IN lambdaPKC/NN acts/VBZ downstream/JJ of/IN Ras/NN but/CC upstream/JJ of/IN mitogen-activated/JJ protein/NN kinase/NN //SYM ERK/NN kinase/NN ./.
P09113418A08
Together/RB ,/, these/DT results/NNS suggest/VBP that/IN oxidants/NNS such/JJ as/IN hydrogen/NN peroxide/NN stimulate/VBP tyrosine/NN phosphorylation/NN of/IN receptor/NN tyrosine/NN kinases/NNS and/CC these/PRP ,/, in/IN turn/NN ,/, mediate/VBP the/DT down-stream/NN signalling/JJ events/NNS including/VBG the/DT recruitment/NN of/IN Grb2/NN by/IN the/DT receptor/NN ,/, activation/NN of/IN ERKs/NNS and/CC induction/NN of/IN c-fos/NN and/CC c-jun/NN expression/NN ./.
P09115275A01
The/DT death/NN domain/NN of/IN the/DT type/NN 1/CD tumor/NN necrosis/NN factor/NN receptor/NN (/( TNFR1/NN )/) mediates/VBZ interactions/NNS with/IN several/JJ proteins/NNS involved/VBN in/IN signaling/NN the/DT downstream/JJ effects/NNS of/IN TNF/NN ./.
P09120270A09
In/IN a/DT model/NN of/IN cartilage/NN breakdown/NN ,/, short-term/NN IL-1-stimulated/JJ proteoglycan/NN resorption/NN and/CC inhibition/NN of/IN proteoglycan/NN synthesis/NN were/VBD unaffected/VBN by/IN SB/NN 203580/CD ,/, while/IN longer/JJR term/NN collagen/NN breakdown/NN was/VBD prevented/VBN ./.
P09124279A03
We/PRP now/RB report/VBP stable/JJ reduction/NN of/IN extracellular/JJ signal-regulated/JJ kinase/NN 1/CD (/( ERK1/NN )/) protein/NN expression/NN and/CC lack/NN of/IN serum-induced/JJ ERK1/NN activation/NN in/IN alkali-dedifferentiated/JJ Madin-Darby/NN canine/JJ kidney-C7/NN focus/VBP (/( MDCK-C7F/NN )/) cells/NNS compared/VBN with/IN their/PRP$ parental/JJ epithelial/JJ MDCK-C7/NN cells/NNS ./.
P09127005A07
The/DT role/NN of/IN mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) pathway/NN on/IN TCC-inducible/JJ mitotic/JJ signaling/NN was/VBD evaluated/VBN by/IN assessing/NN DNA/NN synthesis/NN and/CC activator/NN protein/NN 1/CD (/( AP-1/NN )/) DNA-binding/JJ activity/NN ./.
P09144515A09
In/IN the/DT presence/NN of/IN the/DT MAP/NN kinase/NN kinase/NN (/( MEK/NN )/) inhibitor/NN ,/, PD/NN 098059/CD ,/, phagocytosis/NN was/VBD reduced/VBN by/IN approximately/RB 50/CD %/SYM ,/, while/IN ERK1/NN and/CC ERK2/NN activity/NN was/VBD reduced/VBN by/IN 85/CD to/TO 90/CD %/SYM ./.
P09144545A03
Mechanical/JJ wounding/NN of/IN IEC-6/NN cell/NN monolayers/NNS resulted/VBD in/IN rapid/JJ activation/NN of/IN the/DT extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) and/CC p38/NN MAP/NN kinase/NN pathways/NNS ,/, while/IN c-Jun/NN amino-terminal/JJ protein/NN kinases/NNS were/VBD not/RB significantly/RB activated/VBN ./.
P09148932A10
We/PRP cotransfected/VBD either/CC one/PRP of/IN these/DT mutants/NNS or/CC their/PRP$ empty/JJ vector/NN with/IN an/DT AR-ORE/NN luciferase/NN reporter/NN construct/NN and/CC compared/VBD the/DT hyperosmotically/RB induced/JJ increase/NN in/IN luciferase/NN activity/NN with/IN that/PRP in/IN cells/NNS lipofected/VBN with/IN only/RB the/DT AR-ORE/NN luciferase/NN construct/NN ./.
P09148940A06
These/DT results/NNS suggest/VBP a/DT novel/JJ role/NN for/IN Cdc42Hs/NNS in/IN cell/NN cycle/NN inhibition/NN ./.
P09148971A02
The/DT induction/NN of/IN immediate-early/JJ gene/NN expression/NN in/IN immortalized/JJ mouse/NN liver/NN cells/NNS by/IN the/DT PPs/NNS Wy-14/NN ,/, 643/CD ,/, monoethylhexyl/NN phthalate/NN ,/, ciprofibrate/NN ethyl/NN ester/NN ,/, and/CC clofibrate/NN suggested/VBD that/IN they/PRP may/MD be/VBP activating/VBG growth-regulatory/JJ signal/NN transduction/NN pathways/NNS ./.
P09153215A09
Because/IN hyperosmolarity/NN acutely/RB activates/VBZ the/DT NHE/NN ,/, we/PRP considered/VBD whether/IN the/DT resulting/JJ cytosolic/JJ alkalinization/NN mediates/VBZ the/DT activation/NN of/IN SAPK/NN upon/IN cell/NN shrinkage/NN ./.
P09155017A03
MNK1/NN ,/, but/CC not/RB Mnk2/NN ,/, also/RB binds/VBZ strongly/RB to/TO the/DT stress-activated/JJ kinase/NN ,/, p38/NN ./.
P09159118A04
Inhibiting/NN activation/NN of/IN ERK1/NN and/CC ERK2/NN with/IN the/DT MEK1/NN //SYM 2/CD inhibitor/NN PD98059/NN has/VBZ no/DT effect/NN on/IN insulin/NN secretion/NN ,/, indicating/VBG that/IN ERK/NN activity/NN is/VBZ not/RB necessary/JJ for/IN secretion/NN under/IN these/DT conditions/NNS ./.
P09169474A09
Thapsigargin/NN ,/, which/WDT only/RB minimally/RB induced/VBD c-Fos/NN ,/, produced/VBD a/DT much/RB greater/JJR and/CC more/RB prolonged/JJ c-Jun/NN response/NN than/IN Ang/NN II/CD ./.
P09169593A03
Nuclear/JJ localization/NN of/IN MAP/NN kinase/NN is/VBZ also/RB observed/VBN in/IN 3T3-F442A/NN adipocytes/NNS ,/, NIH-3T3/NN cells/NNS and/CC Fao/NN hepatoma/NN cells/NNS ,/, whereas/IN MEK/NN is/VBZ found/VBN in/IN the/DT nucleus/NN only/RB in/IN Fao/NN and/CC CHO/NN cells/NNS ./.
P09169613A08
The/DT activation/NN is/VBZ confirmed/VBN by/IN MAP/NN kinase/NN activity/NN with/IN similar/JJ kinetics/NNS to/TO the/DT tyrosine/NN phosphorylation/NN ./.
P09180263A02
IFNs/NNS induce/VBP a/DT signaling/JJ event/NN which/WDT involves/VBZ activation/NN of/IN Stat1/NN transcription/NN factor/NN ./.
P09212060A04
The/DT 63-/CD bp/NN MMP1/NN promoter/NN fragment/NN -123/CD to/TO -61/CD confers/VBZ this/DT FGF2/NN response/NN on/IN the/DT rous/NN sarcoma/NN virus/NN minimal/JJ promoter/NN ./.
P09212060A15
Thus/RB ,/, a/DT Ras-/NN and/CC MKP2-regulated/JJ MAPK/NN pathway/NN ,/, independent/JJ of/IN ERK1/NN //SYM ERK2/NN MAPK/NN activity/NN ,/, mediates/VBZ FGF2/NN transcriptional/JJ activation/NN of/IN MMP1/NN in/IN MC3T3-E1/NN osteoblasts/NNS ,/, converging/VBG upon/IN the/DT bipartite/JJ Ets-AP1/NN element/NN ./.
P09228012A05
The/DT glutamate/NN concentration/NN effective/JJ for/IN inducing/NN apoptosis/NN correlated/VBD with/IN that/PRP for/IN inducing/NN p38/NN activation/NN ./.
P09228071A06
To/TO understand/VB how/WRB PC/NN inhibits/VBZ BCP/NN and/CC CPPD-mediated/JJ cellular/JJ effects/NNS ,/, we/PRP have/VBP investigated/VBN the/DT mechanism/NN by/IN which/WDT BCP/NN and/CC CPPD/NN transduce/VBP signals/NNS to/TO the/DT nucleus/NN ./.
P09233830A07
In/IN contrast/NN ,/, TAYF/NN ERK2/NN was/VBD able/JJ to/TO block/VB EGF/NN and/CC insulin-induced/JJ 3TP-Lux-reporter/NN activity/NN ./.
P09242621A04
An/DT equivalent/JJ stimulation/NN is/VBZ seen/VBN in/IN PC12/NN cells/NNS expressing/VBG a/DT dominant/JJ negative/JJ Ras/NN mutant/NN ./.
P09271377A07
In/IN BAF3-mpl/NN cells/NNS ,/, TPO/NN triggered/VBD a/DT weak/JJ and/CC transient/JJ ERK/NN activation/NN ,/, similar/JJ to/TO that/PRP induced/VBN in/IN UT7-mpl/NN delta3/NN cells/NNS ./.
P09287359A11
These/DT results/NNS suggest/VBP that/IN the/DT intracellular/JJ redox/NN levels/NNS may/MD be/VBP directly/RB coupled/VBN to/TO tumor/NN growth/NN ,/, invasion/NN ,/, and/CC metastasis/NN via/IN Elk-1-dependent/JJ induction/NN of/IN c-Fos/NN controlled/JJ genes/NNS ./.
P09299362A04
Control/NN hearts/NNS experienced/VBD 30/CD min/NN of/IN ischemia/NN only/RB ./.
P09312114A03
To/TO investigate/VB the/DT molecular/JJ nature/NN underlying/VBG cellular/JJ responses/NNS to/TO Raf-1/NN activation/NN ,/, we/PRP have/VBP stably/RB transfected/VBN rat/NN salivary/JJ epithelial/JJ Pa-4/NN cells/NNS with/IN human/NN Raf-1-estrogen/NN receptor/NN fusion/NN gene/NN (/( DeltaRaf-1/NN :/: ER/NN )/) and/CC used/VBD mRNA/NN differential/JJ display/NN in/IN search/NN of/IN messages/NNS induced/VBN by/IN DeltaRaf-1/NN :/: ER/NN activation/NN ./.
P09312139A02
Purified/JJ Bcl-2/NN was/VBD found/VBN to/TO be/VB phosphorylated/VBN by/IN the/DT c-Jun/NN N-terminal/JJ kinase/NN //SYM stress-activated/JJ protein/NN kinase/NN (/( JNK/NN //SYM SAPK/NN )/) p54-SAPKbeta/NN ,/, and/CC this/PRP is/VBZ specific/JJ insofar/RB as/IN the/DT extracellular/JJ signal-regulated/JJ kinase/NN 1/CD (/( ERK1/NN )/) and/CC p38/NN //SYM RK/NN //SYM CSBP/NN (/( p38/NN )/) catalyzed/VBD only/RB weak/JJ modification/NN ./.
P09322526A07
Thus/RB ,/, TUDCA/NN signaling/NN towards/IN MAP/NN kinases/NNS is/VBZ different/JJ from/IN hypo-osmotic/JJ MAP-kinase/NN activation/NN ,/, which/WDT is/VBZ sensitive/JJ to/TO inhibitors/NNS of/IN tyrosine/NN kinases/NNS and/CC G-protein/NN function/NN ./.
P09322943A05
The/DT inactivation/NN of/IN Ras/NN ,/, Raf/NN ,/, and/CC MEK/NN directly/RB correlated/VBD with/IN the/DT serine/NN //SYM threonine/NN phosphorylation/NN of/IN SOS/NN and/CC dissociation/NN of/IN SOS/NN from/IN Grb2/NN but/CC not/RB Grb2/NN from/IN tyrosine-phosphorylated/JJ SHC/NN ./.
P09334169A05
NIK/NN was/VBD found/VBN to/TO be/VB unable/JJ to/TO activate/VB JNK/NN //SYM SAPK/NN ,/, mitogen-activated/JJ protein/NN kinase/NN ,/, or/CC p38/NN kinase/NN ./.
P09337851A06
Interestingly/RB ,/, addition/NN of/IN PD98059/NN or/CC dnERK-/NN ,/, but/CC not/RB dnJNK-/NN ,/, resulted/VBD in/IN a/DT dramatic/JJ decrease/NN in/IN cyclin/NN D1/NN protein/NN and/CC mRNA/NN levels/NNS ,/, concomitant/JJ with/IN a/DT decrease/NN in/IN cyclin/NN D1-cyclin-dependent/JJ kinase/NN activity/NN ./.
P09351829A07
JNK-mediated/JJ transcriptional/JJ activation/NN of/IN AP-1/NN is/VBZ the/DT direct/JJ output/NN of/IN LMP-1-triggered/JJ signaling/NN ,/, as/IN shown/VBN by/IN an/DT inducible/JJ LMP-1/NN mutant/NN ./.
P09352861A06
RESULTS/NNS :/: There/EX was/VBD little/DT or/CC no/DT difference/NN in/IN JNK/NN and/CC ERK/NN activity/NN in/IN hyperproliferative/JJ mucosa/NN from/IN DMH-treated/JJ animals/NNS compared/VBN with/IN normal/JJ mucosa/NN from/IN control/NN animals/NNS ./.
P09362525A02
Ligation/NN of/IN this/DT receptor/NN leads/VBZ to/TO prominent/JJ downregulation/NN of/IN T/NN cell/NN proliferation/NN ,/, mainly/RB as/IN a/DT consequence/NN of/IN interference/NN with/IN IL-2/NN production/NN ./.
P09367856A02
This/PRP was/VBD followed/VBN by/IN the/DT sequential/JJ activation/NN of/IN mitogen-activated/JJ protein/NN kinase/NN kinase/NN kinase/NN (/( MAPKKK/NN )/) activity/NN of/IN Raf-1/NN ,/, MAP/NN kinase/NN kinase/NN (/( MAPKK/NN )/) ,/, MAPKs/NNS (/( p44mapk/NN and/CC p42mapk/NN ,/, also/RB called/VBN extracellular/JJ signal-regulated/JJ protein/NN kinase/NN [/( ERK/NN ]/) 1/CD and/CC ERK2/NN ,/, respectively/RB )/) ,/, and/CC S6/NN kinase/NN (/( p90rsk/NN )/) ./.
P09370349A02
A/DT comparable/JJ TNF-alpha-mediated/JJ inhibition/NN of/IN p42/NN //SYM 44/CD mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN activity/NN was/VBD observed/VBN in/IN 10/CD nM/NN EGF-stimulated/JJ cells/NNS ./.
P09372971A01
At/IN least/JJS three/CD mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) cascades/NNS were/VBD identified/VBN in/IN mammals/NNS ,/, each/PRP consisting/VBG of/IN a/DT well-defined/JJ three-kinase/NN module/NN composed/VBN of/IN a/DT MAPK/NN ,/, a/DT MAPK/NN kinase/NN (/( MAPKK/NN )/) ,/, and/CC a/DT MAPKK/NN kinase/NN (/( MAPKKK/NN )/) ./.
P09374731A01
Stimulation/NN of/IN cell/NN signaling/JJ cascades/NNS by/IN oxidants/NNS may/MD be/VBP important/JJ in/IN the/DT pathogenesis/NN of/IN pulmonary/JJ and/CC pleural/JJ diseases/NNS ./.
P09384583A04
MKK7/NN is/VBZ most/RBS similar/JJ to/TO the/DT mediator/NN of/IN morphogenesis/NN ,/, hemipterous/NN (/( hep/NN )/) ,/, in/IN Drosophila/NN ./.
P09388198A02
To/TO investigate/VB the/DT regulation/NN of/IN this/DT cellular/JJ response/NN ,/, we/PRP isolated/VBD the/DT gene/NN for/IN rhoB/NN from/IN a/DT mouse/NN genomic/JJ library/NN ./.
P09389491A04
Insulin-stimulated/JJ phosphorylation/NN of/IN the/DT alpha-subunit/NN of/IN FTase/NN in/IN 3T3-L1/NN fibroblasts/NNS and/CC adipocytes/NNS was/VBD blocked/VBN by/IN the/DT mitogen-activated/JJ protein/NN //SYM extracellular-signal/NN regulated/JJ kinase-kinase/NN inhibitor/NN ,/, PD98059/NN ,/, but/CC not/RB by/IN wortmannin/NN or/CC bisindolylmaleimide/NN ./.
P09390997A03
In/IN the/DT present/JJ investigation/NN ,/, we/PRP provide/VBP evidence/NN that/IN MEK/NN is/VBZ critically/RB involved/VBN in/IN regulating/NN APP/NN processing/NN by/IN both/CC nerve/NN growth/NN factor/NN and/CC phorbol/NN esters/NNS ./.
P09392422A08
The/DT specific/JJ MAPK/NN pathway/NN inhibitor/NN PD98059/NN blocked/VBD TPA-induced/JJ ERK/NN activation/NN ./.
P09397988A03
Point/NN mutations/NNS of/IN p21ras/NN have/VBP been/VBN identified/VBN in/IN various/JJ tumor/NN types/NNS and/CC lead/VBP to/TO constitutive/JJ activation/NN of/IN this/DT protein/NN and/CC subsequent/JJ activation/NN of/IN downstream/JJ pathways/NNS including/VBG the/DT MAPK/NN cascade/NN ./.
P09401960A04
In/IN 3T3-L1/NN adipocytes/NNS and/CC Clone/NN 9/CD cells/NNS ,/, stimulation/NN of/IN sugar/NN transport/NN by/IN puromycin/NN ,/, a/DT translational/JJ inhibitor/NN that/WDT does/VBZ not/RB activate/VBP kinases/NNS ,/, was/VBD not/RB detectable/JJ until/IN 90/CD min/NN after/IN exposure/NN ./.
P09405407A05
A/DT TRAF2/NN mutant/NN ,/, which/WDT inhibits/VBZ both/CC TRAF2-induced/JJ NF-kappaB/NN and/CC SAPK/NN activation/NN ,/, blocked/VBD TNF-induced/JJ GCKR/NN activation/NN ./.
P09407138A08
Stably/RB transfected/JJ clones/NNS of/IN A549/NN cells/NNS expressing/VBG c-JUN/NN (/( S63A/NN ,/, S73A/NN )/) ,/, a/DT transdominant/JJ inhibitor/NN of/IN c-JUN/NN ,/, completely/RB blocked/VBD the/DT EGF-stimulated/JJ proliferation/NN effect/NN but/CC did/VBD not/RB alter/VBP the/DT basal/JJ proliferation/NN rate/NN ./.
P09412490A02
We/PRP identified/VBD a/DT molecule/NN ,/, CEP-1347/NN (/( KT7515/NN )/) ,/, that/WDT rescues/VBZ motoneurons/NNS undergoing/VBG apoptosis/NN and/CC investigated/VBD its/PRP$ effect/NN on/IN ERK1/NN and/CC JNK1/NN activity/NN ./.
P09415703A08
These/DT findings/NNS demonstrate/VBP that/IN reciprocal/JJ alterations/NNS in/IN the/DT SAPK/NN and/CC MAPK/NN cascades/NNS are/VBP associated/VBN with/IN the/DT apoptotic/JJ influence/NN of/IN either/DT lipid/NN inasmuch/RB as/IN (/( i/CD )/) ceramide-mediated/JJ lethality/NN is/VBZ primarily/RB associated/VBN with/IN strong/JJ stimulation/NN of/IN SAPK/NN and/CC weak/JJ inhibition/NN of/IN MAPK/NN ,/, whereas/IN (/( ii/CD )/) sphingosine-mediated/JJ lethality/NN is/VBZ primarily/RB associated/VBN with/IN weak/JJ stimulation/NN of/IN SAPK/NN and/CC strong/JJ inhibition/NN of/IN MAPK/NN ./.
P09417090A05
However/WRB ,/, unlike/IN mammalian/JJ p38/NN MAPK/NN ,/, the/DT addition/NN of/IN lipopolysaccharide/NN (/( LPS/NN )/) did/VBD not/RB significantly/RB affect/VBP the/DT phosphorylation/NN of/IN Dp38/NN in/IN the/DT LPS-responsive/JJ l/NN (/( 2/CD )/) mbn/NN cell/NN line/NN ./.
P09418855A09
In/IN addition/NN ,/, these/DT results/NNS implicate/VBP the/DT p38/NN MAPK/NN as/IN a/DT possible/JJ negative/JJ regulator/NN of/IN TNF/NN signaling/NN that/WDT leads/VBZ to/TO NF-kappaB/NN activation/NN ./.
P09427749A08
MLK2/NN and/CC MLK3/NN interact/VBP with/IN members/NNS of/IN the/DT KIF3/NN family/NN of/IN kinesin/NN superfamily/NN motor/NN proteins/NNS and/CC with/IN KAP3A/NN ,/, the/DT putative/JJ targeting/JJ component/NN of/IN KIF3/NN motor/NN complexes/NNS ,/, suggesting/VBG a/DT potential/JJ link/NN between/IN stress/NN activation/NN and/CC motor/NN protein/NN function/NN ./.
P09430688A03
Here/RB we/PRP identify/VBP six/CD sites/NNS in/IN MAPKAP-K1a/NN that/WDT become/VBP phosphorylated/VBN in/IN transfected/JJ COS-1/NN cells/NNS ./.
P09430728A01
Inactivation/NN of/IN growth/NN factor-regulated/JJ mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinases/NNS (/( ERK1/NN and/CC ERK2/NN )/) has/VBZ been/VBN proposed/VBN to/TO occur/VB in/IN part/NN through/IN dephosphorylation/NN by/IN the/DT dual/JJ specificity/NN MAP/NN kinase/NN phosphatase-1/NN (/( MKP-1/NN )/) ,/, an/DT immediate/JJ early/JJ gene/NN that/WDT is/VBZ induced/VBN by/IN mitogenic/JJ signaling/NN ./.
P09442025A02
We/PRP have/VBP examined/VBN communications/NNS between/IN these/DT stress-/NN and/CC mitogen-induced/JJ signaling/JJ pathways/NNS ./.
P09443400A05
Paclitaxel/NN caused/VBD a/DT rapid/JJ and/CC transient/JJ increase/NN in/IN c-Jun/NN NH2-terminal/JJ kinase/NN (/( JNK/NN )/) activity/NN ,/, a/DT proposed/JJ mediator/NN of/IN stress/NN activation/NN pathways/NNS ./.
P09450967A04
In/IN these/DT interphase-arrested/JJ extracts/NNS ,/, H1/NN kinase/NN activity/NN remained/VBD low/JJ ,/, Cdc2/NN was/VBD tyrosine/NN phosphorylated/VBN ,/, and/CC nuclei/NNS continued/VBD to/TO enlarge/VB ./.
P09452444A07
Furthermore/RB ,/, we/PRP clearly/RB show/VBP that/IN ,/, using/VBG a/DT nuclear/JJ Gal4/NN "/`` one-hybrid/NN "/'' system/NN ,/, the/DT MAPK/NN inhibitors/NNS SB203580/NN and/CC PD0980589/NN have/VBP a/DT direct/JJ repressive/JJ effect/NN on/IN the/DT transactivation/NN potential/NN of/IN the/DT p65/NN kappaB/NN subunit/NN ./.
P09452460A05
Although/IN other/JJ SAPK/NN congeners/NNS might/MD be/VBP activated/VBN upon/IN microtubule/NN depolymerization/NN ,/, the/DT activation/NN of/IN ERK1/NN and/CC ERK2/NN is/VBZ mandatory/JJ for/IN IL-1/NN production/NN as/IN shown/VBN by/IN the/DT blocking/JJ effect/NN of/IN PD/NN 98059/CD ,/, a/DT specific/JJ MEK1/NN //SYM 2/CD inhibitor/NN ./.
P09452512A07
After/IN 15/CD min/NN ,/, livers/NNS were/VBD removed/VBN and/CC prepared/VBN for/IN kinase/NN analyses/NNS ./.
P09459490A01
Vasoconstrictors/NNS ,/, such/JJ as/IN angiotensin/NN II/CD (/( Ang/NN II/CD )/) ,/, are/VBP involved/VBN in/IN the/DT regulatory/JJ mechanisms/NNS of/IN post/RB myocardial/JJ infarction/NN (/( MI/NN )/) hypertrophy/NN ./.
P09467952A05
Inhibition/NN of/IN the/DT Erk2/NN pathway/NN by/IN PD98059/NN ,/, specific/JJ for/IN the/DT upstream/JJ MAP/NN kinase/NN kinase/NN (/( MEK1/NN )/) ,/, abolishes/VBZ TPA-stimulated/JJ junB/NN but/CC not/RB insulin-induced/JJ c-jun/NN ./.
P09469462A03
Protein/NN phosphorylation/NN analysis/NN of/IN cellular/JJ MAP/NN kinases/NNS indicates/VBZ that/IN exposure/NN of/IN human/NN neutrophils/NNS to/TO chemotactic/JJ factor/NN FMLP/NN as/RB well/RB as/IN granulocyte-macrophage/NN CSF/NN ,/, PMA/NN ,/, or/CC ionomycin/NN rapidly/RB induced/VBD the/DT activation/NN of/IN p38/NN and/CC p44/NN //SYM 42/CD MAP/NN kinases/NNS ,/, but/CC stimulation/NN with/IN inflammatory/JJ cytokine/NN TNF-alpha/NN triggered/VBD the/DT activation/NN of/IN p38/NN MAP/NN kinase/NN only/RB ./.
P09482215A08
Both/CC ,/, LPS-/NN and/CC PCW-induced/JJ responses/NNS of/IN astrocytic/JJ cells/NNS required/VBD the/DT presence/NN of/IN soluble/JJ CD14/NN (/( sCD14/NN )/) present/VBP in/IN serum/NN ./.
P09501207A01
UV/NN irradiation/NN induces/VBZ apoptosis/NN in/IN U937/NN human/NN leukemic/JJ cells/NNS that/WDT is/VBZ accompanied/VBN by/IN the/DT activation/NN of/IN both/CC the/DT stress-activated/JJ protein/NN kinase/NN (/( SAPK/NN )/) and/CC p38/NN mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) signal/NN transduction/NN pathways/NNS ./.
P09507015A04
Therefore/RB ,/, in/IN the/DT present/JJ study/NN ,/, we/PRP examined/VBD the/DT consequences/NNS of/IN this/DT restriction/NN on/IN IL-1-mediated/JJ activation/NN of/IN the/DT MAP/NN kinase/NN family/NN and/CC on/IN c-fos/NN expression/NN ./.
P09513050A05
IL-1/NN beta/NN preferentially/RB activated/VBD JNK/NN pathway/NN in/IN a/DT dose-/NN and/CC time-dependent/JJ manner/NN and/CC had/VBD little/DT effect/NN on/IN ERK/NN pathway/NN ./.
P09513899A01
The/DT in/FW vivo/FW signal/NN transduction/NN pathway/NN ,/, responsible/JJ for/IN hypertension-induced/JJ glomerular/JJ injury/NN ,/, remains/VBZ to/TO be/VB clarified/VBN ./.
P09515796A07
These/DT findings/NNS suggest/VBP that/IN activation/NN of/IN p38/NN may/MD contribute/VBP to/TO a/DT more/RB invasive/JJ phenotype/NN in/FW vitro/FW ,/, possibly/RB via/IN the/DT expression/NN of/IN MMP-9/NN ,/, and/CC that/IN targeting/NN of/IN p38/NN using/VBG SB/NN 203580/CD may/MD provide/VBP a/DT novel/JJ means/NNS of/IN controlling/NN invasion/NN of/IN cancers/NNS in/IN which/WDT this/DT MAPK/NN is/VBZ activated/VBN ./.
P09516390A05
Another/DT MAPK/NN ,/, c-Jun-N-terminal/JJ protein/NN kinase/NN (/( JNK/NN )/) ,/, was/VBD also/RB activated/VBN after/IN wounding/NN ./.
P09516391A06
Tyrphostin/NN A46/NN treatment/NN significantly/RB inhibited/VBD ulcer/NN healing/NN and/CC reduced/VBD EGF-R/NN levels/NNS ,/, EGF-R/NN phosphorylation/NN ,/, and/CC ERK1/NN and/CC ERK2/NN activity/NN ./.
P09518544A09
Thus/RB ,/, growth/NN factor/NN stimulation/NN ,/, PKC/NN activation/NN and/CC protein/NN phosphatase/NN inhibition/NN induced/VBD the/DT expression/NN of/IN PGHS-2/NN in/IN primary/JJ amnion/NN cells/NNS by/IN distinct/JJ regulatory/JJ mechanisms/NNS involving/VBG tyrosine/NN kinase/NN (/( s/NNS )/) ./.
P09518660A08
When/WRB PC12D/NN cells/NNS were/VBD transfected/VBN with/IN the/DT dominant/JJ inhibitory/JJ Ha-ras/NN Asn-17/NN gene/NN ,/, the/DT induction/NN of/IN the/DT mutant/JJ Ras/NN protein/NN led/VBD the/DT suppression/NN of/IN the/DT rapid/JJ outgrowth/NN of/IN neurites/NNS in/IN response/NN to/TO NGF/NN but/CC not/RB to/TO dibutyryl/NN cyclic/JJ AMP/NN (/( dbcAMP/NN )/) ./.
P09528766A03
NGF/NN activates/VBZ the/DT extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) ,/, which/WDT in/IN turn/NN activate/VBP the/DT pp90/NN ribosomal/JJ S6/NN kinase/NN (/( RSK/NN )/) family/NN of/IN Ser/NN //SYM Thr/NN kinases/NNS ,/, all/DT three/CD members/NNS of/IN which/WDT were/VBD found/VBN to/TO catalyze/VB CREB/NN Ser-133/NN phosphorylation/NN in/FW vitro/FW and/CC in/FW vivo/FW ./.
P09533945A03
In/IN this/DT study/NN ,/, we/PRP further/RB examined/VBD the/DT signaling/JJ intermediates/NNS responsible/JJ for/IN ERK/NN activation/NN by/IN H2O2/NN in/IN airway/NN smooth/JJ muscle/NN ,/, focusing/VBG on/IN MAP/NN kinase/NN //SYM ERK/NN kinase/NN (/( MEK/NN )/) ,/, a/DT dual-function/NN kinase/NN which/WDT is/VBZ required/VBN and/CC sufficient/JJ for/IN ERK/NN activation/NN in/IN bovine/JJ tracheal/JJ myocytes/NNS ;/: Raf-1/NN ,/, a/DT serine/NN //SYM threonine/NN kinase/NN known/VBN to/TO activate/VB MEK/NN ;/: and/CC PKC/NN ./.
P09535875A07
Involvement/NN of/IN an/DT AP-1/NN site/NN in/IN arsenite/NN induction/NN of/IN heme/NN oxygenase-1/NN gene/NN expression/NN was/VBD studied/VBN ./.
P09535927A05
Consistent/JJ with/IN a/DT role/NN for/IN N-terminal/JJ binding/NN in/IN determining/NN MKP-3/NN specificity/NN ,/, at/IN least/JJS 10-fold/NN higher/JJR concentrations/NNS of/IN purified/JJ MKP-3DeltaN/NN than/IN full-length/NN MKP-3/NN is/VBZ required/VBN to/TO inhibit/VB ERK2/NN activity/NN ./.
P09545341A02
To/TO establish/VB the/DT role/NN of/IN the/DT MAP/NN kinases/NNS in/IN melanogenesis/NN ,/, we/PRP studied/VBD the/DT effects/NNS of/IN a/DT specific/JJ MAP/NN kinase/NN kinase/NN (/( MEK/NN )/) inhibitor/NN PD/NN 98059/CD on/IN different/JJ melanogenic/JJ parameters/NNS ./.
P09546380A07
In/IN contrast/NN ,/, PD98059/NN did/VBD not/RB block/VBP the/DT intimal/JJ cell/NN replication/NN at/IN day/NN 8/CD ./.
P09547255A04
A/DT one-trial/NN in/FW vitro/FW conditioning/JJ procedure/NN consisting/VBG of/IN light/NN (/( CS/NN )/) paired/VBN with/IN the/DT application/NN of/IN 5-HT/NN results/VBZ in/IN the/DT increased/JJ incorporation/NN of/IN 32PO4/NN into/IN proteins/NNS detected/VBN with/IN two-dimensional/JJ gel/NN electrophoresis/NN ./.
P09548470A04
Cross-linking/NN of/IN Fas/NN on/IN T/NN cells/NNS also/RB induced/VBD rapid/JJ activation/NN of/IN p38/NN MAPK/NN and/CC MAPKAP/NN kinase-2/NN ./.
P09566877A06
FN-stimulated/JJ FAK/NN PTK/NN activity/NN was/VBD not/RB significantly/RB affected/VBN by/IN herbimycin/NN A/NN treatment/NN and/CC ,/, under/IN these/DT conditions/NNS ,/, FAK/NN autophosphorylation/NN promoted/VBD Shc/NN binding/NN to/TO FAK/NN ./.
P09570551A04
Treatment/NN of/IN murine/JJ macrophages/NNS with/IN LAMPf/NN resulted/VBD in/IN significant/JJ activation/NN of/IN MAPK/NN family/NN members/NNS extracellular/JJ signal-regulated/JJ kinase/NN 1/CD and/CC 2/CD (/( ERK1/NN //SYM 2/CD )/) ,/, c-Jun/NN NH2-terminal/JJ kinase/NN (/( JNK/NN )/) ,/, and/CC p38/NN ./.
P09570562A09
SB/NN 203580/CD also/RB significantly/RB reduced/VBD the/DT development/NN of/IN the/DT response/NN to/TO des-Arg9-BK/NN as/IN stimulated/VBN by/IN IL-1/NN or/CC EGF/NN ./.
P09579682A02
The/DT patterns/NNS of/IN MAPK/NN activation/NN following/VBG LPS/NN and/CC Abeta/NN treatment/NN were/VBD very/RB similar/JJ ./.
P09593727A08
Dominant-negative/JJ mutants/NNS of/IN Ras/NN (/( but/CC not/RB Rac/NN or/CC Cdc42/NN )/) specifically/RB inhibited/VBD ERK/NN activation/NN by/IN v-Fps/NN and/CC Myr-Fes/NN ,/, demonstrating/VBG that/IN ERK/NN activation/NN occurs/VBZ exclusively/RB downstream/JJ of/IN Ras/NN ./.
P09596579A04
Neither/CC the/DT gain-of-function/NN Sevenmaker/NN ERK2/NN mutant/JJ D319N/NN nor/CC c-Jun/NN amino-terminal/JJ kinase-stress-activated/JJ protein/NN kinase/NN (/( JNK/NN //SYM SAPK/NN )/) or/CC p38/NN MAP/NN kinases/NNS bound/VBD MKP-3/NN or/CC caused/VBD its/PRP$ catalytic/JJ activation/NN ./.
P09596671A04
Our/PRP$ results/NNS demonstrate/VBP that/IN p56Lck/NN and/CC CD45/NN exert/VBP a/DT negative/JJ control/NN on/IN thrombin-induced/JJ p38/NN MAPK/NN activation/NN and/CC [/( Ca2+/NN ]/) i/NN release/NN in/IN Jurkat/NN cells/NNS ./.
P09598985A02
Here/RB ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN SB203580/NN on/IN cardiac/JJ SAPKs/NNS //SYM JNKs/NNS ./.
P09601075A09
These/DT data/NNS indicate/VBP that/IN Gq/NN //SYM 11PCR/NN agonists/NNS activate/VBP multiple/JJ MAPK/NN signalling/JJ pathways/NNS in/IN the/DT heart/NN ,/, all/PRP of/IN which/WDT may/MD contribute/VBP to/TO the/DT overall/JJ response/NN (/( e.g./IN the/DT development/NN of/IN the/DT hypertrophic/JJ phenotype/NN )/) ./.
P09605580A08
6./CD In/IN contrast/NN ,/, the/DT protein/NN tyrosine/NN kinase/NN inhibitor/NN tyrphostin/NN B42/NN (/( a/DT specific/JJ inhibitor/NN of/IN interferon-gamma-activated/JJ janus/NN kinase/NN 2/CD )/) and/CC the/DT protein/NN tyrosine/NN kinase/NN inhibitor/NN tyrphostin/NN A25/NN both/PRP reduced/VBD CM-induced/JJ NOS/NN II/NN mRNA/NN expression/NN in/IN a/DT concentration-dependent/JJ manner/NN ./.
P09614146A04
By/IN Western/NN blotting/NN with/IN phosphospecific/JJ antibodies/NNS and/CC by/IN immunocomplex/NN kinase/NN assay/NN ,/, IL-1beta/NN was/VBD shown/VBN to/TO activate/VB extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) 1/CD //SYM 2/CD and/CC p38/NN mitogen-activated/JJ protein/NN kinase/NN (/( p38/NN )/) in/IN islets/NNS and/CC rat/NN insulinoma/NN cells/NNS ./.
P09626657A04
GnRH/NN as/RB well/RB as/IN tumor-promoting/JJ agent/NN (/( TPA/NN )/) also/RB increased/VBD c-Src/NN activity/NN ,/, which/WDT peaked/VBD at/IN 2/CD min/NN after/IN GnRH/NN stimulation/NN and/CC was/VBD sensitive/JJ both/CC to/TO PKC/NN and/CC to/TO tyrosine/NN kinase/NN inhibitors/NNS ./.
P09645711A06
FSH-induced/JJ GC/NN rounding/NN //SYM aggregation/NN was/VBD blocked/VBN by/IN pretreatment/NN with/IN SB/NN 203580/CD indicating/VBG that/IN p38/NN MAPK/NN activation/NN is/VBZ necessary/JJ for/IN FSH-induced/JJ GC/NN cell/NN shape/NN change/NN ./.
P09658404A07
Since/IN it/PRP is/VBZ not/RB known/VBN whether/IN the/DT CGRP/NN enhancer/NN factors/NNS are/VBP immediate/JJ targets/NNS of/IN MAP/NN kinases/NNS ,/, we/PRP then/RB used/VBD EIk-1-/CD and/CC c-Jun-dependent/JJ reporter/NN genes/NNS that/WDT are/VBP directly/RB activated/VBN by/IN the/DT ERK/NN (/( extracellular/JJ signal-regulated/JJ kinases/NNS )/) and/CC JNK/NN (/( c-Jun/NN N-terminal/JJ kinase/NN )/) MAP/NN kinases/NNS ./.
P09661668A01
The/DT c-Jun/NN N-terminal/JJ kinases/NNS (/( JNKs/NNS )/) ,/, also/RB called/VBN stress-activated/JJ protein/NN kinases/NNS (/( SAPKs/NNS )/) ,/, belong/VBP to/TO the/DT mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) gene/NN super-family/NN ./.
P09671463A09
In/IN contrast/NN ,/, neither/CC dominant/JJ negative/JJ MKK6/NN (/( or/CC SB203580/NN )/) nor/CC PD98059/NN ,/, which/WDT specifically/RB inhibit/VBP p38/NN and/CC ERK/NN MAP/NN kinase/NN pathways/NNS ,/, respectively/RB ,/, could/MD abrogate/VBP the/DT UV-induced/JJ effect/NN ./.
P09683913A08
AP-1/NN DNA/NN and/CC NF-kB/NN binding/JJ activities/NNS increased/VBD 8.7-fold/NN and/CC 7.1-fold/NN (/( P/NN </SYM 0.01/CD )/) ,/, respectively/RB ,/, at/IN 3/CD days/NNS but/CC returned/VBN to/TO normal/JJ levels/NNS by/IN 7/CD days/NNS after/IN ligation/NN ./.
P09685422A02
In/IN this/DT report/NN the/DT mechanism/NN of/IN p38-activated/JJ transcription/NN was/VBD studied/VBN in/IN cardiac/JJ myocytes/NNS where/WRB this/DT MAPK/NN is/VBZ a/DT key/JJ regulator/NN of/IN the/DT cell/NN growth/NN and/CC the/DT cardiac-specific/JJ gene/NN induction/NN that/WDT occurs/VBZ in/IN response/NN to/TO potentially/RB stressful/JJ stimuli/NNS ./.
P09686756A01
Myocardial/JJ infarction/NN results/VBZ in/IN focal/JJ areas/NNS of/IN ischemia/NN ,/, hypoxia/NN ,/, necrosis/NN ,/, and/CC decreased/JJ contractile/JJ function/NN ./.
P09690379A01
Extracellular/JJ signal-related/JJ kinase/NN (/( ERK/NN )/) and/CC c-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinases/NNS are/VBP highly/RB activated/VBN in/IN an/DT in/FW vivo/FW rat/NN model/NN of/IN colorectal/JJ carcinogenesis/NN ./.
P09694839A10
We/PRP conclude/VBP that/IN the/DT carboxyl-terminal/JJ tail/NN of/IN FPRs/NNS is/VBZ necessary/JJ for/IN ligand-mediated/JJ activation/NN of/IN Gi/NN proteins/NNS and/CC MAPK/NN cascades/NNS ./.
P09698157A08
CNQX/NN had/VBD no/DT effect/NN on/IN PAF/NN activation/NN of/IN the/DT kinases/NNS ,/, indicating/VBG that/IN PAF/NN is/VBZ downstream/JJ of/IN kainate/NN activation/NN ./.
P09698606A01
Hydrogen/NN peroxide/NN (/( H2O2/NN )/) has/VBZ emerged/VBN as/IN an/DT important/JJ intracellular/JJ signaling/JJ molecule/NN and/CC has/VBZ been/VBN shown/VBN to/TO stimulate/VB the/DT growth/NN of/IN vascular/JJ smooth/JJ muscle/NN cells/NNS ./.
P09705357A05
Selective/JJ inhibition/NN of/IN COX-2/NN activity/NN suppressed/VBD the/DT production/NN of/IN prostaglandin/NN E2/NN by/IN >/SYM 90/CD %/SYM but/CC did/VBD not/RB alter/VBP the/DT progress/NN of/IN the/DT morphological/JJ transformation/NN ./.
P09706165A03
We/PRP hypothesized/VBD that/IN p38/NN MAPK/NN activity/NN is/VBZ integral/JJ to/TO ICAM-1/NN up-regulation/NN on/IN pulmonary/JJ endothelium/NN ./.
P09712025A09
N-acetyl-L-cysteine/NN pretreatment/NN ,/, which/WDT blocks/VBZ CD40-mediated/JJ JNK/NN activation/NN ,/, does/VBZ not/RB affect/VBP the/DT ability/NN of/IN CD40/NN to/TO inhibit/VB anti-IgM-mediated/JJ ERK2/NN activation/NN and/CC apoptosis/NN ./.
P09714186A12
We/PRP conclude/VBP that/IN phosphorylation/NN of/IN the/DT CD44/NN receptor/NN results/VBZ in/IN an/DT increase/NN in/IN tyrosine/NN phosphorylation/NN ,/, leading/VBG to/TO the/DT activation/NN of/IN a/DT cytoplasmic/JJ cascade/NN and/CC cell/NN proliferation/NN ;/: this/PRP concurs/VBZ with/IN previous/JJ work/NN ,/, which/WDT showed/VBD that/IN o-HA-induced/JJ proliferation/NN of/IN endothelial/JJ cells/NNS is/VBZ CD44-receptor-mediated/JJ and/CC accompanied/VBN by/IN early/JJ response/NN gene/NN activation/NN ./.
P09715266A04
Involvement/NN of/IN a/DT specific/JJ MAPK/NN ,/, ERK/NN ,/, in/IN LPS-stimulated/JJ TxB2/NN production/NN was/VBD further/RB tested/VBN using/VBG a/DT specific/JJ MAPK/NN cascade/NN inhibitor/NN ,/, PD98059/NN (/( PD/NN )/) ./.
P09716183A04
The/DT following/JJ results/NNS demonstrate/VBP that/IN TBP/NN phosphorylation/NN occurs/VBZ as/IN a/DT result/NN of/IN activation/NN of/IN an/DT extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) protein/NN kinase/NN :/: (/( a/NN )/) overexpression/NN of/IN mitogen-activated/JJ protein/NN kinase/NN phosphatase-1/NN blocks/VBZ phorbol/NN 12-myristate/NN 13-acetate/NN (/( PMA/NN )/) -induced/JJ phosphorylation/NN of/IN TBP/NN both/CC in/FW vitro/FW and/CC in/FW vivo/FW ;/: (/( b/NN )/) pretreatment/NN with/IN the/DT ERK/NN kinase/NN kinase/NN inhibitor/NN PD098059/NN also/RB blocks/VBZ PMA-induced/JJ phosphorylation/NN of/IN TBP/NN both/CC in/FW vitro/FW and/CC in/FW vivo/FW ;/: and/CC (/( c/NN )/) phosphorylation/NN of/IN TBP/NN is/VBZ observed/VBN when/WRB serum-starved/JJ NIH/NN 3T3/NN cells/NNS are/VBP stimulated/VBN with/IN fresh/JJ serum/NN ,/, another/DT activator/NN of/IN the/DT ERK/NN pathway/NN ./.
P09720795A12
However/WRB ,/, the/DT reduction/NN of/IN c-fos/NN and/CC c-myc/NN mRNA/NN levels/NNS by/IN 10/CD (/( -5/CD )/) M/NN EGC/NN did/VBD not/RB achieve/VBP significance/NN ./.
P09721723A09
Furthermore/RB ,/, stimulation/NN of/IN D2/NN receptors/NNS promoted/VBD [/( 3H/NN ]/) thymidine/NN incorporation/NN with/IN a/DT pattern/NN similar/JJ to/TO that/PRP for/IN kinase/NN activation/NN ./.
P09722508A06
Furthermore/RB ,/, we/PRP demonstrated/VBD that/IN Galpha11/NN Q209L/NN stimulated/VBD Src/NN family/NN kinase/NN activity/NN and/CC induced/VBD tyrosine/NN phosphorylation/NN of/IN several/JJ proteins/NNS in/IN HEK-293/NN cells/NNS ./.
P09729476A06
However/WRB ,/, both/CC acute/JJ and/CC chronic/JJ ethanol/NN inhibited/VBD hepatocyte/NN proliferation/NN induced/VBN by/IN insulin/NN and/CC epidermal/JJ growth/NN factor/NN ./.
P09730903A01
We/PRP investigated/VBD the/DT effects/NNS of/IN D1/NN dopamine/NN receptor/NN stimulation/NN on/IN the/DT activation/NN of/IN mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) in/IN SK-N-MC/NN human/NN neuroblastoma/NN cells/NNS ./.
P09733758A01
Three/CD adrenergic/JJ receptor/NN families/NNS that/WDT selectively/RB activate/VBP three/CD different/JJ G/NN proteins/NNS (/( alpha1/NN //SYM Gq/NN //SYM 11/CD ,/, alpha2/NN //SYM Gi/NN ,/, and/CC beta/NN //SYM Gs/NN )/) were/VBD used/VBN to/TO study/VB mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) activation/NN and/CC differentiation/NN in/IN PC12/NN cells/NNS ./.
P09755064A05
Elimination/NN of/IN the/DT Ets/NN motifs/NNS adjacent/JJ to/TO key/JJ regulatory/JJ serum/NN response/NN elements/NNS in/IN the/DT Egr-1/NN promoter/NN diminished/VBD the/DT effect/NN of/IN hypotonicity/NN but/CC failed/VBN to/TO abolish/VB it/PRP ./.
P09758646A01
Two/CD subgroups/NNS of/IN mitogen-activated/JJ protein/NN kinases/NNS ,/, c-jun/NN NH2-terminal/JJ kinase/NN (/( JNK/NN )/) and/CC extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) ,/, are/VBP thought/VBN to/TO be/VB involved/VBN in/IN cultured/JJ cardiac/JJ myocyte/NN hypertrophy/NN and/CC gene/NN expression/NN ./.
P09765228A06
Phosphorylation/NN of/IN ERK/NN in/IN response/NN to/TO CCh/NN was/VBD mimicked/VBN by/IN the/DT protein/NN kinase/NN C/NN (/( PKC/NN )/) activator/NN ,/, phorbol/NN myristate/NN acetate/NN (/( 100/CD nM/NN )/) ,/, but/CC was/VBD not/RB altered/VBN by/IN the/DT PKC/NN inhibitor/NN GF/NN 109203X/NN (/( 1/CD microM/NN )/) ./.
P09765295A03
The/DT molecular/JJ events/NNS that/WDT follow/VBP and/CC that/WDT transduce/VBP signals/NNS from/IN these/DT receptors/NNS to/TO the/DT nucleus/NN are/VBP still/RB poorly/RB defined/VBN ./.
P09766635A04
JNKs/NNS were/VBD not/RB stimulated/VBN by/IN TNF-alpha/NN or/CC GM-CSF/NN ./.
P09766656A10
Thus/RB ,/, intracellular/JJ porphyrins/NNS synthesized/VBN from/IN ALA/NN are/VBP sufficient/JJ to/TO elicit/VB activation/NN of/IN p38/NN on/IN photosensitization/NN ./.
P09768359A10
Nuclear/JJ export/NN of/IN p38/NN and/CC MAPKAP/NN kinase-2/NN may/MD permit/VBP them/PRP to/TO phosphorylate/VB substrates/NNS in/IN the/DT cytoplasm/NN ./.
P09769323A09
These/DT data/NNS are/VBP the/DT first/JJ demonstration/NN that/IN the/DT SAPKs/NNS are/VBP necessary/JJ for/IN the/DT development/NN of/IN agonist-induced/JJ cardiomyocyte/NN hypertrophy/NN ,/, and/CC suggest/VBP that/IN in/IN response/NN to/TO ET-1/NN ,/, they/PRP transduce/VBP critical/JJ signals/NNS governing/VBG the/DT hypertrophic/JJ response/NN ./.
P09770423A05
Studies/NNS with/IN selective/JJ MAPK/NN inhibitors/NNS revealed/VBD that/IN p38/NN was/VBD the/DT main/JJ inducer/NN of/IN junB/NN expression/NN ,/, whereas/IN both/DT MAPK/NN pathways/NNS were/VBD involved/VBN in/IN the/DT induction/NN of/IN c-fos/NN ./.
P09771965A08
In/IN contrast/NN ,/, agents/NNS that/WDT did/VBD not/RB have/VBP this/DT marked/JJ effect/NN did/VBD not/RB increase/VBP MCL1/NN ./.
P09774360A06
In/IN addition/NN ,/, PD/NN 098059/CD ,/, an/DT antagonist/NN of/IN MEK/NN (/( MAP/NN kinase/NN //SYM ERK/NN kinase/NN )/) ,/, the/DT upstream/JJ kinase/NN of/IN ERK/NN ,/, significantly/RB reduced/VBD the/DT PDGF-induced/JJ activation/NN of/IN ERK/NN and/CC potently/RB inhibited/VBD the/DT expression/NN of/IN MKP-1/NN after/IN stimulation/NN with/IN PDGF/NN ,/, thereby/RB demonstrating/VBG the/DT induction/NN of/IN MKP-1/NN in/IN response/NN to/TO activation/NN of/IN the/DT ERK/NN signaling/JJ cascade/NN ./.
P09774447A07
Paclitaxel/NN activated/VBD JNK/NN ,/, and/CC to/TO a/DT lesser/JJR degree/NN p38/NN ,/, but/CC not/RB ERK1/NN ./.
P09776729A07
In/IN contrast/NN ,/, the/DT specific/JJ p38/NN antagonist/NN SKF-86002/NN increased/VBD Na+/NN //SYM H+/NN exchange/NN ./.
P09779822A03
We/PRP found/VBD that/IN not/RB only/RB the/DT DNA/NN fragmentation/NN induced/VBN by/IN 1/CD microM/NN Hg2+/NN but/CC also/RB the/DT cell/NN death/NN bypassing/JJ DNA/NN fragmentation/NN caused/VBN by/IN 10/CD microM/NN or/CC more/DT Hg2+/NN was/VBD partly/RB inhibited/VBN by/IN protein/NN kinase/NN inhibitors/NNS such/JJ as/IN staurosporine/NN and/CC herbimycin/NN A/NN ./.
P09790955A02
The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO define/VB the/DT role/NN of/IN inducible/JJ phosphatases/NNS in/IN ERK/NN MAPK/NN regulation/NN in/IN cardiac/JJ myocytes/NNS ./.
P09792916A07
Thus/RB ,/, this/PRP is/VBZ the/DT first/JJ report/NN showing/VBG that/IN LPA/NN induces/VBZ not/RB only/RB ERK/NN activation/NN but/CC also/RB JNK/NN activation/NN ,/, which/WDT may/MD be/VBP responsible/JJ for/IN the/DT induction/NN of/IN DNA/NN synthesis/NN in/IN LPA-stimulated/JJ Swiss/NN 3T3/NN fibroblasts/NNS ./.
P09804610A04
SB/NN 203,580/CD ,/, an/DT inhibitor/NN of/IN p38/NN ,/, significantly/RB attenuated/VBD phenylephrine-/NN and/CC anisomycin-induced/JJ ERK/NN inhibition/NN ./.
P09809995A06
Importantly/RB ,/, the/DT p36/NN MBP/NN kinase/NN was/VBD immunologically/RB different/JJ from/IN MAPK/NN superfamily/NN molecules/NNS such/JJ as/IN ERK1/NN ,/, JNK/NN isoforms/NNS ,/, and/CC p38/NN MAPK/NN ./.
P09811332A06
Anaplastic/JJ progression/NN in/IN oligodendrogliomas/NNS resulted/VBD in/IN a/DT larger/JJR number/NN of/IN cells/NNS with/IN active/JJ ERK/NN //SYM MAPK/NN ./.
P09813041A01
Growth/NN hormone/NN (/( GH/NN )/) ,/, a/DT major/JJ regulator/NN of/IN normal/JJ body/NN growth/NN and/CC metabolism/NN ,/, regulates/VBZ cellular/JJ gene/NN expression/NN ./.
P09815259A05
The/DT activation/NN of/IN JNK/NN in/IN these/DT cells/NNS appears/VBZ to/TO be/VB mediated/VBN by/IN the/DT MAP/NN kinase/NN kinase/NN MKK7/NN since/IN high/JJ levels/NNS of/IN MKK7/NN and/CC low/JJ levels/NNS of/IN Sek-1/NN //SYM MKK4/NN gene/NN expression/NN were/VBD detected/VBN in/IN thymocytes/NNS ./.
P09822700A09
Again/RB ,/, MHV-3/NN exposure/NN led/VBD to/TO increased/JJ p38/NN and/CC ERK/NN tyrosine/NN phosphorylation/NN ./.
P09822710A08
These/DT results/NNS indicate/VBP that/IN cholesterol/NN or/CC cholesterol-sensitive/JJ compartments/NNS in/IN the/DT plasma/NN membrane/NN play/VBP a/DT selective/JJ and/CC essential/JJ role/NN in/IN activation/NN of/IN ERK/NN ,/, but/CC not/RB JNK/NN ,/, by/IN shear/NN stress/NN ./.
P09822758A10
It/PRP was/VBD concluded/VBN that/IN ERK/NN and/CC JNK/NN are/VBP specifically/RB and/CC differentially/RB activated/VBN in/IN the/DT insular/JJ cortex/NN after/IN exposure/NN to/TO a/DT novel/JJ taste/NN ,/, and/CC that/IN this/DT activation/NN is/VBZ required/VBN for/IN consolidation/NN of/IN long-term/NN taste/NN memory/NN ./.
P09832564A10
In/IN contrast/NN to/TO its/PRP$ effects/NNS on/IN ERK/NN ,/, PTEN/NN expression/NN did/VBD not/RB affect/VBP c-Jun/NN NH2-terminal/JJ kinase/NN (/( JNK/NN )/) or/CC PDGF-stimulated/JJ Akt/NN ./.
P09837905A04
Specific/JJ inhibitors/NNS of/IN cyclooxygenase-/NN ,/, lipoxygenase-/NN ,/, and/CC cytochrome/NN P450-dependent/JJ metabolism/NN did/VBD not/RB affect/VBP AA-induced/JJ MKP-1/NN expression/NN ,/, indicating/VBG that/IN eicosanoid/NN biosynthesis/NN was/VBD not/RB involved/VBN in/IN this/DT process/NN ./.
P09845339A05
Although/IN it/PRP had/VBD little/DT or/CC no/DT effect/NN on/IN the/DT activity/NN of/IN c-Jun/NN N-terminal/JJ kinase/NN ,/, isoproterenol/NN and/CC a/DT number/NN of/IN other/JJ treatments/NNS which/WDT activated/VBD p38/NN MAPK/NN were/VBD found/VBN to/TO stimulate/VB AMP-activated/JJ protein/NN kinase/NN in/IN fat/NN cells/NNS ./.
P09847406A06
Reverse/JJ transcription-PCR/NN and/CC sequencing/JJ analysis/NN of/IN the/DT respective/JJ amplicon/NN clearly/RB demonstrates/VBZ that/IN CeTRAF/NN is/VBZ in/IN fact/NN transcribed/VBD in/IN C./NN elegans/NN ./.
P09850168A04
IgG-SA/NN stimulated/VBD a/DT maximal/JJ ERK/NN activity/NN at/IN 30/CD min/NN ,/, whereas/IN p38/NN activity/NN was/VBD maximal/JJ at/IN 5/CD min/NN ./.
P09862461A02
However/WRB ,/, the/DT G/NN alpha/NN i2-mediated/JJ mitogenic/JJ signaling/JJ pathways/NNS remain/VBP to/TO be/VB elucidated/VBN ./.
P09867813A07
We/PRP failed/VBD to/TO observe/VB any/DT significant/JJ induction/NN and/or/CC modulation/NN of/IN the/DT A-Raf/NN ,/, B-Raf/NN or/CC c-Raf-1/NN kinase/NN activities/NNS ,/, thus/RB suggesting/VBG the/DT existence/NN of/IN a/DT MEK/NN kinase/NN different/JJ from/IN the/DT classical/JJ Raf/NN kinases/NNS that/WDT directly/RB or/CC indirectly/RB can/MD be/VBP modulated/VBN by/IN Ca2+/NN //SYM calmodulin/NN ./.
P09867839A09
Importantly/RB ,/, we/PRP found/VBD that/IN p38/NN MAPK/NN was/VBD essential/JJ for/IN stabilizing/NN COX-2/NN mRNA/NN :/: when/WRB cells/NNS stimulated/VBN for/IN 4/CD h/NN with/IN LPS/NN were/VBD treated/VBN with/IN actinomycin/NN D/NN ,/, COX-2/NN mRNA/NN decayed/VBD slowly/RB ./.
P09874178A03
MAPK/NN signaling/NN was/VBD determined/VBN by/IN assessing/NN MEK/NN (/( also/RB referred/VBN to/TO as/IN MAPK/NN kinase/NN )/) activity/NN by/IN measuring/NN phosphorylated/JJ extracellular/JJ signal-regulated/JJ kinase/NN (/( pp44ERK/NN -/: 1/CD and/CC pp42ERK/NN -/: 2/CD )/) expression/NN ,/, and/CC ERK/NN activity/NN by/IN measuring/NN ERK-2-dependent/JJ phosphorylation/NN of/IN myelin/NN basic/JJ protein/NN (/( MBP/NN )/) ./.
P09880523A03
The/DT present/JJ study/NN was/VBD undertaken/VBN to/TO explore/VB whether/IN TL1/NN induces/VBZ apoptosis/NN in/IN endothelial/JJ cells/NNS and/CC ,/, if/IN so/RB ,/, to/TO explore/VB its/PRP$ mechanism/NN of/IN action/NN ./.
P09886415A08
Collectively/RB ,/, these/DT findings/NNS support/VBP the/DT involvement/NN of/IN p46/NN JNK/NN //SYM SAPK/NN and/CC its/PRP$ upstream/JJ kinases/NNS in/IN regulating/NN the/DT induction/NN of/IN iNOS/NN following/VBG ligation/NN of/IN the/DT TNF-alpha/NN receptor/NN CD120a/NN (/( p55/NN )/) in/IN the/DT presence/NN of/IN IFN-gamma/NN ./.
P09890973A01
The/DT yeast/NN serine/NN //SYM threonine/NN kinase/NN STE20/NN activates/VBZ a/DT signaling/JJ cascade/NN that/WDT includes/VBZ STE11/NN (/( mitogen-activated/JJ protein/NN kinase/NN kinase/NN kinase/NN )/) ,/, STE7/NN (/( mitogen-activated/JJ protein/NN kinase/NN kinase/NN )/) ,/, and/CC FUS3/NN //SYM KSS1/NN (/( mitogen-activated/JJ protein/NN kinase/NN )/) in/IN response/NN to/TO signals/NNS from/IN both/CC Cdc42/NN and/CC the/DT heterotrimeric/JJ G/NN proteins/NNS associated/VBN with/IN transmembrane/JJ pheromone/NN receptors/NNS ./.
P09892211A01
Epidermal/JJ growth/NN factor/NN (/( EGF/NN )/) and/CC insulin-like/JJ growth/NN factor/NN I/CD (/( IGF-I/NN )/) are/VBP potent/JJ mitogens/NNS that/WDT regulate/VBP proliferation/NN of/IN prostate/NN cancer/NN cells/NNS via/IN autocrine/JJ and/CC paracrine/JJ loops/NNS and/CC promote/VBP tumor/NN metastasis/NN ./.
P09892211A13
Moreover/RB ,/, our/PRP$ results/NNS demonstrate/VBP that/IN selective/JJ blockade/NN of/IN the/DT EGF/NN receptor/NN in/IN prostate/NN cancer/NN cells/NNS does/VBZ not/RB only/RB inhibit/VBP the/DT action/NN of/IN EGF/NN ,/, but/CC also/RB IGF-I-induced/JJ activation/NN of/IN the/DT MAPK/NN pathway/NN and/CC the/DT interaction/NN with/IN the/DT PKA/NN pathway/NN ./.
P09916683A04
MAPK-activated/JJ protein/NN kinase-2/NN (/( MAPKAPK-2/NN )/) ,/, an/DT in/FW vivo/FW substrate/NN for/IN p38/NN ,/, was/VBD also/RB activated/VBN by/IN T/NN cell/NN signaling/NN ./.
P09920737A08
The/DT levels/NNS of/IN proliferating/JJ cell/NN nuclear/JJ antigen/NN (/( PCNA/NN )/) protein/NN as/IN a/DT marker/NN for/IN cell/NN proliferation/NN were/VBD induced/VBN at/IN 2/CD h/NN and/CC significantly/RB increased/VBN to/TO 24/CD h/NN after/IN the/DT injection/NN ./.
P09923649A01
Collagenase-1/NN (/( matrix/NN metalloproteinase-1/NN ,/, MMP-1/NN )/) is/VBZ expressed/VBN by/IN several/JJ types/NNS of/IN cells/NNS ,/, including/VBG fibroblasts/NNS ,/, and/CC apparently/RB plays/VBZ an/DT important/JJ role/NN in/IN the/DT remodeling/NN of/IN collagenous/JJ extracellular/JJ matrix/NN in/IN various/JJ physiologic/JJ and/CC pathologic/JJ situations/NNS ./.
P09927616A06
In/IN addition/NN ,/, BRL/NN 37344/CD and/CC propranolol/NN ,/, ligands/NNS that/WDT act/VBP as/IN agonists/NNS in/IN the/DT stimulation/NN of/IN cyclase/NN ,/, act/VBP as/IN antagonists/NNS for/IN ERK/NN activation/NN ./.
P09927621A06
The/DT Ca++/NN chelator/NN bis/JJ (/( 2-aminophenoxy/NN )/) ethane-N-N-N'-N'-tetraacetate/NN (/( BAPTA/NN )/) dose/NN dependently/RB abolished/VBD NE-stimulated/JJ Ca++/NN responses/NNS but/CC not/RB ERK/NN or/CC JNK/NN activation/NN ./.
P09928003A08
These/DT observations/NNS suggest/VBP that/IN PACAP/NN and/CC IL-6/NN act/VBP to/TO inhibit/VB the/DT JNK/NN //SYM SAPK/NN signaling/JJ pathway/NN ,/, thereby/RB protecting/VBG neurons/NNS against/IN apoptosis/NN ./.
P09931118A06
Dominant-negative/JJ mutants/NNS of/IN Ras/NN and/CC Rac/NN inhibited/VBD IL-1beta-stimulated/JJ hBNP/NN luciferase/NN activity/NN by/IN 64/CD %/SYM and/CC 90/CD %/SYM ,/, respectively/RB ./.
P09931133A11
Furthermore/RB ,/, Ang/NN II/CD and/CC HG/NN combined/VBN had/VBD additive/JJ effects/NNS on/IN AP-1/NN activity/NN ./.
P09933603A04
We/PRP show/VBP that/IN ,/, like/IN ERK/NN and/CC JNK/NN activation/NN ,/, activation/NN of/IN p38/NN and/CC its/PRP$ downstream/JJ substrate/NN MAP/NN kinase-activated/JJ protein/NN kinase/NN 2/CD by/IN interleukin-3/NN or/CC G-CSF/NN requires/VBZ Ras/NN activation/NN ./.
P09933636A06
These/DT results/NNS show/VBP for/IN the/DT first/JJ time/NN that/IN SAPK2/NN //SYM p38/NN plays/VBZ an/DT essential/JJ role/NN in/IN C2C12/NN cell/NN differentiation/NN ./.
P09973482A04
Addition/NN of/IN Ag/NN (/( OVA/NN )/) to/TO mouse/NN bone/NN marrow-derived/JJ mast/JJ cells/NNS (/( BMMC/NN )/) sensitized/VBN with/IN anti-OVA/NN IgE/NN triggers/VBZ the/DT activation/NN of/IN three/CD members/NNS of/IN the/DT mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN family/NN ,/, c-Jun/NN amino-terminal/JJ kinase/NN (/( JNK/NN )/) ,/, p38/NN MAP/NN kinase/NN (/( p38/NN )/) ,/, and/CC extracellular/JJ signal-regulated/JJ kinases/NNS ./.
P09988712A07
Inhibition/NN of/IN receptor/NN endocytosis/NN by/IN use/NN of/IN sequestration-defective/JJ mutants/NNS of/IN beta-arrestin1/NN and/CC dynamin/NN attenuated/VBD 5-HT1A/NN receptor-stimulated/JJ Erk1/NN //SYM 2/CD activation/NN ./.
P10021319A09
Interestingly/RB ,/, there/EX is/VBZ a/DT second/JJ delayed/JJ peak/NN of/IN p44-MAPK/NN activation/NN after/IN 4-24/CD h/NN of/IN stimulation/NN with/IN NO/NN donors/NNS ./.
P10036133A06
The/DT assay/NN was/VBD optimized/VBN and/CC the/DT K0.5/NN value/NN for/IN ATP/NN was/VBD found/VBN to/TO be/VB 0.9/CD microM/NN and/CC the/DT Km/NN for/IN stathmin/NN was/VBD determined/VBN to/TO be/VB 16/CD microM/NN ./.
P10037715A01
Cellular/JJ ischemia/NN results/VBZ in/IN activation/NN of/IN a/DT number/NN of/IN kinases/NNS ,/, including/VBG p38/NN mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) ;/: however/WRB ,/, it/PRP is/VBZ not/RB yet/RB clear/JJ whether/IN p38/NN MAPK/NN activation/NN plays/VBZ a/DT role/NN in/IN cellular/JJ damage/NN or/CC is/VBZ part/NN of/IN a/DT protective/JJ response/NN against/IN ischemia/NN ./.
P10037749A03
Using/VBG the/DT mitogen-activated/JJ protein/NN kinase/NN kinase/NN (/( MEK1/NN //SYM 2/CD )/) inhibitor/NN PD98059/NN and/CC dominant/JJ negative/JJ forms/NNS of/IN Ras/NN (/( N17/NN )/) and/CC ERK1/NN (/( K71R/NN )/) ,/, we/PRP found/VBD that/IN activation/NN of/IN Ras/NN and/CC extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) is/VBZ necessary/JJ for/IN colony-stimulating/JJ factor-1/NN (/( CSF-1/NN )/) -mediated/JJ c-Myc/NN expression/NN and/CC DNA/NN synthetic/JJ (/( S/NN )/) phase/NN entry/NN ./.
P10051431A06
Agonist-stimulated/JJ Ins/NN (/( 1/CD ,/, 4/CD ,/, 5/CD )/) P3/NN accumulation/NN in/IN CHO-m3/NN cells/NNS was/VBD insensitive/JJ to/TO pertussis/NN toxin/NN (/( PTX/NN )/) ,/, consistent/JJ with/IN a/DT Gq/NN //SYM phosphoinositide-specific/JJ phospholipase/NN C-beta/NN mediated/JJ pathway/NN ,/, whereas/IN a/DT significant/JJ component/NN of/IN ERK/NN and/CC JNK/NN activation/NN in/IN CHO-m3/NN cells/NNS was/VBD PTX-sensitive/JJ ,/, indicating/VBG Gi/NN //SYM o/NN involvement/NN ./.
P10066377A06
VEGF/NN activated/VBD the/DT phosphorylation/NN of/IN extracellular/JJ signal/NN regulated/JJ kinase/NN (/( ERK/NN )/) 1/CD (/( p44/NN mitogen-activated/JJ protein/NN kinase/NN ;/: MAPK/NN )/) and/CC ERK2/NN (/( p42/NN MAPK/NN )/) in/IN a/DT time-/NN and/CC concentration-dependent/JJ manner/NN ./.
P10066421A06
PTPBR7/NN made/VBD complexes/NNS with/IN ERK1/NN //SYM ERK2/NN in/FW vivo/FW and/CC dephosphorylated/VBD ERK1/NN in/FW vitro/FW ./.
P10067836A03
GLP-1/NN increased/VBD p38/NN MAP/NN kinase/NN activity/NN 2.5-/CD and/CC 2.0-fold/NN over/IN the/DT basal/JJ level/NN in/IN both/CC CHO/NN //SYM GLPR/NN cells/NNS and/CC rat/NN insulinoma/NN cells/NNS (/( RIN/NN 1046-38/CD )/) ,/, respectively/RB ./.
P10068590A03
Dose-related/JJ inhibition/NN of/IN iNOS/NN production/NN was/VBD demonstrated/VBN when/WRB inhibitors/NNS were/VBD added/VBN 1/CD h/NN before/IN ,/, simultaneously/RB with/IN ,/, or/CC 1/CD h/NN after/IN LPS/NN plus/CC rIFN-gamma/NN stimulation/NN ./.
P10082472A04
[/( Ca2+/NN ]/) i/NN and/CC pHi/NN were/VBD measured/VBN by/IN fura-2/NN and/CC BCECF/NN methodology/NN ,/, respectively/RB ,/, and/CC contraction/NN was/VBD determined/VBN by/IN photomicroscopy/NN ./.
P10085241A03
This/DT phenomenon/NN occurs/VBZ even/RB though/IN HaCaT/NN cells/NNS remain/VBP proliferatively/RB responsive/JJ to/TO both/DT agonists/NNS ,/, suggesting/VBG a/DT HaCaT-specific/JJ defect/NN in/IN a/DT PMA-mediated/JJ signal/NN transduction/NN pathway/NN ./.
P10086335A09
Thus/RB ,/, we/PRP suggest/VBP that/IN constitutive/JJ activation/NN of/IN the/DT Raf/NN //SYM MEK/NN //SYM ERK/NN and/CC JNK/NN pathways/NNS is/VBZ necessary/JJ for/IN Ras-induced/JJ transformation/NN of/IN HT1080/NN but/CC not/RB DLD-1/NN cells/NNS ./.
P10089132A05
SB/NN 203580/CD ,/, a/DT selective/JJ p38/NN kinase/NN inhibitor/NN ,/, was/VBD used/VBN to/TO examine/VB the/DT role/NN of/IN p38/NN kinase/NN in/IN MCP-1/NN expression/NN ./.
P10092315A02
METHODS/NNS :/: The/DT role/NN of/IN mitogen-activated/JJ protein/NN kinases/NNS for/IN proteolysis/NN control/NN was/VBD studied/VBN in/IN perfused/JJ rat/NN liver/NN ./.
P10098852A01
Nitric/JJ oxide/NN (/( NO/NN )/) is/VBZ a/DT signaling/JJ molecule/NN that/WDT mediates/VBZ several/JJ physiological/JJ processes/NNS in/IN a/DT range/NN of/IN cell/NN and/CC tissue/NN types/NNS ./.
P10196203A09
In/IN conclusion/NN ,/, this/DT study/NN demonstrates/VBZ that/IN the/DT ERK/NN pathway/NN is/VBZ required/VBN for/IN AICD/NN of/IN T/NN cells/NNS and/CC appears/VBZ to/TO regulate/VB the/DT induction/NN of/IN Nur77/NN and/CC FasL/NN expression/NN during/IN AICD/NN ./.
P10196228A06
Using/VBG stably/RB transfected/JJ RAW/NN 264.7/CD cells/NNS with/IN the/DT kinase-deleted/JJ dominant-negative/JJ mutant/NN of/IN TbetaR-II/NN (/( TbetaR-IIM/NN )/) cDNA/NN ,/, we/PRP demonstrate/VBP that/IN this/DT protective/JJ effect/NN by/IN TGF-beta1/NN is/VBZ completely/RB abrogated/VBN ./.
P10202013A04
We/PRP found/VBD that/IN amino/JJ acids/NNS 35-45/CD of/IN the/DT CD40/NN cytoplasmic/JJ domain/NN constitute/VBP an/DT independent/JJ signaling/JJ motif/NN that/WDT is/VBZ sufficient/JJ for/IN activation/NN of/IN the/DT JNK/NN and/CC p38/NN MAPK/NN pathways/NNS ,/, as/RB well/RB as/IN for/IN induction/NN of/IN I/NN kappa/NN B/NN alpha/NN phosphorylation/NN and/CC degradation/NN ./.
P10202034A07
We/PRP conclude/VBP that/IN okadaic/JJ acid-induced/JJ IL-6/NN gene/NN expression/NN is/VBZ at/IN least/JJS partly/RB mediated/VBN through/IN the/DT ERK1/NN //SYM 2/CD and/CC JNK/NN pathway-dependent/JJ activation/NN of/IN NF-kappa/NN B/NN transcriptional/JJ capacity/NN ./.
P10202148A06
We/PRP conclude/VBP that/IN the/DT p38/NN MAP/NN kinase/NN ,/, activated/VBN through/IN MKK3/NN ,/, is/VBZ required/VBN for/IN the/DT production/NN of/IN inflammatory/JJ cytokines/NNS by/IN both/CC antigen-presenting/JJ cells/NNS and/CC CD4/NN (/( +/SYM )/) T/NN cells/NNS ./.
P10207024A10
These/DT data/NNS indicate/VBP that/IN constitutive/JJ beta3AR/NN coupling/NN to/TO Gi/NN proteins/NNS serves/VBZ both/CC to/TO restrain/VB Gs-mediated/JJ activation/NN of/IN adenylyl/NN cyclase/NN and/CC to/TO initiate/VB additional/JJ signal/NN transduction/NN pathways/NNS ,/, including/VBG the/DT ERK1/NN //SYM 2/CD MAP/NN kinase/NN cascade/NN ./.
P10207619A02
The/DT multiplicity/NN of/IN these/DT pathways/NNS allows/VBZ the/DT cell/NN to/TO respond/VB to/TO divergent/JJ extracellular/JJ stimuli/NNS by/IN initiating/NN a/DT broad/JJ array/NN of/IN responses/NNS ranging/VBG from/IN cell/NN growth/NN to/TO apoptosis/NN ./.
P10212278A06
Here/RB ,/, we/PRP describe/VBP the/DT transient/JJ activation/NN of/IN SAPK/NN //SYM JNKs/NNS by/IN tumor-like/JJ hypoxia/NN ,/, and/CC the/DT concurrent/JJ transcriptional/JJ activation/NN of/IN MKP-1/NN ,/, a/DT stress-inducible/JJ member/NN of/IN the/DT MAPK/NN phosphatase/NN (/( MKP/NN )/) family/NN of/IN dual/JJ specificity/NN protein-tyrosine/NN phosphatases/NNS ./.
P10216124A05
Culture/NN of/IN hepatocytes/NNS with/IN glucagon/NN for/IN 16/CD hours/NNS also/RB inhibited/VBD the/DT stimulation/NN by/IN EGF/NN of/IN activation/NN of/IN ERK2/NN and/CC p70/NN (/( S6k/NN )/) (/( by/IN approximately/RB 50/CD %/SYM )/) ./.
P10218497A05
Protein-bound/JJ 3-nitrotyrosine/NN was/VBD detected/VBN ./.
P10221768A01
The/DT expression/NN of/IN the/DT p38/NN subfamily/NN of/IN mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) was/VBD examined/VBN in/IN rat/NN islets/NNS of/IN Langerhans/NN and/CC pancreatic/JJ beta-cell/NN lines/NNS ,/, and/CC its/PRP$ involvement/NN in/IN the/DT regulation/NN of/IN insulin/NN secretion/NN was/VBD investigated/VBN ./.
P10224067A03
TGF-beta/NN treatment/NN resulted/VBD in/IN a/DT time-dependent/JJ activation/NN of/IN HPK1/NN ,/, which/WDT was/VBD accompanied/VBN by/IN similar/JJ kinetics/NNS of/IN JNK1/NN activation/NN ./.
P10224117A02
Although/IN mammalian/JJ MAPKs/NNS are/VBP most/RBS abundantly/RB expressed/VBN in/IN postmitotic/JJ and/CC terminally/RB differentiated/JJ neuronal/JJ cells/NNS ,/, their/PRP$ function/NN in/IN the/DT central/JJ nervous/JJ system/NN is/VBZ still/RB largely/RB undefined/JJ ./.
P10226075A03
Kinase/NN activity/NN for/IN MEK1/NN was/VBD assessed/VBN by/IN in/FW vitro/FW phosphorylation/NN assay/NN ./.
P10318806A08
Finally/RB ,/, the/DT expression/NN of/IN dominant-negative/JJ Ras/NN but/CC not/RB dominant-negative/JJ Rac/NN inhibited/VBD p38/NN activation/NN by/IN PDGF/NN ,/, suggesting/VBG that/IN Ras/NN is/VBZ a/DT potent/JJ mediator/NN in/IN the/DT p38/NN activation/NN pathway/NN downstream/JJ of/IN PDGF/NN receptors/NNS ./.
P10321726A05
To/TO this/DT end/NN ,/, we/PRP examined/VBD changes/NNS in/IN cellular/JJ morphology/NN and/CC MAPK/NN activation/NN in/IN NE-stimulated/JJ BEC/NN monolayer/NN ,/, and/CC the/DT effect/NN of/IN PD/NN 98059/CD as/IN the/DT specific/JJ inhibitor/NN for/IN MAPK/NN kinase-1/NN (/( MEK-1/NN ,/, the/DT upstream/JJ regulator/NN of/IN MAPK/NN )/) on/IN NE-induced/JJ changes/NNS in/IN cellular/JJ morphology/NN and/CC MAPK/NN activation/NN ./.
P10329718A01
The/DT transcription/NN factor/NN Pax6/NN is/VBZ required/VBN for/IN normal/JJ development/NN of/IN the/DT central/JJ nervous/JJ system/NN ,/, the/DT eyes/NNS ,/, nose/NN ,/, and/CC pancreas/NN ./.
P10329725A01
Cellular/JJ calcium/NN (/( Ca2+/NN )/) and/CC the/DT Ca2+-binding/JJ protein/NN calmodulin/NN (/( CaM/NN )/) regulate/VBP the/DT activities/NNS of/IN Ca2+/NN //SYM CaM-dependent/JJ protein/NN kinases/NNS and/CC protein/NN phosphatase/NN 2B/NN (/( calcineurin/NN )/) ./.
P10330143A05
The/DT efficiency/NN of/IN phosphorylation/NN in/FW vitro/FW and/CC transcriptional/JJ activation/NN in/FW vivo/FW of/IN MEF2A/NN and/CC MEF2C/NN by/IN these/DT p38/NN subtypes/NNS requires/VBZ the/DT presence/NN of/IN a/DT kinase/NN docking/JJ domain/NN (/( D-domain/NN )/) ./.
P10330161A02
The/DT mechanisms/NNS responsible/JJ for/IN these/DT different/JJ cellular/JJ fates/NNS are/VBP unclear/JJ ./.
P10330170A08
Moreover/RB ,/, in/IN addition/NN to/TO JNK/NN ,/, ERK5/NN ,/, p38alpha/NN ,/, and/CC p38gamma/NN were/VBD found/VBN to/TO stimulate/VB the/DT c-jun/NN promoter/NN by/IN acting/NN on/IN distinct/JJ responsive/JJ elements/NNS ./.
P10331432A03
TUNEL-positive/JJ cells/NNS were/VBD present/JJ at/IN all/DT stages/NNS studied/VBN until/IN 7/CD days/NNS after/IN injury/NN ,/, and/CC percentage/NN positivity/NN for/IN these/DT cells/NNS was/VBD maximal/JJ at/IN 3/CD days/NNS after/IN injury/NN ./.
P10334038A02
Immunoblotting/NN using/VBG an/DT anti-phosphoMAPK/NN antibody/NN (/( Ab/NN )/) revealed/VBD that/IN anti-IgG/NN Ab/NN induced/VBD rapid/JJ phosphorylation/NN of/IN MAPK/NN in/IN the/DT cells/NNS ./.
P10336426A07
Safingol/NN ,/, a/DT selective/JJ inhibitor/NN for/IN PKCalpha/NN ,/, did/VBD not/RB show/VBP any/DT inhibitory/JJ effect/NN on/IN UVB-induced/JJ mitogen-activated/JJ protein/NN kinase/NN activation/NN ./.
P10336565A01
The/DT family/NN of/IN basic/JJ secretagogues/NNS of/IN connective/JJ tissue/NN mast/JJ cells/NNS act/VBP as/IN receptor/NN mimetic/JJ agents/NNS ,/, which/WDT trigger/VBP exocytosis/NN by/IN directly/RB activating/NN G/NN proteins/NNS ./.
P10336676A09
However/WRB ,/, glutamate-stimulated/JJ ERK/NN activation/NN remained/VBD unaffected/VBN ./.
P10339476A02
We/PRP investigated/VBD whether/IN this/DT failure/NN of/IN IL-4/NN to/TO promote/VB growth/NN was/VBD because/IN of/IN its/PRP$ unique/JJ inability/NN to/TO activate/VB the/DT Ras/NN //SYM Raf/NN //SYM Erk/NN pathway/NN ./.
P10340949A09
Together/RB ,/, these/DT data/NNS suggest/VBP that/IN in/IN bovine/JJ tracheal/JJ myocytes/NNS :/: (/( 1/CD )/) activation/NN of/IN MAPK/NN by/IN PDGF/NN is/VBZ dependent/JJ on/IN Ras/NN ;/: (/( 2/CD )/) active/JJ Ras/NN is/VBZ sufficient/JJ for/IN ERK/NN activation/NN but/CC is/VBZ insufficient/JJ for/IN maximal/JJ activation/NN of/IN JNK/NN or/CC p38/NN ;/: (/( 3/CD )/) activation/NN of/IN Rac1/NN is/VBZ sufficient/JJ for/IN maximal/JJ JNK/NN activation/NN ;/: and/CC (/( 4/CD )/) Ras/NN ,/, MEK/NN ,/, and/CC ERK/NN constitute/VBP a/DT distinct/JJ pathway/NN to/TO cyclin/NN D1/NN transcriptional/JJ activation/NN ./.
P10347160A03
Mutational/JJ analysis/NN of/IN the/DT LMP1/NN cytoplasmic/JJ COOH/NN terminus/NN revealed/VBD that/IN p38/NN activation/NN occurs/VBZ from/IN both/CC the/DT tumor/NN necrosis/NN factor/NN receptor-associated/JJ factor/NN (/( TRAF/NN )/) -interacting/JJ ,/, membrane-proximal/JJ COOH-terminal/JJ activating/JJ region/NN (/( CTAR/NN )/) 1/CD domain/NN (/( amino/JJ acids/NNS 186-231/CD )/) and/CC the/DT extreme/JJ tumor/NN necrosis/NN factor/NN receptor-associated/JJ death/NN domain/NN (/( TRADD/NN )/) binding/JJ CTAR2/NN region/NN (/( amino/JJ acids/NNS 351-386/CD )/) ./.
P10349832A08
These/DT contrasting/JJ ionic/JJ dependencies/NNS suggest/VBP a/DT mechanism/NN by/IN which/WDT NMDA/NN receptor/NN activation/NN may/MD ,/, under/IN distinct/JJ conditions/NNS ,/, differentially/RB regulate/VBP neuronal/JJ MAPKs/NNS and/CC their/PRP$ divergent/JJ functions/NNS ./.
P10354505A10
Furthermore/RB ,/, downregulation/NN of/IN LPS-uptake/NN in/IN LPS-tolerant/JJ macrophages/NNS was/VBD not/RB observed/VBN ./.
P10356298A04
Neurite/NN outgrowth/NN induced/VBN by/IN bFGF/NN ,/, LN/NN ,/, or/CC N-cadherin/NN was/VBD strongly/RB inhibited/VBN by/IN treatment/NN with/IN inhibitors/NNS of/IN ERK/NN kinase/NN activation/NN ,/, but/CC not/RB by/IN an/DT inhibitor/NN of/IN p38/NN MAPK/NN ./.
P10359012A03
The/DT activity/NN of/IN JNK1/NN was/VBD also/RB significantly/RB induced/VBN ,/, with/IN JNK1/NN protein/NN levels/NNS increasing/NN moderately/RB during/IN exposure/NN to/TO TPA/NN ./.
P10366004A07
The/DT time-course/NN of/IN the/DT N-terminal/JJ phosphorylation/NN of/IN c-Jun/NN as/IN determined/VBN by/IN immunocytochemistry/NN paralleled/VBD the/DT activity/NN of/IN c-Jun/NN N-terminal/JJ kinase/NN 1/CD and/CC showed/VBD a/DT compartment-specific/JJ regulation/NN between/IN 3/CD and/CC 12/CD h/NN ./.
P10372920A05
The/DT phosphorylation/NN pattern/NN of/IN extracellular/JJ regulated/JJ kinases/NNS (/( ERK/NN 1/CD //SYM 2/CD )/) ,/, c-jun/NN N-terminal/JJ activated/JJ kinases/NNS (/( JNK/NN )/) and/CC p38/NN in/IN PC12/NN cells/NNS is/VBZ strikingly/RB different/JJ ./.
P10374718A05
Both/PDT these/DT responses/NNS were/VBD receptor/NN mediated/VBN as/IN ,/, adrenomedullin-/NN (/( 22-52/CD )/) inhibited/VBD these/DT effects/NNS ./.
P10376935A10
Additional/JJ studies/NNS showed/VBD that/IN DADLE/NN stimulated/VBD an/DT increase/NN in/IN cfos/NN mRNA/NN ;/: this/PRP was/VBD reduced/VBN by/IN the/DT inhibitor/NN of/IN MAPK/NN //SYM ERK/NN kinase/NN (/( MEK/NN )/) ,/, PD98059/NN ./.
P10380884A02
This/DT okadaic/JJ acid/NN mediated/JJ activation/NN of/IN MAP/NN kinases/NNS correlated/VBD with/IN increased/JJ AP-1/NN binding/NN to/TO a/DT consensus/NN TPA/NN responsive/JJ element/NN (/( TRE/NN )/) and/CC elevated/JJ TRE/NN dependent/JJ transcription/NN ./.
P10381634A06
Likewise/RB ,/, activation/NN of/IN JNKs/NNS was/VBD not/RB observed/VBN in/IN etoposide-treated/JJ submandibular/JJ C6/NN cells/NNS ,/, and/CC the/DT amount/NN of/IN activated/JJ ERK1/NN and/CC ERK2/NN decreased/VBD only/RB slightly/RB ./.
P10395291A08
Treatment/NN of/IN HF/NN with/IN PD98059/NN blocks/VBZ the/DT induction/NN of/IN crystal-stimulated/JJ collagenase/NN 1/CD (/( MMP-1/NN )/) and/CC stromelysin/NN (/( MMP-3/NN )/) expression/NN ./.
P10395651A03
In/IN this/DT study/NN ,/, using/VBG an/DT established/JJ FDC/NN line/NN ,/, HK/NN cells/NNS ,/, we/PRP compared/VBD the/DT effects/NNS of/IN CD40/NN and/CC TNF/NN receptor/NN triggering/NN on/IN cytokine/NN induction/NN and/CC activation/NN of/IN mitogen-activated/JJ protein/NN kinase/NN family/NN ./.
P10395662A05
These/DT data/NNS indicate/VBP that/IN there/EX is/VBZ discrimination/NN in/IN the/DT biochemical/JJ pathways/NNS that/WDT are/VBP necessary/JJ to/TO specify/VB CD4/NN and/CC CD8/NN lineage/NN commitment/NN and/CC can/MD reconcile/VBP previously/RB conflicting/JJ reports/NNS on/IN the/DT influence/NN of/IN MAPK/NN activation/NN in/IN commitment/NN and/CC maturation/NN of/IN thymocytes/NNS ./.
P10400419A03
Enhanced/JJ activity/NN of/IN p38/NN and/CC JNK/NN was/VBD not/RB only/RB observed/VBN during/IN apoptosis/NN but/CC also/RB in/IN TF-1/NN cells/NNS stimulated/VBN with/IN IL-1/NN ./.
P10401575A05
Both/CC endogenous/JJ and/CC over-expressed/JJ MEKK1/NN colocalized/VBD with/IN alpha-actinin/NN along/IN actin/NN stress/NN fibers/NNS and/CC at/IN focal/JJ adhesions/NNS ./.
P10402237A05
We/PRP found/VBD that/IN despite/IN high/JJ levels/NNS of/IN Ras-GTP/NN in/IN each/DT cell/NN line/NN expressing/VBG mutant/JJ K-ras/NN ,/, elevated/JJ levels/NNS of/IN active/JJ Erk1/NN and/CC Erk2/NN were/VBD not/RB detectable/JJ under/IN conditions/NNS of/IN exponential/JJ growth/NN or/CC serum-starvation/NN ./.
P10409243A05
In/IN contrast/NN ,/, the/DT synthetic/JJ substrate/NN poly-D-lysine/NN conferred/VBD no/DT protection/NN ./.
P10413589A07
Expression/NN of/IN the/DT type/NN II/CD collagen/NN gene/NN ,/, a/DT hallmark/NN of/IN chondrogenesis/NN in/IN vertebrates/NNS ,/, was/VBD also/RB induced/VBN by/IN GDF-5/NN treatment/NN and/CC strongly/RB suppressed/VBN by/IN SB202190/NN ./.
P10413591A03
The/DT effect/NN was/VBD dose-dependent/JJ in/IN the/DT range/NN between/IN 0.1/CD and/CC 30/CD microM/NN ./.
P10415025A10
A/DT small/JJ deletion/NN (/( aa/NN 1-46/CD )/) in/IN the/DT N-terminal/JJ portion/NN of/IN LC-PTP/NN or/CC Arg/NN to/TO Ala/NN substitutions/NNS at/IN aa/NN 41/CD and/CC 42/CD resulted/VBD in/IN the/DT loss/NN of/IN ERK/NN binding/JJ activity/NN ./.
P10428055A02
Treatment/NN with/IN dibutyryl/NN cGMP/NN (/( DBcGMP/NN )/) dose-dependently/RB increased/VBD the/DT phosphorylation/NN of/IN both/CC p44/NN and/CC p42/NN isoforms/NNS of/IN MAPK/NN ./.
P10428774A09
Ectopic/JJ expression/NN of/IN Delta/NN alpha/NN or/CC Y707A/NN resulted/VBD in/IN increased/JJ basal/JJ phosphorylation/NN of/IN pp140/NN compared/VBN with/IN that/PRP of/IN WT/NN ,/, presenting/VBG the/DT possibility/NN that/IN pp140/NN is/VBZ a/DT novel/JJ RSK/NN substrate/NN ./.
P10432304A06
The/DT addition/NN of/IN endothelin-1/NN resulted/VBD in/IN the/DT phosphorylation/NN and/CC activation/NN of/IN cPLA/NN (/( 2/CD )/) ./.
P10433244A08
Microinjection/NN of/IN p85-SH2/NN and/or/CC catalytically/RB inactive/JJ MAP/NN kinase/NN (/( [/( K71A/NN ]/) Erk1/NN )/) GST/NN fusion/NN protein/NN gave/VBD the/DT same/JJ results/NNS as/IN treatment/NN with/IN wortmannin/NN and/CC PD98059/NN ./.
P10438726A06
Concurrent/JJ ligation/NN of/IN CD22/NN and/CC BCR/NN enhanced/VBD BCR-mediated/JJ ERK-2/NN activation/NN without/IN appreciably/RB modulating/NN CD22-induced/JJ SAPK/NN activation/NN ./.
P10440527A08
Thus/RB ,/, the/DT enhanced/JJ activation/NN of/IN JNKs/NNS or/CC ERKs/NNS occurs/VBZ in/IN various/JJ cardiovascular/JJ disease/NN models/NNS ,/, supporting/VBG the/DT notion/NN that/IN MAPKs/NNS may/MD be/VBP a/DT useful/JJ target/NN for/IN treatment/NN of/IN cardiovascular/JJ hypertrophy/NN and/CC remodeling/NN ./.
P10440934A08
Conversely/RB ,/, NIH3T3/NN and/CC K562/NN cells/NNS stably/RB overexpressing/VBG the/DT wild-type/NN ERK1/NN develop/VBP resistance/NN to/TO killing/NN by/IN heat/NN ./.
P10445668A01
We/PRP report/VBP that/IN okadaic/JJ acid/NN (/( OA/NN )/) ,/, a/DT known/JJ inhibitor/NN of/IN Ser/NN //SYM Thr/NN phosphatases/NNS ,/, protects/VBZ pig/NN myocardium/NN against/IN ischemic/JJ injury/NN in/IN an/DT in/FW vivo/FW model/NN and/CC stimulates/VBZ the/DT activities/NNS of/IN stress-activated/JJ protein/NN kinases/NNS //SYM c-Jun/NN N-terminal/JJ kinases/NNS (/( SAPKs/NNS //SYM JNKs/NNS )/) ./.
P10445797A03
DESIGN/NN :/: Pharmacological/JJ agents/NNS which/WDT selectively/RB interact/VBP with/IN specific/JJ target/NN proteins/NNS involved/VBN in/IN signal/NN transduction/NN through/IN a/DT Gi-MAPK/NN pathway/NN have/VBP recently/RB become/VBP available/JJ ./.
P10447711A05
A/DT chemical/JJ inhibitor/NN of/IN ERK/NN activation/NN ,/, PD/NN 098059/CD ,/, inhibits/VBZ ERK/NN activation/NN and/CC apoptosis/NN ,/, while/IN JNK/NN activation/NN is/VBZ not/RB inhibited/VBN ./.
P10454547A02
First/RB ,/, a/DT biphasic/JJ MEK/NN //SYM ERK/NN activation/NN was/VBD evidenced/VBN in/IN G/NN (/( 1/CD )/) phase/NN of/IN hepatocytes/NNS from/IN regenerating/JJ liver/NN but/CC not/RB from/IN sham-operated/JJ control/NN animals/NNS ./.
P10454547A13
These/DT results/NNS allow/VBP us/PRP to/TO point/VB to/TO a/DT growth/NN factor/NN dependency/NN in/IN mid-late/JJ G/NN (/( 1/CD )/) phase/NN of/IN proliferating/JJ hepatocytes/NNS in/FW vivo/FW as/IN observed/VBN in/FW vitro/FW in/IN proliferating/JJ hepatocytes/NNS and/CC argue/VBP for/IN a/DT crucial/JJ role/NN of/IN the/DT MEK/NN //SYM ERK/NN cascade/NN signalling/JJ pathway/NN ./.
P10455028A09
TGF-beta/NN (/( 1/CD )/) had/VBD no/DT effect/NN on/IN the/DT expression/NN of/IN c-myc/NN or/CC p27/NN (/( kip1/NN )/) and/CC weakly/RB attenuated/VBD the/DT expression/NN of/IN cyclin/NN D/NN (/( 1/CD )/) ./.
P10455914A03
The/DT role/NN of/IN p38/NN and/CC other/JJ MAPKs/NNS (/( ERK/NN and/CC SAPK/NN //SYM JNK/NN )/) in/IN regulating/NN PMN/NN apoptosis/NN after/IN LPS/NN stimulation/NN is/VBZ unknown/VBN ./.
P10455916A03
Here/RB we/PRP investigated/VBD the/DT effect/NN of/IN mechanical/JJ injury/NN of/IN endothelial/JJ cells/NNS on/IN the/DT mitogen-activated/JJ kinase/NN signaling/JJ pathways/NNS ,/, extracellular-signal-regulated/JJ kinases/NNS (/( ERKs/NNS )/) ,/, C-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN //SYM SAPK/NN )/) ,/, and/CC p38/NN ./.
P10471327A07
Low-dose/NN X-rays/NNS also/RB activated/VBD the/DT p38/NN MAPK/NN ./.
P10471813A01
We/PRP have/VBP identified/VBN a/DT novel/JJ Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) -binding/JJ protein/NN ,/, termed/VBN JNKBP1/NN ,/, and/CC examined/VBN its/PRP$ binding/JJ affinity/NN for/IN JNK1/NN ,/, JNK2/NN ,/, JNK3/NN ,/, and/CC extracellular/JJ signal-regulated/JJ kinase/NN 2/CD (/( ERK2/NN )/) in/IN COS-7/NN cells/NNS ./.
P10472421A06
The/DT levels/NNS of/IN a/DT dual/JJ specificity/NN tyrosine/NN phosphatase/NN ,/, MKP2/NN ,/, were/VBD significantly/RB decreased/VBN in/IN cerebellar/JJ vermis/NN (/( 1716/CD +/-/SYM 465/CD versus/CC 2372/CD +/-/SYM 429/CD arbitrary/JJ units/NNS ,/, U/NN =/SYM 12/CD ,/, p/NN </SYM .02/CD )/) from/IN schizophrenic/JJ patients/NNS ./.
P10479400A08
PD98059/NN also/RB inhibited/VBD induction/NN of/IN IL-2/NN by/IN phorbol/NN 12-myristate/NN 13-acetate/NN (/( PMA/NN )/) ,/, and/CC AP1-linked/JJ reporter/NN gene/NN expression/NN in/IN response/NN to/TO PMA/NN but/CC not/RB IL-1/NN ./.
P10487205A02
This/PRP results/VBZ in/IN modification/NN of/IN cellular/JJ gene/NN expression/NN ./.
P10488090A03
Treatment/NN of/IN human/NN hepatoma/NN (/( HepG2/NN )/) and/CC murine/JJ hepatoma/NN (/( Hepa1c1c7/NN )/) cells/NNS with/IN tert-butylhydroquinone/NN (/( tBHQ/NN )/) or/CC sulforaphane/NN (/( SUL/NN )/) ,/, two/CD potent/JJ phase/NN II/CD enzyme/NN inducers/NNS ,/, stimulated/VBD the/DT activity/NN of/IN extracellular/JJ signal-regulated/JJ protein/NN kinase/NN 2/CD (/( ERK2/NN )/) but/CC not/RB c-Jun/NN N-terminal/JJ kinase/NN 1/CD ./.
P10488148A08
In/IN contrast/NN ,/, all/PRP of/IN the/DT stimuli/NNS activated/VBD AP-1/NN via/IN a/DT MAPK-dependent/JJ pathway/NN ./.
P10489373A04
YopJ-related/JJ proteins/NNS that/WDT are/VBP found/VBN in/IN a/DT number/NN of/IN bacterial/JJ pathogens/NNS of/IN animals/NNS and/CC plants/NNS may/MD function/VBP to/TO block/VB MKKs/NNS so/IN that/IN host/NN signaling/JJ responses/NNS can/MD be/VBP modulated/VBN upon/IN infection/NN ./.
P10490955A01
Cell-cell/NN and/CC cell-matrix/NN interactions/NNS play/VBP important/JJ regulatory/JJ roles/NNS in/IN lymphocyte/NN homeostasis/NN ./.
P10493750A04
Neuregulin/NN induced/VBD expression/NN of/IN immediate/JJ early/JJ genes/NNS c-jun/NN and/CC c-fos/NN ,/, which/WDT followed/VBD and/CC depended/VBD on/IN the/DT ERK/NN activation/NN ./.
P10496957A05
Apoptosis/NN is/VBZ antagonized/VBN by/IN the/DT addition/NN of/IN fetal/JJ calf/NN serum/NN or/CC the/DT simultaneous/JJ generation/NN of/IN NO/NN and/CC superoxide/NN (/( O/NN (/( 2/CD )/) (/( -/SYM )/) )/) ,/, another/DT biological/JJ inflammatory/JJ mediator/NN ./.
P10498289A09
This/DT effect/NN was/VBD also/RB completely/RB inhibited/VBN by/IN moexiprilat/NN (/( 10/CD (/( -7/CD )/) M/NN )/) and/CC enalaprilat/NN (/( 10/CD (/( -7/CD )/) M/NN )/) ./.
P10498647A07
Suppression/NN of/IN ERK/NN activation/NN was/VBD associated/VBN with/IN complete/JJ inhibition/NN of/IN HSC/NN proliferation/NN and/CC with/IN a/DT 57/CD %/SYM reduction/NN in/IN chemotaxis/NN ./.
P10499523A05
The/DT ET-1-induced/JJ activation/NN of/IN MAP/NN kinase/NN was/VBD reduced/VBN by/IN an/DT EGFR/NN kinase/NN inhibitor/NN (/( AG1478/NN )/) but/CC not/RB by/IN a/DT platelet-derived/JJ growth/NN factor/NN receptor/NN kinase/NN inhibitor/NN (/( AG1296/NN )/) ./.
P10501211A01
Tumor/NN necrosis/NN factor-alpha/NN (/( TNF-alpha/NN )/) is/VBZ a/DT cytokine/NN that/WDT elicits/VBZ cell/NN responses/NNS by/IN activating/NN the/DT mitogen-activated/JJ protein/NN kinase/NN (/( MAP/NN kinase/NN )/) cascade/NN and/CC transcription/NN factors/NNS such/JJ as/IN nuclear/JJ factor-kappaB/NN (/( NF-kappaB/NN )/) ./.
P10504489A10
The/DT activation/NN of/IN the/DT p38/NN and/CC the/DT ERK1/NN ,/, 2/CD MAPKs/NNS occurred/VBD following/VBG TNF-alpha/NN stimulation/NN ./.
P10506137A02
The/DT involvement/NN of/IN MAPK/NN (/( mitogen-activated/JJ protein/NN kinase/NN )/) pathways/NNS in/IN this/DT adaptive/JJ increase/NN of/IN transport/NN activity/NN was/VBD studied/VBN in/IN cultured/JJ human/NN fibroblasts/NNS ./.
P10506143A01
c-Jun/NN N-terminal/JJ protein/NN kinase/NN (/( JNK/NN )/) ,/, a/DT member/NN of/IN the/DT mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN family/NN ,/, regulates/VBZ gene/NN expression/NN in/IN response/NN to/TO various/JJ extracellular/JJ stimuli/NNS ./.
P10506145A02
We/PRP have/VBP previously/RB shown/VBN that/IN mouse/NN Sertoli/NN cells/NNS respond/VBP to/TO TNF-alpha/NN by/IN increasing/NN interleukin-6/NN production/NN and/CC intercellular/JJ adhesion/NN molecule-1/NN (/( ICAM-1/NN )/) expression/NN (/( 1/CD )/) ./.
P10506169A03
Activation/NN of/IN the/DT epidermal/JJ growth/NN factor/NN receptor/NN (/( EGFR/NN )/) signaling/JJ pathway/NN due/JJ to/TO the/DT enhanced/JJ transforming/JJ growth/NN factor/NN alpha/NN (/( TGFalpha/NN )/) expression/NN plays/VBZ an/DT important/JJ role/NN in/IN the/DT induction/NN of/IN COX-2/NN by/IN IFN-gamma/NN ./.
P10506481A04
In/IN newborn/NN rat/NN VSMCs/NNS ,/, Ang/NN II/CD activates/VBZ extracellular/JJ signal-regulated/JJ protein/NN kinase/NN (/( ERK/NN )/) ,/, c-Jun/NN N-terminal/JJ protein/NN kinase/NN (/( JNK/NN )/) ,/, and/CC p38/NN mitogen-activated/JJ protein/NN kinase/NN ./.
P10508274A04
Wortmannin/NN ,/, an/DT inhibitor/NN of/IN phosphatidylinositol/NN 3-kinase/NN ,/, partially/RB inhibited/VBD ERK2/NN and/CC p38/NN activation/NN triggered/VBN through/IN the/DT B/NN cell/NN receptor/NN whereas/IN activation/NN of/IN JNK1/NN and/CC p38/NN through/IN CD40/NN was/VBD not/RB affected/VBN ./.
P10510396A01
Neutrophils/NNS stimulated/VBN with/IN the/DT chemoattractant/NN FMLP/NN or/CC the/DT phorbol/NN ester/NN PMA/NN are/VBP known/VBN to/TO exhibit/VB activation/NN of/IN a/DT 90-kDa/NN renaturable/JJ protein/NN kinase/NN ./.
P10512765A04
These/DT compounds/NNS ,/, exemplified/VBN by/IN SB/NN 203580/CD ,/, are/VBP exceptionally/RB effective/JJ in/IN cell-based/JJ assays/NNS ,/, including/VBG the/DT inhibition/NN of/IN inflammatory/JJ cytokine/NN production/NN ./.
P10512860A02
Growth/NN factors/NNS are/VBP thought/VBN to/TO regulate/VB cyclin/NN D1/NN expression/NN because/IN they/PRP stimulate/VBP sustained/JJ extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) activity/NN ./.
P10514426A02
Recent/JJ studies/NNS have/VBP implicated/VBN Gadd45/NN and/CC two/CD related/JJ proteins/NNS ,/, MyD118/NN //SYM Gadd45beta/NN and/CC CR6/NN //SYM Gadd45gamma/NN ,/, as/IN initiators/NNS of/IN JNK/NN //SYM p38/NN signaling/NN via/IN their/PRP$ interaction/NN with/IN an/DT upstream/JJ kinase/NN MTK1/NN ./.
P10519165A08
HO-3/NN has/VBZ very/RB low/JJ activity/NN ;/: its/PRP$ physiological/JJ function/NN probably/RB involves/VBZ heme/NN binding/NN ./.
P10521430A03
Further/RB ,/, insulin/NN effects/NNS on/IN ERK/NN were/VBD inhibited/VBN by/IN kinase-inactive/JJ 3-phosphoinositide-dependent/JJ protein/NN kinase-1/NN (/( PDK-1/NN )/) ,/, and/CC by/IN mutation/NN of/IN Thr-410/NN in/IN the/DT activation/NN loop/NN of/IN PKC-zeta/NN ,/, which/WDT is/VBZ the/DT target/NN of/IN PDK-1/NN and/CC is/VBZ essential/JJ for/IN PI3K/NN //SYM PDK-1-dependent/JJ activation/NN of/IN PKC-zeta/NN ./.
P10521481A01
Engagement/NN of/IN the/DT tumor/NN necrosis/NN factor-alpha/NN (/( TNF-alpha/NN )/) receptors/NNS by/IN the/DT TNF-alpha/NN ligand/NN results/VBZ in/IN the/DT rapid/JJ induction/NN of/IN TNF-alpha/NN gene/NN expression/NN ./.
P10522849A07
Elastase/NN release/NN from/IN PMNs/NNS was/VBD determined/VBN by/IN cleavage/NN of/IN the/DT substrate/NN Ala-Ala-Pro-Val-pNA/NN ./.
P10527936A09
Addition/NN of/IN the/DT ATP/NN hydrolase/NN apyrase/NN to/TO the/DT bath/NN greatly/RB reduced/VBD the/DT hypotonicity-induced/JJ Erk-1/NN //SYM 2/CD activation/NN ,/, but/CC did/VBD not/RB affect/VBP the/DT swelling-induced/JJ isotope/NN efflux/NN or/CC whole-cell/NN Cl/NN (/( -/SYM )/) currents/NNS ./.
P10529371A05
However/WRB ,/, the/DT inhibition/NN was/VBD partial/JJ (/( approximately/RB 50/CD %/SYM )/) ,/, while/IN inhibition/NN of/IN PC/NN hydrolysis/NN was/VBD almost/RB complete/JJ ,/, suggesting/VBG a/DT concomitant/JJ inhibition/NN of/IN PLA2/NN activity/NN ./.
P10531305A08
Cells/NNS deficient/JJ in/IN a/DT major/JJ quinone/NN reductase/NN ,/, NQO1/NN ,/, displayed/VBD hypersensitivity/NN to/TO dicoumarol/NN stress/NN inhibition/NN ,/, whereas/IN SAPK/NN in/IN cells/NNS reconstituted/VBN with/IN the/DT NQO1/NN gene/NN displayed/VBD relative/JJ dicoumarol/NN resistance/NN ./.
P10534331A06
Stimulation/NN with/IN IL-6/NN resulted/VBD in/IN proliferation/NN of/IN malignant/JJ cholangiocytes/NNS ./.
P10537068A10
These/DT results/NNS indicate/VBP that/IN the/DT ERK/NN cascade/NN plays/VBZ a/DT central/JJ role/NN in/IN MK-mediated/JJ neuronal/JJ survival/NN via/IN inhibition/NN of/IN caspase-3/NN activation/NN ./.
P10537140A04
PD98059/NN ,/, a/DT specific/JJ inhibitor/NN of/IN the/DT upstream/JJ kinase/NN that/WDT activates/VBZ p42/NN //SYM p44/NN MAP/NN kinase/NN ,/, inhibited/VBD the/DT IL-1alpha-induced/JJ IL-6/NN synthesis/NN as/RB well/RB as/IN the/DT phosphorylation/NN of/IN p42/NN //SYM p44/NN MAP/NN kinase/NN induced/VBN by/IN IL-1alpha/NN ./.
P10542260A02
We/PRP report/VBP here/RB studies/NNS on/IN these/DT processes/NNS in/IN a/DT human/NN keratinocyte/NN line/NN (/( HaCaT/NN )/) ,/, which/WDT is/VBZ a/DT constitutive/JJ producer/NN of/IN tissue/NN factor/NN (/( TF/NN )/) and/CC responds/VBZ to/TO both/CC FVIIa/NN and/CC FXa/NN with/IN elevation/NN of/IN cytosolic/JJ Ca/NN (/( 2+/CD )/) ,/, phosphorylation/NN of/IN extracellular/JJ signal-regulated/JJ kinase/NN (/( Erk/NN )/) 1/CD //SYM 2/CD ,/, p38/NN (/( MAPK/NN )/) ,/, and/CC c-Jun/NN N-terminal/JJ kinase/NN ,/, and/CC up-regulation/NN of/IN transcription/NN of/IN the/DT early/JJ growth/NN response/NN gene-1/NN (/( egr-1/NN )/) ./.
P10543994A06
Inhibition/NN of/IN the/DT transient/JJ ERK/NN activation/NN by/IN MEK/NN inhibitor/NN PD098059/NN attenuated/VBD the/DT H/NN (/( 2/CD )/) O/NN (/( 2/CD )/) -induced/JJ apoptosis/NN ./.
P10551817A07
More/RB importantly/RB ,/, we/PRP demonstrate/VBP that/IN activation/NN of/IN the/DT p42/NN //SYM p44/NN MAPK/NN pathway/NN in/IN quiescent/JJ cells/NNS induced/VBD the/DT phosphorylation/NN and/CC shift/NN of/IN HIF-1alpha/NN ,/, which/WDT was/VBD abrogated/VBN in/IN presence/NN of/IN the/DT MEK/NN inhibitor/NN ,/, PD/NN 98059/CD ./.
P10551874A03
In/IN HepG2/NN cells/NNS ,/, repression/NN of/IN MAP/NN kinase/NN activity/NN by/IN treatment/NN with/IN the/DT mitogen-activated/JJ protein/NN kinase/NN //SYM extracellular/JJ signal-regulated/JJ kinase/NN kinase/NN inhibitor/NN PD98059/NN caused/VBD a/DT 5-8-fold/NN increase/NN in/IN apoCIII/NN transcriptional/JJ activity/NN ./.
P10553083A03
Compared/VBN with/IN cag+/NN strains/NNS ,/, cag-/NN clinical/JJ isolates/NNS were/VBD less/RB potent/JJ in/IN inducing/NN MAP/NN kinase/NN ,/, particularly/RB JNK/NN and/CC p38/NN ,/, activation/NN ./.
P10555036A07
The/DT cAMP/NN mimetics/NNS ,/, 3-isobutyl-1-methyl/NN xanthine/NN plus/CC forskolin/NN ,/, completely/RB blocked/VBD IL-17-induced/JJ NO/NN production/NN ./.
P10558995A02
The/DT specific/JJ role/NN of/IN the/DT p44/NN MAPK/NN isoform/NN in/IN the/DT whole/JJ animal/NN was/VBD evaluated/VBN by/IN generation/NN of/IN p44/NN MAPK-deficient/JJ mice/NNS by/IN homologous/JJ recombination/NN in/IN embryonic/JJ stem/NN cells/NNS ./.
P10559244A03
Immunoprecipitation/NN experiments/NNS with/IN anti-extracellular/JJ signal-regulated/JJ kinase/NN 1/CD (/( ERK1/NN )/) or/CC anti-ERK2/NN antibodies/NNS followed/VBN by/IN MBP/NN kinase/NN assays/NNS ,/, and/CC direct/JJ in-gel/NN kinase/NN assays/NNS for/IN MBP/NN ,/, show/VBP that/IN p44/NN //SYM ERK1/NN but/CC not/RB p42/NN //SYM ERK2/NN is/VBZ stimulated/VBN in/IN OA-treated/JJ spermatocytes/NNS ./.
P10562267A03
METHODS/NNS AND/CC RESULTS/NNS :/: When/WRB cultured/JJ cardiac/JJ myocytes/NNS of/IN neonatal/JJ rats/NNS were/VBD exposed/VBN to/TO 1/CD micromol/NN //SYM L/NN DM/NN for/IN 24/CD hours/NNS ,/, many/DT cells/NNS became/VBD positive/JJ for/IN TUNEL/NN staining/NN ,/, with/IN morphological/JJ changes/NNS characteristic/JJ of/IN apoptosis/NN ./.
P10570156A09
Finally/RB ,/, DNA/NN damage-induced/JJ MKK6/NN and/CC p38/NN activation/NN was/VBD diminished/VBN in/IN c-Abl/NN null/JJ fibroblasts/NNS ./.
P10572244A01
We/PRP previously/RB reported/VBN that/IN prostaglandin/NN F/NN (/( 2alpha/NN )/) (/( PGF/NN (/( 2alpha/NN )/) )/) activates/VBZ both/CC phosphoinositide-hydrolyzing/JJ phospholipase/NN C/NN and/CC phosphatidylcholine-hydrolyzing/JJ phospholipase/NN D/NN in/IN osteoblast-like/JJ MC3T3-E1/NN cells/NNS and/CC then/RB induces/VBZ the/DT activation/NN of/IN protein/NN kinase/NN C/NN (/( PKC/NN )/) ./.
P10572244A12
These/DT results/NNS indicate/VBP that/IN PGF/NN (/( 2alpha/NN )/) stimulates/VBZ the/DT induction/NN of/IN HSP27/NN via/IN p42/NN //SYM p44/NN MAP/NN kinase/NN activation/NN ,/, which/WDT depends/VBZ on/IN upstream/JJ PKC/NN activation/NN in/IN osteoblasts/NNS ./.
P10579326A05
EGF/NN induced/VBD an/DT increase/NN in/IN c-myc/NN ,/, but/CC not/RB c-fos/NN or/CC c-jun/NN ,/, mRNA/NN levels/NNS in/IN subconfluent/JJ hepatocyte/NN cultures/NNS ./.
P10580747A10
These/DT results/NNS indicate/VBP that/IN TGF-beta1/NN specifically/RB activates/VBZ MEK1/NN and/CC subsequent/JJ ERK/NN pathways/NNS in/IN CRAC/NN ,/, and/CC that/IN the/DT activation/NN of/IN this/DT MAPK/NN pathway/NN plays/VBZ a/DT role/NN in/IN the/DT mitogenic/JJ response/NN to/TO TGF-beta1/NN ./.
P10580837A03
This/DT step/NN is/VBZ crucial/JJ for/IN the/DT initiation/NN of/IN translation/NN ./.
P10581177A02
Using/VBG human/NN helper/NN T/NN cell/NN clones/NNS ,/, we/PRP examined/VBD effects/NNS of/IN cAMP/NN on/IN c-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) and/CC extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) ,/, which/WDT are/VBP assumed/VBN to/TO play/VB a/DT role/NN in/IN T/NN cell/NN regulation/NN ./.
P10585423A12
Taken/VBN together/RB ,/, the/DT present/JJ study/NN demonstrated/VBD that/IN 1/CD ,/, 25/CD (/( OH/NN )/) (/( 2/CD )/) D/NN (/( 3/CD )/) stimulated/VBD AP-1/NN activation/NN in/IN CaCo-2/NN cells/NNS by/IN a/DT PKC-alpha-/NN and/CC JNK-dependent/JJ mechanism/NN leading/VBG to/TO increases/NNS in/IN cellular/JJ differentiation/NN ./.
P10586114A08
Despite/IN the/DT fact/NN that/IN IL-3/NN did/VBD induce/VBP p38/NN and/CC ERK/NN kinase/NN activity/NN ,/, it/PRP was/VBD not/RB able/JJ to/TO enhance/VB IL-6/NN protein/NN secretion/NN ,/, which/WDT coincided/VBD with/IN the/DT inability/NN of/IN IL-3/NN to/TO induce/VB NFkappaB/NN (/( nuclear/JJ factor/NN kappaB/NN )/) activation/NN and/CC IkappaB/NN (/( inhibitory/JJ protein/NN kappaB/NN )/) degradation/NN ./.
P10590051A03
Withdrawal/NN of/IN EPO/NN from/IN the/DT cell/NN culture/NN medium/NN resulted/VBD in/IN sustained/JJ activation/NN of/IN JNKs/NNS plus/CC p38/NN MAP/NN kinase/NN ,/, and/CC inactivation/NN of/IN ERKs/NNS ,/, preceding/VBG apoptosis/NN of/IN the/DT cells/NNS ./.
P10591028A10
AP-1/NN DNA/NN binding/JJ activities/NNS spurred/VBN by/IN low/JJ or/CC high/JJ doses/NNS of/IN isoproterenol/NN administration/NN increased/VBD at/IN 12/CD h/NN ,/, reached/VBD their/PRP$ peak/NN of/IN 24.1-/CD and/CC 37.1-fold/NN (/( P/NN </SYM 0.01/CD )/) ,/, respectively/RB ,/, at/IN 24/CD h/NN ,/, and/CC thereafter/RB decreased/VBD ./.
P10593906A07
Overexpression/NN of/IN the/DT kinase-dead/NN mutant/JJ form/NN of/IN MKK3/NN or/CC MKK6/NN demonstrated/VBD that/IN either/PRP of/IN these/DT two/CD mutant/JJ kinase/NN inhibited/VBD IL-1beta-induced/JJ p38/NN (/( MAPK/NN )/) (/( but/CC not/RB JNK/NN //SYM SAPK/NN )/) phosphorylation/NN and/CC iNOS/NN expression/NN ./.
P10593919A01
We/PRP have/VBP investigated/VBN the/DT cellular/JJ mechanisms/NNS that/WDT participate/VBP in/IN reducing/NN insulin/NN sensitivity/NN in/IN response/NN to/TO increased/JJ oxidant/NN stress/NN in/IN skeletal/JJ muscle/NN ./.
P10594022A07
Taken/VBN together/RB ,/, these/DT results/NNS demonstrate/VBP that/IN ASK1/NN is/VBZ a/DT crucial/JJ element/NN of/IN NGF/NN withdrawal-induced/JJ activation/NN of/IN the/DT Cdc42-c-Jun/NN pathway/NN and/CC neuronal/JJ apoptosis/NN ./.
P10601128A01
The/DT expression/NN of/IN inducible/JJ nitric/JJ oxide/NN synthase/NN (/( iNOS/NN )/) is/VBZ a/DT characteristic/JJ response/NN to/TO inflammation/NN and/CC can/MD be/VBP inhibited/VBN with/IN sodium/NN salicylate/NN ./.
P10601328A05
Furthermore/RB ,/, treatment/NN of/IN COS-7/NN cells/NNS with/IN PKA/NN activators/NNS ,/, or/CC overexpression/NN of/IN the/DT Calpha/NN catalytic/JJ subunit/NN of/IN PKA/NN ,/, inhibited/VBD the/DT cytoplasmic/JJ retention/NN of/IN ERK2/NN and/CC p38alpha/NN by/IN wild-type/NN PTP-SL/NN ,/, but/CC not/RB by/IN a/DT PTP-SL/NN S231A/NN mutant/NN ./.
P10602479A06
There/EX was/VBD no/DT effect/NN of/IN HRG/NN on/IN the/DT state/NN of/IN phosphorylation/NN and/CC localization/NN of/IN focal/JJ adhesion/NN kinase/NN ./.
P10608465A09
The/DT matching/JJ response/NN of/IN ERK/NN activation/NN to/TO TGF-1/NN in/IN SHR/NN cells/NNS suggests/VBZ that/IN the/DT MAP/NN kinase-signaling/JJ pathway/NN remains/VBZ largely/RB unchanged/VBN in/IN the/DT regulation/NN of/IN vascular/JJ smooth/JJ muscle/NN growth/NN by/IN TGF-1/NN in/IN spontaneously/RB hypertensive/JJ rats/NNS ./.
P10611240A02
We/PRP describe/VBP here/RB a/DT novel/JJ form/NN of/IN dsRNA-triggered/JJ signaling/NN that/WDT leads/VBZ to/TO the/DT stimulation/NN of/IN the/DT p38/NN mitogen-activated/JJ protein/NN kinase/NN (/( p38/NN MAPK/NN )/) and/CC the/DT c-Jun/NN NH/NN (/( 2/CD )/) -terminal/JJ kinase/NN (/( JNK/NN )/) and/CC of/IN their/PRP$ respective/JJ activators/NNS MKK3/NN //SYM 6/CD and/CC SEK1/NN //SYM MKK4/NN ./.
P10614711A01
A/DT novel/JJ clonal/JJ cell/NN line/NN transfected/VBN with/IN the/DT delta-opioid/NN receptor/NN (/( delta-OR/NN )/) encoding/JJ gene/NN was/VBD used/VBN to/TO study/VB agonist-activated/JJ regulation/NN of/IN cell/NN proliferation/NN ./.
P10616838A05
Western/NN blot/NN analysis/NN demonstrated/VBD a/DT significant/JJ increase/NN in/IN the/DT protein/NN expression/NN of/IN glomerular/JJ ERK/NN and/CC JNK/NN in/IN Dahl-S/NN rats/NNS fed/VBN a/DT high-salt/NN diet/NN ./.
P10617109A07
Thus/RB ,/, proteasome/NN inhibitors/NNS induce/VBP sustained/JJ ERK/NN activation/NN in/IN a/DT Ras-dependent/JJ manner/NN ./.
P10617147A09
U0126/NN ,/, another/DT chemically/RB unrelated/JJ inhibitor/NN of/IN the/DT MAPK/NN cascade/NN ,/, mimicked/VBD the/DT effect/NN of/IN PD98059/NN on/IN mu-receptor/NN phosphorylation/NN and/CC desensitization/NN ./.
P10617652A03
We/PRP showed/VBD that/IN phosphorylation/NN of/IN tyrosine/NN 490/CD is/VBZ required/VBN for/IN activation/NN of/IN phosphoinositide/NN 3-OH/NN kinase/NN ,/, whereas/IN phosphorylation/NN of/IN tyrosine/NN 785/CD is/VBZ required/VBN for/IN activation/NN of/IN phospholipase/NN C-gamma/NN ./.
P10620499A03
However/WRB ,/, whereas/IN the/DT CRE/NN is/VBZ necessary/JJ and/CC sufficient/JJ for/IN promoter/NN activation/NN by/IN cAMP/NN ,/, it/PRP is/VBZ necessary/JJ but/CC not/RB sufficient/JJ for/IN activation/NN by/IN NGF/NN ./.
P10623598A08
Nonetheless/RB ,/, in/IN response/NN to/TO TNF/NN ,/, JNK/NN activation/NN was/VBD restored/VBN in/IN the/DT TGF-beta1/NN matrix-stimulated/JJ cells/NNS ./.
P10625698A05
Contraction-stimulated/JJ phosphorylation/NN of/IN ERK1/NN //SYM 2/CD and/CC p38/NN (/( MAPK/NN )/) was/VBD completely/RB inhibited/VBN by/IN pretreatment/NN with/IN PD98059/NN (/( MAPK/NN kinase/NN inhibitor/NN )/) and/CC SB203580/NN (/( p38/NN (/( MAPK/NN )/) inhibitor/NN )/) ,/, respectively/RB ./.
P10627532A10
In/IN contrast/NN ,/, inhibition/NN of/IN stress/NN MAP/NN kinase/NN pathways/NNS does/VBZ not/RB impair/VBP the/DT ability/NN of/IN Z/NN expression/NN vectors/NNS to/TO disrupt/VB viral/JJ latency/NN ,/, presumably/RB because/IN expression/NN of/IN Z/NN under/IN the/DT control/NN of/IN a/DT strong/JJ heterologous/JJ promoter/NN bypasses/VBZ the/DT need/NN to/TO activate/VB Z/NN transcription/NN ./.
P10637276A03
Persistent/JJ activation/NN of/IN p38/NN MAP/NN kinase/NN blocks/VBZ fetal/JJ thymocyte/NN development/NN at/IN the/DT CD25/NN (/( +/SYM )/) CD44/NN (/( -/SYM )/) stage/NN in/FW vivo/FW ,/, and/CC results/VBZ in/IN the/DT lack/NN of/IN T/NN cells/NNS in/IN the/DT peripheral/JJ immune/JJ system/NN of/IN adult/JJ mice/NNS ./.
P10639586A02
Radiation/NN exposure/NN caused/VBD prolonged/VBN (/( approximately/RB 1/CD h/NN )/) MAPK/NN activations/NNS in/IN U937/NN cells/NNS ./.
P10640438A10
Inhibitors/NNS of/IN protein/NN kinase/NN C/NN (/( PKC/NN )/) (/( Ro318220/NN ,/, GF109203X/NN )/) and/CC the/DT ERK/NN cascade/NN (/( PD98059/NN )/) attenuated/VBD the/DT increase/NN in/IN c-Jun/NN induced/VBN by/IN IL-1/NN beta/NN ,/, but/CC LY294002/NN (/( an/DT inhibitor/NN of/IN phosphatidylinositol/NN 3/CD '/SYM kinase/NN )/) and/CC SB203580/NN (/( an/DT inhibitor/NN of/IN p38-MAPK/NN ,/, which/WDT also/RB inhibits/VBZ certain/JJ JNK/NN isoforms/NNS )/) had/VBD no/DT effect/NN ./.
P10640689A01
In/IN rat/NN type/NN I/CD astrocytes/NNS and/CC C6/NN glioma/NN cells/NNS ,/, sphingosine/NN 1-phosphate/NN (/( S1P/NN )/) clearly/RB induced/VBD the/DT expression/NN of/IN fibroblast/NN growth/NN factor-2/NN (/( FGF-2/NN )/) mRNA/NN to/TO an/DT extent/NN comparable/JJ to/TO that/PRP achieved/VBN by/IN platelet-derived/JJ growth/NN factor/NN (/( PDGF/NN )/) and/CC endothelin/NN ./.
P10640739A05
In/IN contrast/NN ,/, the/DT phosphorylation/NN of/IN LAT/NN and/CC enhanced/JJ association/NN with/IN Grb2/NN led/VBD to/TO activation/NN of/IN extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) mitogen-activated/JJ protein/NN kinase/NN ./.
P10642305A06
In/IN separate/JJ experiments/NNS ,/, 5-HT/NN (/( 10/CD nmol/NN //SYM L/NN )/) potentiated/VBD contraction/NN in/IN response/NN to/TO NE/NN (/( 20/CD nmol/NN //SYM L/NN )/) by/IN approximately/RB 200/CD %/SYM to/TO 300/CD %/SYM and/CC to/TO ET-1/NN (/( 0.3/CD and/CC 1/CD nmol/NN //SYM L/NN )/) by/IN 640/CD %/SYM and/CC 180/CD %/SYM ,/, respectively/RB ./.
P10644049A07
These/DT results/NNS suggest/VBP that/IN ara-C-induced/JJ apoptotic/JJ DNA/NN fragmentation/NN and/CC loss/NN of/IN clonogenicity/NN occur/VBP through/IN a/DT p38-dependent/JJ pathway/NN ./.
P10644517A04
Further/JJ studies/NNS show/VBP that/IN NaCl-inducible/JJ ERK1/NN and/CC ERK2/NN (/( ERK1/NN //SYM 2/CD )/) activation/NN is/VBZ a/DT consequence/NN of/IN cPKC/NN and/CC nPKC/NN activation/NN ,/, because/IN either/CC downregulation/NN with/IN 12-O-tetradecanoylphorbol/NN 13-acetate/NN or/CC selective/JJ inhibition/NN of/IN cPKC/NN and/CC nPKC/NN by/IN GF-109203X/NN and/CC rottlerin/NN largely/RB inhibited/VBD the/DT stimulation/NN of/IN ERK1/NN //SYM 2/CD phosphorylation/NN by/IN NaCl/NN ./.
P10644575A08
Caerulein/NN hyperstimulation/NN strongly/RB activated/VBD JNK/NN ,/, p38/NN ,/, and/CC ERK/NN ./.
P10644709A09
Taken/VBN together/RB ,/, our/PRP$ findings/NNS strongly/RB suggest/VBP that/IN selenite/NN differentially/RB modulates/VBZ the/DT mammalian/JJ mitogen-activated/JJ protein/NN kinase/NN pathways/NNS and/CC that/IN it/PRP can/MD repress/VBP the/DT JNK/NN //SYM SAPK/NN signaling/JJ pathway/NN by/IN inhibiting/NN JNK/NN //SYM SAPK/NN through/IN a/DT thiol/NN redox/NN mechanism/NN ./.
P10644746A05
The/DT effect/NN of/IN nitric/JJ oxide/NN was/VBD mimicked/VBN by/IN addition/NN of/IN 8-bromo-cGMP/NN ,/, indicating/VBG that/IN activation/NN of/IN soluble/JJ guanylyl/NN cyclase/NN was/VBD involved/VBN ./.
P10649432A06
Low/JJ serum/NN (/( 0.3/CD %/SYM )/) markedly/RB increased/VBD type/NN I/CD collagen/NN mRNA/NN ./.
P10650934A08
Determination/NN of/IN JNK/NN activity/NN using/VBG an/DT immune/JJ complex/NN assay/NN demonstrated/VBD a/DT 3.3-/CD and/CC 3.5-fold/NN increase/NN in/IN JNK1/NN and/CC -2/CD activity/NN ,/, respectively/RB ,/, 30/CD min/NN after/IN treatment/NN with/IN 100/CD ng/NN //SYM ml/NN IGF-I/NN ./.
P10652360A01
Vascular/JJ endothelial/JJ cells/NNS are/VBP unique/JJ in/IN that/IN they/PRP exit/VBP from/IN the/DT cell/NN cycle/NN when/WRB they/PRP come/VBP into/IN contact/NN with/IN each/DT other/PRP ./.
P10653605A01
A/DT mutant/JJ Escherichia/NN coli/NN lipopolysaccharide/NN (/( LPS/NN )/) lacking/VBG myristoyl/NN fatty/JJ acid/NN markedly/RB stimulates/VBZ the/DT activity/NN of/IN manganese/NN superoxide/NN dismutase/NN (/( MnSOD/NN )/) without/IN inducing/NN tumor/NN necrosis/NN factor/NN alpha/NN (/( TNFalpha/NN )/) production/NN by/IN human/NN monocytes/NNS (/( Tian/NNP et/CC al./NN ,/, 1998/CD ,/, Am/NN J/NN Physiol/NN 275/CD :/: C740./NN )/) ,/, suggesting/VBG that/IN induction/NN of/IN MnSOD/NN and/CC TNFalpha/NN by/IN LPS/NN are/VBP regulated/VBN through/IN different/JJ signal/NN transduction/NN pathways/NNS ./.
P10660688A01
Neuropeptide/NN Y/NN (/( NPY/NN )/) has/VBZ been/VBN shown/VBN to/TO participate/VB in/IN the/DT cardiovascular/JJ response/NN mediated/VBN by/IN the/DT sympathetic/JJ system/NN ./.
P10667594A03
However/WRB ,/, the/DT signaling/JJ mechanisms/NNS by/IN which/WDT oncogenic/JJ Ras/NN controls/VBZ cancer/NN cell/NN growth/NN is/VBZ poorly/RB characterized/VBN ./.
P10668633A06
Infarct/NN size/NN (/( measured/VBN by/IN triphenyltetrazolium/NN staining/NN )/) in/IN isolated/JJ rabbit/NN hearts/NNS subjected/VBN to/TO 30/CD min/NN regional/JJ ischemia/NN and/CC 2/CD h/NN reperfusion/NN was/VBD 31.0/CD +/-/SYM 2.6/CD %/SYM of/IN the/DT risk/NN zone/NN in/IN controls/NNS and/CC was/VBD 10.3/CD +/-/SYM 2.2/CD %/SYM in/IN PC/NN hearts/NNS (/( p/NN </SYM 0.001/CD )/) ./.
P10670688A02
MAPK/NN activation/NN was/VBD sphingolipid-specific/JJ in/IN cells/NNS from/IN both/DT species/NNS ./.
P10673361A06
These/DT results/NNS suggest/VBP that/IN the/DT susceptibility/NN to/TO oxidative/JJ stress/NN in/IN mutant/JJ MtPK/NN cDNA/NN transformants/NNS involves/VBZ differential/JJ signaling/JJ pathways/NNS evoked/VBN following/VBG oxidative/JJ stress/NN ./.
P10674496A03
We/PRP also/RB demonstrate/VBP that/IN TNF-alpha-induced/JJ over-expression/NN of/IN GFAP/NN was/VBD significantly/RB attenuated/VBN by/IN the/DT MAPK/NN inhibitor/NN PD98059/NN ./.
P10677489A08
These/DT findings/NNS separate/VBP GPCR/NN endocytosis/NN from/IN the/DT requirement/NN for/IN clathrin-mediated/JJ endocytosis/NN in/IN EGFR/NN transactivation-mediated/JJ ERK/NN activation/NN and/CC suggest/VBP that/IN it/PRP is/VBZ the/DT receptor/NN tyrosine/NN kinase/NN or/CC another/DT downstream/JJ effector/NN that/WDT must/MD engage/VBP the/DT endocytic/JJ machinery/NN ./.
P10677502A03
High/JJ concentrations/NNS of/IN stauro/NN of/IN up/IN to/TO 1/CD microM/NN only/RB partially/RB inhibit/VBP IL-3-stimulated/JJ Bcl2/NN phosphorylation/NN but/CC completely/RB block/VBP PKC-mediated/JJ Bcl2/NN phosphorylation/NN in/FW vitro/FW ./.
P10678124A05
P42/NN //SYM p44/NN ,/, p38/NN MAPK/NN ,/, and/CC p46/NN //SYM p58/NN JNK/NN protein/NN expression/NN were/VBD measured/VBN by/IN Western/NN blot/NN ./.
P10679516A03
AVP/NN stimulated/VBD the/DT phosphorylation/NN of/IN p42/NN //SYM p44/NN MAP/NN kinase/NN and/CC p38/NN MAP/NN kinase/NN ./.
P10683294A03
Inhibition/NN of/IN either/CC xanthine/NN oxidase/NN with/IN allopurinol/NN or/CC nitric/JJ oxide/NN synthase/NN with/IN N/NN (/( G/NN )/) -monomethyl-l-arginine/NN produces/VBZ a/DT small/JJ but/CC significant/JJ improvement/NN in/IN the/DT efficacy/NN of/IN MC-CM/NN while/IN inclusion/NN of/IN pyrrolidine/NN dithiocarbamate/NN ,/, a/DT hydroxyl/NN radical/NN scavenger/NN widely/RB used/VBN as/IN an/DT antioxidant/NN ,/, lowers/VBZ MC-CM-induced/JJ ChAT/NN activity/NN ./.
P10683529A06
The/DT PMA-induced/JJ astrocyte/NN stellation/NN and/CC ERK1/NN //SYM 2/CD phosphorylation/NN were/VBD blocked/VBN by/IN specific/JJ PKC/NN inhibitors/NNS ,/, GF-109203X/NN (/( 0.01-1/CD microM/NN )/) and/CC calphostin/NN C/NN (/( 1/CD microM/NN )/) ./.
P10684871A03
17beta-Estradiol/NN increased/VBD B-Raf/NN activity/NN and/CC MEK/NN (/( MAP/NN kinase/NN //SYM ERK/NN kinase/NN )/) -dependent/JJ ERK/NN phosphorylation/NN in/IN cerebral/JJ cortical/JJ explants/NNS derived/VBN from/IN both/CC ERKO/NN and/CC their/PRP$ wild-type/NN littermates/NNS ./.
P10684886A06
Immunohistochemical/JJ examination/NN of/IN brain/NN sections/NNS after/IN quinpirole/NN administration/NN revealed/VBD significant/JJ increases/NNS in/IN ERK1/NN //SYM 2/CD immunostaining/NN in/IN perinuclear/JJ and/CC intranuclear/JJ areas/NNS of/IN striatal/JJ neurons/NNS ./.
P10686508A03
In/IN the/DT present/JJ study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN sodium/NN salicylate/NN (/( NaSal/NN )/) ,/, a/DT nonsteroidal/JJ anti-inflammatory/JJ drug/NN ,/, on/IN mitogen-activated/JJ protein/NN kinases/NNS (/( MAPK/NN )/) and/CC apoptosis/NN of/IN human/NN eosinophils/NNS ./.
P10698349A05
Analysis/NN of/IN mitogen/NN activated/JJ protein/NN kinases/NNS (/( MAPK/NN )/) pathways/NNS induced/VBN by/IN C5b-9/NN in/IN aortic/JJ SMC/NN revealed/VBD that/IN extracellular/JJ signal/NN regulated/JJ kinase/NN (/( ERK/NN )/) 1/CD ,/, c-jun/NN NH2-terminal/JJ kinase/NN (/( JNK/NN )/) 1/CD ,/, and/CC p38/NN MAPK/NN are/VBP all/PRP activated/VBN by/IN C5b-9/NN ./.
P10700554A07
The/DT glutamate/NN concentration/NN effective/JJ for/IN inducing/NN apoptotic-like/JJ cell/NN death/NN was/VBD correlated/VBN with/IN that/PRP for/IN inducing/NN ERK1/NN //SYM 2/CD diphosphorylation/NN ./.
P10704154A07
It/PRP is/VBZ also/RB conceivable/JJ that/IN growth/NN factor/NN stimulation/NN of/IN airway/NN smooth/JJ muscle/NN simultaneously/RB elicits/VBZ signaling/NN through/IN negative/JJ regulatory/JJ pathways/NNS such/JJ as/IN the/DT p38/NN mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN pathway/NN ,/, perhaps/RB as/IN a/DT safeguard/NN against/IN excessive/JJ growth/NN ./.
P10706854A04
MAP/NN kinase/NN activation/NN was/VBD studied/VBN in/IN eotaxin-stimulated/JJ eosinophils/NNS (/( more/RB than/IN 97/CD %/SYM purity/NN )/) by/IN Western/NN blotting/NN and/CC immune-complex/NN kinase/NN assays/NNS ./.
P10708257A06
In/IN order/NN to/TO bypass/VB the/DT receptor-proximal/JJ age-dependent/JJ defects/NNS previously/RB described/VBN ,/, we/PRP used/VBD phorbol/NN ester/NN (/( PMA/NN )/) and/CC Ca2+/NN ionophore/NN (/( A23187/NN )/) as/IN co-mitogens/NNS ./.
P10708707A02
Immunoblot/NN analysis/NN with/IN antibodies/NNS against/IN a/DT phosphorylated/JJ form/NN of/IN p38/NN MAPK/NN showed/VBD that/IN fMLP-stimulated/JJ p38/NN MAPK/NN activation/NN was/VBD dependent/JJ on/IN a/DT pertussis/NN toxin-sensitive/JJ G/NN protein/NN ./.
P10712263A06
These/DT results/NNS indicate/VBP that/IN colonic/JJ smooth/JJ muscle/NN M/NN (/( 2/CD )/) receptors/NNS are/VBP coupled/VBN to/TO ERK/NN and/CC p38/NN MAP/NN kinases/NNS ./.
P10712344A08
TNF-alpha/NN induced/VBD p38/NN MAP/NN kinase/NN and/CC Erk/NN phosphorylation/NN ,/, but/CC neither/CC SB/NN 203580/CD nor/CC PD/NN 98059/CD inhibited/VBD RANTES/NN production/NN ./.
P10713403A05
These/DT results/NNS suggest/VBP that/IN the/DT MEK/NN //SYM ERK/NN signal/NN transduction/NN cascade/NN is/VBZ involved/VBN in/IN the/DT neurotrophic/JJ effect/NN of/IN EGF/NN ./.
P10720480A06
Delineating/NN the/DT signal/NN transduction/NN mechanisms/NNS regulating/VBG the/DT cellular/JJ effects/NNS of/IN NT/NN will/MD provide/VBP important/JJ insights/NNS into/IN the/DT molecular/JJ pathways/NNS responsible/JJ for/IN NT-mediated/JJ effects/NNS on/IN both/CC normal/JJ and/CC neoplastic/JJ cells/NNS ./.
P10722731A03
Activation/NN of/IN MAP/NN kinase/NN appears/VBZ to/TO be/VB essential/JJ for/IN propagating/NN a/DT wide/JJ variety/NN of/IN extracellular/JJ signals/NNS from/IN the/DT plasma/NN membrane/NN to/TO the/DT nucleus/NN ./.
P10722758A06
ERK/NN was/VBD selectively/RB activated/VBN in/IN MLE-15/NN cells/NNS by/IN hypertonic/JJ stress/NN ,/, and/CC inhibition/NN of/IN ERK/NN activation/NN with/IN two/CD distinct/JJ mitogen-activated/JJ extracellular/JJ regulated/JJ kinase/NN kinase/NN (/( MEK/NN )/) inhibitors/NNS ,/, U0126/NN and/CC PD98059/NN ,/, blocked/VBD AQP5/NN induction/NN ./.
P10727428A09
Dominant-negative/JJ Ras/NN also/RB partly/RB inhibited/VBD the/DT phenylephrine-induced/JJ activation/NN of/IN ANF/NN promoter/NN ./.
P10727463A02
Although/IN c-Jun/NN NH2-terminal/JJ kinase/NN (/( JNK/NN )/) and/CC p38/NN mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) may/MD be/VBP involved/VBN in/IN apoptosis/NN in/IN various/JJ cell/NN types/NNS ,/, the/DT mode/NN of/IN regulation/NN of/IN FasL/NN expression/NN during/IN AICD/NN in/IN T/NN cells/NNS by/IN these/DT two/CD MAPKs/NNS is/VBZ incompletely/RB understood/VBN ./.
P10727525A01
A/DT variety/NN of/IN G/NN protein-coupled/JJ receptors/NNS (/( GPCRs/NNS )/) are/VBP phosphorylated/VBN by/IN G/NN protein-coupled/JJ receptor/NN kinase/NN 2/CD (/( GRK2/NN )/) ./.
P10728664A08
Thus/RB ,/, activation/NN of/IN IRF7/NN through/IN the/DT JNK/NN signaling/JJ pathway/NN may/MD play/VBP a/DT role/NN in/IN the/DT transcriptional/JJ regulation/NN of/IN genes/NNS in/IN response/NN to/TO DNA-damaging/JJ agents/NNS ./.
P10733514A02
We/PRP hypothesized/VBD that/IN myosin/NN light/JJ chain/NN kinase/NN (/( MLCK/NN )/) could/MD be/VBP phosphorylated/VBN and/CC activated/VBN by/IN ERK/NN ,/, thereby/RB linking/VBG the/DT MAP/NN kinase/NN pathway/NN to/TO the/DT activation/NN of/IN cytoskeletal/JJ components/NNS required/VBN for/IN pseudopod/NN formation/NN ./.
P10733575A03
The/DT DH/NN and/CC Cdc25/NN domains/NNS possess/VBP guanine/NN nucleotide/NN exchange/NN factor/NN (/( GEF/NN )/) activity/NN and/CC interact/VBP with/IN Rac/NN and/CC Ras/NN ,/, respectively/RB ./.
P10735617A11
Both/CC 2-mercaptoethanol/NN and/CC a/DT p38/NN inhibitor/NN (/( SB202190/NN )/) inhibited/VBD alpha-SMA/NN expression/NN by/IN day/NN 5/CD cells/NNS ./.
P10745095A03
While/IN phosphorylation/NN of/IN ERK/NN and/CC JNK/NN was/VBD inhibited/VBN by/IN the/DT pretreatment/NN of/IN a/DT PKC/NN inhibitor/NN ,/, bisindolylmaleimide/NN I/CD ,/, activation/NN of/IN p38/NN MAPK/NN was/VBD upregulated/VBN by/IN the/DT same/JJ pretreatment/NN ./.
P10747973A04
As/IN cells/NNS recover/VBP from/IN stress/NN ,/, the/DT punctate/JJ granules/NNS gradually/RB disappear/VBP ,/, and/CC HSF-1/NN appears/VBZ in/IN a/DT diffused/JJ staining/JJ pattern/NN in/IN the/DT cytoplasm/NN and/CC nucleus/NN ./.
P10749150A10
Moreover/RB ,/, a/DT dominant-negative/JJ Rac/NN (/( Rac/NN N17/NN )/) blocked/VBD serum-induced/JJ PTHRP/NN gene/NN expression/NN ./.
P10751227A02
We/PRP tested/VBD the/DT hypothesis/NN that/IN oxidants/NNS might/MD be/VBP involved/VBN in/IN the/DT signal/NN transduction/NN pathway/NN linking/VBG the/DT receptor/NN to/TO extracellular/JJ signal-regulated/JJ protein/NN kinase/NN (/( ERK/NN )/) ./.
P10753509A06
Other/JJ blots/NNS showed/VBD the/DT specific/JJ appearance/NN of/IN the/DT phosphorylated/JJ EGFR/NN and/CC of/IN phospho-ERK-1/NN //SYM 2/CD in/IN response/NN to/TO EGF/NN ./.
P10753873A05
This/DT induction/NN was/VBD mediated/VBN transcriptionally/RB through/IN the/DT AP-1/NN (/( c-Fos/NN //SYM JunD/NN )/) and/CC CCAAT/NN //SYM enhancer-binding/JJ protein/NN elements/NNS as/RB well/RB as/IN through/IN an/DT E-box/NN repressor/NN site/NN in/IN the/DT proximal/JJ regulatory/JJ region/NN of/IN the/DT FGF-BP/NN promoter/NN ./.
P10753946A10
These/DT findings/NNS describe/VBP a/DT novel/JJ inside-out/RB signaling/JJ pathway/NN by/IN which/WDT the/DT ERK/NN cascade/NN may/MD regulate/VBP events/NNS involved/VBN in/IN adhesion/NN ./.
P10764405A01
The/DT third/JJ cytoplasmic/JJ loop/NN of/IN the/DT angiotensin/NN (/( Ang/NN )/) II/CD type/NN 1/CD receptor/NN (/( AT/NN (/( 1/CD )/) )/) is/VBZ important/JJ for/IN receptor/NN coupling/NN to/TO G/NN proteins/NNS and/CC activation/NN of/IN downstream/JJ events/NNS ./.
P10764405A12
This/DT study/NN shows/VBZ for/IN the/DT first/JJ time/NN a/DT direct/JJ link/NN between/IN kinase/NN activation/NN and/CC inhibition/NN of/IN apoptosis/NN dependent/JJ on/IN amino/JJ acids/NNS 221/CD and/CC 222/CD in/IN the/DT third/JJ cytoplasmic/JJ loop/NN of/IN the/DT AT/NN (/( 1/CD )/) ./.
P10764628A03
Two/CD myeloid/NN models/NNS ,/, RAW/NN 264.7/CD murine/JJ macrophage/NN and/CC U937/NN human/NN leukemic/JJ cells/NNS were/VBD used/VBN ./.
P10764657A03
The/DT study/NN was/VBD performed/VBN to/TO further/RB characterize/VB the/DT role/NN of/IN ROS/NN in/IN Ang/NN II-mediated/JJ MAP/NN kinase/NN activation/NN and/CC the/DT regulation/NN of/IN the/DT transcription/NN factor/NN activator/NN protein-1/NN (/( AP-1/NN )/) ./.
P10766791A09
These/DT results/NNS demonstrate/VBP an/DT essential/JJ role/NN for/IN Src/NN and/CC Cas/NN in/IN H/NN (/( 2/CD )/) O/NN (/( 2/CD )/) -mediated/JJ activation/NN of/IN JNK/NN and/CC suggest/VBP a/DT new/JJ redox-sensitive/JJ pathway/NN for/IN JNK/NN activation/NN mediated/VBN by/IN Src/NN ./.
P10770956A02
The/DT family/NN of/IN mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) is/VBZ involved/VBN in/IN the/DT regulation/NN of/IN cardiac/JJ myocyte/NN growth/NN and/CC apoptosis/NN ./.
P10775139A05
In/IN contrast/NN ,/, ramp/NN flow/NN was/VBD unable/JJ to/TO significantly/RB induce/VB gene/NN expression/NN and/CC even/RB inhibited/VBD the/DT activation/NN of/IN ERK1/NN //SYM ERK2/NN ./.
P10781369A07
RESULTS/NNS :/: GLP-2-treated/JJ cells/NNS demonstrated/VBD a/DT greater/JJR than/IN 10-fold/NN increase/NN in/IN proliferation/NN ./.
P10781688A05
Although/IN K562/NN cells/NNS were/VBD very/RB resistant/JJ to/TO sorbitol-induced/JJ apoptosis/NN ,/, DNA/NN fragmentation/NN was/VBD induced/VBN rapidly/RB in/IN Jurkat/NN ,/, HL-60/NN and/CC U937/NN cells/NNS after/IN exposure/NN to/TO sorbitol/NN ,/, despite/IN that/IN these/DT apoptosis-sensitive/JJ cells/NNS have/VBP similar/JJ or/CC lower/JJR activities/NNS of/IN JNK/NN //SYM SAPK/NN and/CC p38/NN kinase/NN compared/VBN with/IN K562/NN cells/NNS after/IN treatment/NN of/IN sorbitol/NN ./.
P10781927A06
In/IN cells/NNS pretreated/VBN with/IN PMA/NN for/IN 24/CD h/NN and/CC with/IN either/CC the/DT PKC/NN inhibitor/NN staurosporine/NN or/CC the/DT tyrosine/NN kinase/NN inhibitor/NN genistein/NN for/IN 1h/NN ,/, substantially/RB reduced/VBD the/DT [/( 3H/NN ]/) thymidine/NN incorporation/NN and/CC p42/NN //SYM p44/NN MAPK/NN phosphorylation/NN in/IN response/NN to/TO OX-LDL/NN ./.
P10787425A06
Neither/CC haploids/NNS nor/CC diploids/NNS ,/, however/WRB ,/, showed/VBD marked/JJ penetration/NN of/IN agar/NN medium/NN ./.
P10788473A09
In/IN a/DT third/JJ approach/NN ,/, we/PRP examined/VBD the/DT activation/NN of/IN MAPK/NN factors/NNS and/CC PKC/NN isoforms/NNS during/IN the/DT progression/NN of/IN load-induced/JJ hypertrophy/NN in/IN aortic/JJ banded/JJ rats/NNS with/IN or/CC without/IN cyclosporine/NN ./.
P10788507A10
Expression/NN of/IN Gab1DeltaPI3K/NN had/VBD no/DT apparent/JJ effect/NN on/IN ERK2/NN activation/NN by/IN LPA/NN and/CC EGF/NN in/IN the/DT cells/NNS that/WDT we/PRP have/VBP examined/VBN ./.
P10791952A11
Together/RB ,/, these/DT data/NNS suggest/VBP that/IN multivalent/JJ aggregation/NN of/IN the/DT alpha/NN (/( 3/CD )/) beta/NN (/( 1/CD )/) integrin/NN regulates/VBZ proteinase/NN expression/NN ,/, matrix/NN proteolysis/NN ,/, and/CC subsequent/JJ cellular/JJ behavior/NN ./.
P10794718A04
Both/DT types/NNS of/IN stimuli/NNS resulted/VBD in/IN a/DT significant/JJ activation/NN of/IN JNK/NN and/CC p38/NN ,/, which/WDT closely/RB paralleled/VBD the/DT time-dependent/JJ induction/NN of/IN apoptosis/NN ./.
P10800946A06
Anisomycin/NN (/( 1/CD microM/NN )/) treatment/NN mimics/VBZ the/DT cytokine-induced/JJ enhancement/NN of/IN arachidonic/JJ acid/NN production/NN and/CC activates/VBZ the/DT p38/NN MAPK/NN pathway/NN ,/, but/CC does/VBZ not/RB activate/VBP the/DT NF-kappaB/NN pathway/NN ./.
P10801798A02
The/DT group/NN I/CD germinal/JJ center/NN kinase/NN family/NN members/NNS selectively/RB activate/VBP the/DT JNK/NN pathway/NN ./.
P10807411A10
Activation/NN of/IN NF-kappaB/NN occurred/VBD at/IN 30/CD min/NN ,/, and/CC increased/JJ activity/NN continued/VBD for/IN 6/CD h/NN ./.
P10807739A06
JNK/NN and/CC ERK/NN were/VBD activated/VBN by/IN ET-1/NN binding/NN to/TO a/DT single/JJ receptor/NN (/( ET-1A/NN )/) but/CC differed/VBD in/IN their/PRP$ downstream/JJ mechanisms/NNS :/: only/RB JNK/NN activation/NN was/VBD sensitive/JJ to/TO the/DT radical/NN scavenger/NN N-acetylcysteine/NN and/CC diphenylene/NN iodonium/NN ,/, an/DT inhibitor/NN of/IN NADPH/NN oxidase/NN ,/, indicating/VBG a/DT role/NN for/IN ROS/NN ./.
P10807911A08
The/DT prolactin-induced/JJ activation/NN of/IN JNK/NN was/VBD prolonged/VBN and/CC accompanied/VBN by/IN a/DT significant/JJ increase/NN in/IN c-Jun/NN mRNA/NN abundance/NN and/CC c-Jun/NN protein/NN synthesis/NN ./.
P10807920A03
AVP/NN activated/VBD all/DT three/CD MAP/NN kinase/NN family/NN members/NNS :/: ERKs/NNS ,/, JNKs/NNS ,/, and/CC p38/NN MAP/NN kinase/NN ./.
P10807932A06
The/DT IL-1beta-induced/JJ increase/NN in/IN the/DT number/NN of/IN (/( 125/CD )/) I-PDGF-AA-binding/JJ sites/NNS at/IN the/DT cell/NN surface/NN was/VBD reduced/VBN >/SYM 70/CD %/SYM by/IN pretreatment/NN with/IN SB203580/NN ./.
P10809726A04
Calphostin/NN C/NN ,/, an/DT inhibitor/NN of/IN protein/NN kinase/NN C/NN ,/, blocked/VBD the/DT induction/NN of/IN COX-2/NN by/IN MIAs/NNS ./.
P10811116A07
Treatment/NN with/IN PMA/NN increased/VBD activator/NN protein-1/NN activity/NN and/CC the/DT binding/NN of/IN c-Jun/NN to/TO the/DT cyclic/JJ AMP/NN response/NN element/NN of/IN the/DT COX-2/NN promoter/NN ,/, effects/NNS that/WDT were/VBD blocked/VBN by/IN ursolic/JJ acid/NN ./.
P10817569A10
CONCLUSION/NN :/: These/DT results/NNS indicate/VBP that/IN ERK-1/NN //SYM ERK-2/NN signaling/NN and/CC transcriptional/JJ activation/NN through/IN AP-1/NN and/CC NF-kappaB/NN are/VBP essential/JJ for/IN the/DT induction/NN of/IN IL-8/NN expression/NN in/IN mononuclear/JJ phagocytes/NNS in/IN response/NN to/TO CPPD/NN and/CC MSU/NN crystals/NNS ./.
P10821851A04
By/IN contrast/NN ,/, SB/NN 203580/CD ,/, an/DT inhibitor/NN of/IN stress-activated/JJ protein/NN kinase-2/NN (/( SAPK2/NN )/) //SYM p38/NN MAP/NN kinase/NN ,/, had/VBD no/DT effect/NN on/IN any/PRP of/IN the/DT above/JJ parameters/NNS ,/, and/CC PPI/NN promoter/NN activity/NN and/CC PDX-1.c-myc/NN localization/NN were/VBD unaffected/VBN by/IN over-expression/NN of/IN the/DT upstream/JJ kinase/NN MKK6/NN (/( MAP/NN kinase/NN kinase-6/NN )/) or/CC wild-type/NN p38/NN //SYM SAPK2/NN ,/, respectively/RB ./.
P10833473A04
Intestinal/JJ epithelial/JJ barrier/NN function/NN was/VBD characterized/VBN through/IN transepithelial/JJ electrical/JJ resistance/NN and/CC mannitol/NN tracer/NN flux/NN ./.
P10840014A11
Furthermore/RB ,/, we/PRP found/VBD that/IN JNK1/NN specific/JJ antisense/NN oligonucleotide/NN could/MD suppress/VBP caspase-3/NN activity/NN but/CC not/RB affect/VBP H/NN (/( 2/CD )/) O/NN (/( 2/CD )/) generation/NN and/CC could/MD block/VBP apoptosis/NN induced/VBN by/IN high/JJ glucose/NN ./.
P10842159A04
The/DT antiproliferative/JJ and/CC p21/NN stimulatory/JJ effects/NNS of/IN NO/NN were/VBD not/RB suppressed/VBN by/IN the/DT soluble/JJ guanylate/NN cyclase/NN inhibitor/NN ODQ/NN ,/, implicating/VBG cGMP-independent/JJ signaling/NN ./.
P10843711A08
On/IN the/DT other/JJ hand/NN ,/, PD98059/NN inhibited/VBD actin/NN polymerization/NN stimulated/VBN by/IN Fc/NN gamma/NN R/NN cross-linking/NN ,/, while/IN SB203580/NN had/VBD no/DT effect/NN ./.
P10843887A04
We/PRP tested/VBD the/DT role/NN of/IN caldesmon/NN and/CC HSP27/NN phosphorylation/NN in/IN the/DT contractile/JJ response/NN of/IN vascular/JJ smooth/JJ muscle/NN by/IN using/NN inhibitors/NNS of/IN both/DT MAP/NN kinase/NN pathways/NNS ./.
P10845922A02
We/PRP demonstrate/VBP that/IN ligation/NN of/IN CD11b/NN (/( Mac-1/NN ,/, CR3/NN )/) or/CC CD11c/NN (/( p150/NN ,/, CR4/NN )/) alpha/NN chains/NNS of/IN beta2/NN integrins/NNS by/IN mAbs/NN or/CC soluble/JJ chimeric/JJ CD23/NN (/( sCD23/NN )/) on/IN human/NN freshly/RB isolated/JJ monocytes/NNS rapidly/RB stimulates/VBZ high/JJ levels/NNS of/IN interleukin-1beta/NN production/NN ./.
P10849439A02
Because/IN inflammatory/JJ processes/NNS are/VBP often/RB accompanied/VBN by/IN hsp/NN expression/NN and/CC because/IN stress/NN and/CC cytokines/NNS share/VBP several/JJ signaling/JJ pathways/NNS ,/, we/PRP investigated/VBD the/DT possibility/NN that/IN hsp70/NN might/MD modulate/VBP the/DT cellular/JJ response/NN to/TO cytokines/NNS ./.
P10849670A04
Exposure/NN to/TO moderate/JJ hypoxia/NN (/( 5/CD %/SYM O2/NN )/) was/VBD found/VBN to/TO progressively/RB stimulate/VB phosphorylation/NN and/CC activation/NN of/IN p38/NN gamma/NN in/IN particular/NN ,/, and/CC also/RB p38/NN alpha/NN ,/, two/CD isoforms/NNS of/IN the/DT p38/NN family/NN of/IN stress-activated/JJ protein/NN kinases/NNS ./.
P10864142A01
The/DT signal/NN transduction/NN pathways/NNS activated/VBN by/IN arachidonic/JJ acid/NN that/WDT lead/VBP to/TO p38/NN mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) activation/NN in/IN neutrophils/NNS remains/VBZ unclear/JJ ./.
P10864961A08
To/TO investigate/VB possible/JJ roles/NNS of/IN p38/NN in/IN RGC/NN death/NN ,/, a/DT p38/NN MAP/NN kinase/NN inhibitor/NN ,/, SB203580/NN ,/, was/VBD administered/VBN intravitreally/RB at/IN the/DT time/NN of/IN axotomy/NN and/CC repeated/VBN at/IN 5/CD and/CC 10/CD d/NN ./.
P10867029A03
Arachidonic/JJ acid/NN release/NN and/CC eicosanoid/NN production/NN induced/VBN by/IN stimuli/NNS that/WDT do/VBP (/( A23187/NN ,/, zymosan/NN )/) or/CC do/VBP not/RB (/( phorbol/NN myristate/NN acetate/NN (/( PMA/NN )/) ,/, okadaic/JJ acid/NN )/) mobilize/VBP calcium/NN were/VBD quantitatively/RB suppressed/VBN in/IN cPLA/NN (/( 2/CD )/) -deficient/JJ mouse/NN peritoneal/JJ macrophages/NNS ./.
P10871841A06
TPA-induced/JJ MEK1/NN //SYM 2/CD and/CC Raf-1/NN phosphorylation/NN were/VBD reduced/VBN in/IN these/DT cells/NNS ./.
P10874022A02
Three/CD major/JJ mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) ,/, c-JUN/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) ,/, p38/NN and/CC extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) ,/, have/VBP been/VBN shown/VBN to/TO regulate/VB apoptosis/NN ./.
P10874022A14
Together/RB ,/, the/DT results/NNS of/IN this/DT study/NN suggest/VBP that/IN JNK/NN and/CC p38/NN cooperatively/RB participate/VBP in/IN apoptosis/NN induced/VBN by/IN Cd/NN and/CC that/IN the/DT decreased/JJ ERK/NN signal/NN induced/VBN by/IN low/JJ Cd/NN doses/NNS contributes/VBZ to/TO growth/NN inhibition/NN or/CC apoptosis/NN ./.
P10874129A03
We/PRP now/RB report/VBP that/IN cycloheximide/NN ,/, a/DT protein/NN synthesis/NN inhibitor/NN ,/, caused/VBD an/DT almost/RB complete/JJ reversion/NN of/IN the/DT inhibitory/JJ effects/NNS of/IN dex/NN on/IN cPLA/NN (/( 2/CD )/) activation/NN ./.
P10880959A10
Leucine/NN residues/NNS in/IN the/DT sequence/NN were/VBD crucial/JJ for/IN the/DT NES/NN activity/NN ,/, as/IN the/DT activity/NN was/VBD lost/VBN on/IN replacement/NN of/IN the/DT leucines/NNS to/TO alanines/NNS ./.
P10888249A04
Overexpression/NN of/IN MEK1/NN EE/NN in/IN MCs/NNS activated/VBD ERK1/NN //SYM 2/CD and/CC subsequently/RB induced/VBD atrial/JJ natriuretic/JJ peptide/NN (/( ANP/NN )/) mRNA/NN expression/NN ./.
P10892858A07
EGF-induced/JJ PGE2/NN production/NN was/VBD suppressed/VBN by/IN AACOCF3/NN ,/, a/DT phospholipase/NN A2/NN (/( cPLA2/NN )/) inhibitor/NN ./.
P10892858A19
These/DT results/NNS indicate/VBP that/IN the/DT mitogenic/JJ response/NN to/TO EGF/NN in/FW vivo/FW in/IN the/DT proliferating/JJ basal/JJ cell/NN layer/NN may/MD be/VBP dependent/JJ on/IN the/DT level/NN of/IN its/PRP$ PKA/NN activity/NN ./.
P10898493A09
In/IN subpopulation/NN analyses/NNS ,/, synergistic/JJ activation/NN of/IN Raf1/NN was/VBD consistently/RB observed/VBN in/IN the/DT IgDlow/NN but/CC not/RB in/IN the/DT IgDhigh/NN cells/NNS ./.
P10898517A04
In/IN marked/JJ contrast/NN to/TO ERK/NN activation/NN ,/, c-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) activation/NN was/VBD observed/VBN in/IN all/DT mutants/NNS when/WRB co-stimulated/VBN with/IN CD28/NN ./.
P10899931A09
The/DT first/PRP ,/, peaking/VBG at/IN 1/CD h/NN ,/, is/VBZ transient/JJ ,/, does/VBZ not/RB require/VBP protein/NN synthesis/NN ,/, and/CC is/VBZ regulated/VBN at/IN the/DT transcriptional/JJ level/NN ./.
P10903502A12
The/DT Fg/NN :/: ICAM-1/NN endothelial/JJ cell/NN survival/NN pathway/NN appears/VBZ to/TO be/VB mediated/VBN via/IN the/DT activation/NN and/CC upregulation/NN of/IN ERK-1/NN //SYM 2/CD and/CC A1/NN ./.
P10903733A06
Analysis/NN of/IN deletion/NN mutants/NNS of/IN the/DT intracytoplasmic/JJ tail/NN of/IN BCMA/NN showed/VBD that/IN the/DT 25-aa/NN protein/NN segment/NN ,/, from/IN position/NN 119/CD to/TO 143/CD ,/, conserved/VBN between/IN mouse/NN and/CC human/NN BCMA/NN ,/, is/VBZ essential/JJ for/IN its/PRP$ association/NN with/IN the/DT TRAFs/NNS and/CC the/DT activation/NN of/IN NF-kappa/NN B/NN ,/, Elk-1/NN ,/, and/CC c-Jun/NN N-terminal/JJ kinase/NN ./.
P10903806A05
When/WRB added/VBN together/RB ,/, p38i/NN and/CC MEKi/NN decreased/VBD IL-1/NN beta-induced/JJ nitrite/NN production/NN over/IN 24/CD hours/NNS by/IN 60/CD %/SYM ,/, but/CC did/VBD not/RB affect/VBP IL-1/NN beta-induced/JJ manganese/NN superoxide/NN dismutase/NN (/( MnSOD/NN )/) mRNA/NN expression/NN ./.
P10906152A09
The/DT MAP/NN kinase/NN kinase/NN inhibitor/NN PD98059/NN completely/RB inhibits/VBZ AngII-induced/JJ p27/NN (/( Kip1/NN )/) expression/NN and/CC (/( 3/CD )/) [/( H/NN ]/) leucine/NN incorporation/NN into/IN proteins/NNS as/IN a/DT previously/RB established/JJ marker/NN of/IN cell/NN hypertrophy/NN ./.
P10910078A07
Each/PRP of/IN five/CD mirk/NN transfectants/NNS proliferated/VBD when/WRB switched/VBN to/TO serum-free/JJ medium/NN and/CC regained/VBD rapid/JJ growth/NN when/WRB serum/NN was/VBD restored/VBN ,/, whereas/IN five/CD vector/NN control/NN transfectants/NNS and/CC three/CD kinase-dead/NN mutant/JJ mirk/NN transfectants/NNS did/VBD not/RB ./.
P10910949A12
Neither/CC the/DT specific/JJ kinase/NN inhibitors/NNS nor/CC expression/NN of/IN MKK7A/NN altered/VBD Cr/NN (/( VI/CD )/) -induced/JJ cytotoxicity/NN ./.
P10913001A02
We/PRP tested/VBD the/DT hypothesis/NN that/IN this/DT coupling/NN is/VBZ mediated/VBN by/IN enzymes/NNS of/IN the/DT phosphatidylinositol/NN (/( PI/NN )/) 3-kinase/NN family/NN ./.
P10913368A01
The/DT generation/NN of/IN proinflammatory/JJ eicosanoids/NNS in/IN response/NN to/TO tumor/NN necrosis/NN factor/NN (/( TNF/NN )/) involves/VBZ the/DT activation/NN of/IN cytosolic/JJ phospholipase/NN A/NN (/( 2/CD )/) (/( cPLA/NN (/( 2/CD )/) )/) ,/, presumably/RB by/IN phosphorylation/NN through/IN extracellular/JJ signal-regulated/JJ kinases/NNS (/( ERK/NN )/) ./.
P10915907A03
Recombinant/JJ human/NN bFGF/NN (/( 0.1-10/CD ng/NN //SYM ml/NN )/) induced/VBD phosphorylation/NN of/IN p44/NN //SYM 42/CD MAPK/NN (/( ERK1/NN //SYM 2/CD )/) in/IN a/DT concentration-/NN and/CC time-dependent/JJ manner/NN ./.
P10923358A12
CONCLUSION/NN :/: It/PRP seems/VBZ likely/JJ that/IN a/DT specific/JJ interaction/NN between/IN MAPK/NN and/CC p38MAPK/NN signaling/JJ pathway/NN may/MD be/VBP involved/VBN in/IN the/DT determination/NN of/IN the/DT cell/NN death/NN mechanism/NN in/IN pancreatic/JJ acini/NNS subjected/VBN to/TO stressful/JJ stimuli/NNS ./.
P10924699A04
Cycloheximide/NN (/( CHX/NN ,/, 20/CD microM/NN )/) ,/, a/DT protein/NN synthesis/NN inhibitor/NN ,/, alone/JJ caused/VBD increases/NNS of/IN c-fos/NN and/CC c-jun/NN mRNA/NN levels/NNS ./.
P10925166A05
These/DT findings/NNS suggest/VBP that/IN PKA/NN inhibition/NN prevents/VBZ depolarization-induced/JJ PYK2/NN //SYM MAP/NN kinase/NN pathway/NN activation/NN ,/, thereby/RB inhibiting/VBG the/DT early/JJ gene/NN expression/NN ./.
P10925255A06
Target/NN cell-induced/JJ IFN-gamma/NN and/CC FcgammaRIIIA-induced/JJ TNF-alpha/NN mRNA/NN accumulation/NN was/VBD similarly/RB affected/VBN under/IN the/DT same/JJ conditions/NNS ./.
P10926840A03
Transport/NN was/VBD stimulated/VBN maximally/RB by/IN anisomycin/NN (/( 2/CD microM/NN )/) and/CC blocked/VBN by/IN SB203580/NN (/( 20/CD microM/NN )/) ,/, confirming/VBG involvement/NN of/IN the/DT p38/NN pathway/NN ./.
P10930980A08
Interestingly/RB ,/, both/CC EPO/NN and/CC SCF/NN induced/VBD activation/NN of/IN PI3K/NN ./.
P10935911A05
MAP/NN kinase/NN activity/NN ,/, caused/VBN by/IN calcium/NN influx/NN ,/, was/VBD determined/VBN using/VBG either/CC a/DT specific/JJ synthetic/JJ peptide/NN ,/, or/CC an/DT in/IN gel/NN kinase/NN assay/NN ./.
P10940738A05
ERK/NN activation/NN was/VBD mimicked/VBN by/IN cholera/NN toxin/NN ,/, forskolin/NN and/CC 8bromo-cAMP/NN ./.
P10945503A02
The/DT signalling/JJ pathways/NNS employing/VBG the/DT mitogen-activated/JJ ERK-activating/JJ kinase/NN (/( MEK/NN )/) and/CC the/DT extracellular-regulated/JJ kinase/NN (/( ERK/NN )/) are/VBP critical/JJ in/IN growth/NN factors/NNS signalling/NN ./.
P10945608A02
Under/IN nonstressed/JJ conditions/NNS ,/, increased/JJ expression/NN of/IN GSTp/NN via/IN a/DT tet-off-inducible/JJ GSTp/NN in/IN NIH/NN 3T3/NN cells/NNS increased/VBD the/DT phosphorylation/NN of/IN mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN kinase/NN 4/CD ,/, p38/NN ,/, extracellular/JJ receptor/NN kinase/NN (/( ERK/NN )/) ,/, and/CC inhibitor/NN of/IN kappa-kinase/NN (/( IKK/NN )/) ,/, and/CC reduced/VBD phosphorylation/NN of/IN MAP/NN kinase/NN kinase/NN 7/CD and/CC Jun/NN NH2-terminal/JJ kinase/NN (/( JNK/NN )/) ./.
P10953046A07
Marked/JJ activation/NN of/IN the/DT JNK/NN pathway/NN through/IN SEK1/NN and/CC apoptosis/NN signal-regulating/JJ kinase/NN 1/CD (/( ASK1/NN )/) ,/, an/DT upstream/JJ kinase/NN of/IN SEK1/NN ,/, was/VBD demonstrated/VBN by/IN the/DT transient/JJ transfection/NN of/IN cDNA/NN for/IN wild-type/NN SEK1/NN or/CC ASK1/NN together/RB with/IN JNK/NN into/IN COS-7/NN cells/NNS ./.
P10958675A08
To/TO determine/VB if/IN Src/NN family/NN kinases/NNS (/( SFKs/NNS )/) are/VBP involved/VBN ,/, we/PRP demonstrated/VBD that/IN CSF-1/NN activated/VBD Fyn/NN and/CC Lyn/NN in/IN cells/NNS expressing/VBG wild-type/NN (/( WT/NN )/) or/CC DeltaKI/NN receptors/NNS ./.
P10958679A07
Development/NN of/IN thermotolerance/NN was/VBD not/RB associated/VBN with/IN Akt/NN or/CC ERK1/NN and/CC -2/CD regulation/NN ,/, and/CC inhibition/NN of/IN these/DT kinases/NNS did/VBD not/RB reduce/VBP acquired/JJ thermotolerance/NN ./.
P10960082A12
Immunoblot/NN analysis/NN demonstrated/VBD the/DT translocation/NN of/IN the/DT conventional/JJ isoform/NN cPKC-alpha/NN from/IN cytosol/NN to/TO membrane/NN following/VBG treatment/NN with/IN IL-1beta/NN ./.
P10961885A06
Although/IN the/DT site/NN surrounding/VBG serine/NN 721/CD is/VBZ an/DT optimum/NN consensus/NN sequence/NN for/IN mitogen-activated/JJ family/NN of/IN protein/NN kinases/NNS (/( MAPKs/NNS )/) -mediated/JJ phosphorylation/NN ,/, we/PRP demonstrate/VBP that/IN IL-12/NN does/VBZ not/RB induce/VBP extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) or/CC c-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) activation/NN in/IN T/NN and/CC natural/JJ killer/NN (/( NK/NN )/) cells/NNS and/CC that/IN IL-12-induced/JJ STAT4/NN transcriptional/JJ activity/NN is/VBZ not/RB affected/VBN by/IN these/DT kinases/NNS ./.
P10965886A04
The/DT purpose/NN of/IN the/DT present/JJ study/NN was/VBD to/TO investigate/VB the/DT role/NN of/IN the/DT MAP/NN kinase/NN pathway/NN in/IN regulating/NN IGFBP-1/NN synthesis/NN by/IN IL-1beta/NN ./.
P10969830A06
Inhibition/NN of/IN ERK-1/NN //SYM 2/CD and/CC p38/NN did/VBD not/RB prevent/VBP but/CC aggravated/VBD IL-1beta-induced/JJ cell/NN death/NN ./.
P10971222A01
Activation/NN of/IN mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinases/NNS has/VBZ been/VBN implicated/VBN in/IN the/DT signal/NN transduction/NN pathways/NNS linking/VBG exercise/NN to/TO adaptive/JJ changes/NNS of/IN muscle/NN protein/NN expression/NN ./.
P10972672A09
Pretreatment/NN with/IN MAP/NN kinase/NN kinase/NN inhibitor/NN PD098059/NN or/CC JNK-c-Jun/NN //SYM AP-1/NN inhibitor/NN curcumin/NN attenuated/VBD the/DT H2O2-induced/JJ apoptosis/NN ./.
P10989603A05
Among/IN MAPK/NN ,/, extracellular-signal/NN related/JJ kinase/NN (/( ERK/NN )/) 1/CD //SYM 2/CD was/VBD activated/VBN by/IN UV/NN regardless/RB of/IN the/DT oxidative/JJ level/NN ,/, while/IN c-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) activation/NN was/VBD inhibited/VBN in/IN NAC-treated/JJ and/CC in/IN hypoxic/JJ cultures/NNS ./.
P10994762A03
Therefore/RB ,/, the/DT present/JJ study/NN aimed/VBD to/TO determine/VB whether/IN the/DT trophic/JJ effects/NNS of/IN AngII/NN and/CC the/DT AngII-induced/JJ haemodynamic/JJ load/NN were/VBD associated/VBN with/IN specific/JJ cardiac/JJ MAPK/NN pathways/NNS during/IN the/DT development/NN of/IN hypertrophy/NN ./.
P10994854A04
Peak/JJ expression/NN represented/VBD a/DT 2.7-fold/NN ,/, 3.7-fold/NN ,/, and/CC 4.8-fold/NN increase/NN in/IN each/PRP of/IN these/DT MAPKs/NNS ,/, respectively/RB ./.
P10995825A01
Long-term/NN potentiation/NN (/( LTP/NN )/) in/IN perforant/JJ path-granule/NN cell/NN synapses/NNS is/VBZ decreased/VBN in/IN aged/JJ rats/NNS ,/, stressed/JJ rats/NNS ,/, and/CC rats/NNS injected/VBN intracerebroventricularly/RB with/IN the/DT proinflammatory/JJ cytokine/NN interleukin-1beta/NN (/( IL-1beta/NN )/) ./.
P10997694A04
Here/RB ,/, we/PRP examine/VBP the/DT role/NN of/IN MAPKs/NNS in/IN TGF-beta-induced/JJ gene/NN expression/NN of/IN extracellular/JJ matrix/NN proteins/NNS in/IN mesangial/JJ cells/NNS ./.
P10999952A03
Using/VBG Chinese/NN hamster/NN ovary/NN cells/NNS stably/RB transfected/VBN with/IN the/DT CB/NN (/( 1/CD )/) receptor/NN cDNA/NN ,/, we/PRP show/VBP here/RB that/IN Delta/NN (/( 9/CD )/) -tetrahydrocannabinol/NN (/( THC/NN )/) ,/, the/DT major/JJ active/JJ component/NN of/IN marijuana/NN ,/, induces/VBZ the/DT activation/NN of/IN c-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) ./.
P11002425A08
These/DT results/NNS implicate/VBP ERK/NN activation/NN in/IN EWS/NN //SYM FLI-1/NN transformation/NN and/CC suggest/VBP that/IN this/DT signaling/JJ pathway/NN may/MD be/VBP important/JJ in/IN the/DT pathogenesis/NN of/IN Ewing/NN 's/POS sarcoma/NN ./.
P11003655A04
We/PRP have/VBP identified/VBN the/DT guanine/NN nucleotide/NN exchange/NN factors/NNS Sos1/NN and/CC Sos2/NN as/IN novel/JJ binding/JJ partners/NNS of/IN Abi-1/NN ./.
P11004363A01
OBJECTIVE/NN :/: To/TO investigate/VB whether/IN the/DT activity/NN of/IN the/DT three/CD mitogen-activated/JJ protein/NN kinases/NNS (/( Jun/NN aminoterminal/JJ kinase/NN ,/, extracellular/JJ regulated/JJ kinase/NN ,/, and/CC p38/NN )/) is/VBZ altered/VBN in/IN placental/JJ tissue/NN of/IN women/NNS with/IN preeclampsia/NN and/CC hemolysis/NN ,/, elevated/JJ liver/NN enzymes/NNS ,/, low/JJ platelets/NNS (/( HELLP/NN )/) syndrome/NN ./.
P11005808A05
A/DT MEK-specific/JJ inhibitor/NN ,/, PD98059/NN ,/, inhibited/VBD heat/NN shock/NN ERK/NN MAPK/NN activation/NN by/IN >/SYM 75/CD %/SYM ./.
P11006227A08
The/DT PI-3/NN kinase/NN 85-kDa/NN subunit/NN was/VBD decreased/VBN 25/CD %/SYM in/IN LY294002-treated/JJ tissue/NN ,/, and/CC collagen/NN binding/NN also/RB decreased/VBD significantly/RB in/IN tissues/NNS treated/VBN with/IN MEK-1/NN and/CC PI-3/NN kinase/NN inhibitors/NNS compared/VBN with/IN control/NN tissues/NNS ./.
P11006268A10
The/DT protein/NN kinase/NN A/NN inhibitor/NN H89/NN inhibited/VBD the/DT stimulation/NN of/IN phosphorylation/NN of/IN p38-MAPKs/NNS by/IN forskolin/NN ,/, whereas/IN inhibitors/NNS of/IN protein/NN kinase/NN C/NN ,/, p70/NN (/( S6k/NN )/) ,/, and/CC phosphatidylinositol/NN 3-kinase/NN were/VBD ineffective/JJ ./.
P11010976A04
We/PRP also/RB found/VBD that/IN the/DT preferential/JJ activation/NN of/IN p38alpha/NN by/IN MKK6/NN correlated/VBD with/IN more/RB efficient/JJ binding/NN of/IN MKK6/NN to/TO p38alpha/NN than/IN to/TO p38gamma/NN ./.
P11012613A05
Further/RB ,/, SB/NN 203580/CD ,/, a/DT specific/JJ p38/NN MAPK/NN inhibitor/NN ,/, was/VBD additive/JJ with/IN dexamethasone/NN in/IN inducing/NN eosinophil/NN apoptosis/NN ,/, while/IN JNK1/NN //SYM 2/CD antisense/NN phosphorothioate/NN oligodeoxynucleotides/NNS did/VBD not/RB show/VBP any/DT significant/JJ effect/NN ./.
P11012878A02
The/DT induction/NN of/IN c-fos/NN in/IN response/NN to/TO MC/NN stretch/NN has/VBZ been/VBN shown/VBN ./.
P11012878A14
Nuclear/JJ protein/NN binding/NN to/TO AP-1/NN was/VBD also/RB determined/VBN under/IN these/DT conditions/NNS ./.
P11013043A06
The/DT ECs/NNS were/VBD then/RB subjected/VBN to/TO 10/CD dyne/NN //SYM cm/NN (/( 2/CD )/) shear/NN with/IN the/DT use/NN of/IN a/DT parallel/JJ flow/NN chamber/NN for/IN up/IN to/TO 120/CD minutes/NNS ./.
P11016630A01
Methyl/NN methanesulfonate/NN (/( MMS/NN )/) ,/, a/DT direct-acting/JJ alkylating/JJ agent/NN ,/, is/VBZ a/DT strong/JJ brain/NN carcinogen/NN but/CC a/DT poor/JJ hepatocarcinogen/NN in/IN rats/NNS ./.
P11018755A02
We/PRP have/VBP used/VBN a/DT non-mammalian/JJ vertebrate/NN model/NN ,/, the/DT frog/NN Rana/NN esculenta/NN ,/, to/TO investigate/VB the/DT regulation/NN of/IN extracellular/JJ signal-regulated/JJ kinase/NN 1/CD and/CC 2/CD (/( ERK1/NN //SYM 2/CD )/) activity/NN in/IN the/DT testis/NN during/IN the/DT annual/JJ sexual/JJ cycle/NN and/CC to/TO study/VB whether/IN E/NN (/( 2/CD )/) exerts/VBZ a/DT role/NN in/IN spermatogenesis/NN through/IN the/DT regulation/NN of/IN ERK1/NN //SYM 2/CD activity/NN ./.
P11023661A09
These/DT studies/NNS demonstrate/VBP cooperation/NN between/IN the/DT MAPK/NN and/CC NF-kappaB/NN signaling/JJ pathways/NNS for/IN IL-1-dependent/JJ collagenase-1/NN transcription/NN ,/, and/CC they/PRP define/VBP a/DT dichotomy/NN of/IN IL-1-/CD and/CC TNF-elicited/JJ signaling/NN that/WDT is/VBZ relevant/JJ to/TO cytokine-mediated/JJ connective/JJ tissue/NN disease/NN ./.
P11027277A11
The/DT results/NNS of/IN this/DT study/NN suggest/VBP that/IN PI3-K/NN may/MD be/VBP required/VBN for/IN the/DT signals/NNS initiated/VBN by/IN TrkA/NN internalization/NN and/CC demonstrate/VBP that/IN specific/JJ endocytic/JJ events/NNS may/MD distinguish/VBP ERK/NN signaling/NN via/IN Rap1/NN and/CC Ras/NN ./.
P11027490A07
These/DT findings/NNS establish/VBP a/DT key/JJ role/NN for/IN p38/NN MAPK/NN in/IN antigen/NN receptor-mediated/JJ apoptosis/NN of/IN CH31/NN B/NN cells/NNS ./.
P11031257A02
Blockade/NN of/IN the/DT ERK/NN pathway/NN by/IN treatment/NN with/IN PD98059/NN ,/, a/DT specific/JJ inhibitor/NN of/IN mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN //SYM ERK/NN kinase/NN (/( MEK/NN )/) ,/, completely/RB suppressed/VBD the/DT growth/NN of/IN tumor/NN cells/NNS in/IN which/WDT the/DT pathway/NN is/VBZ constitutively/RB activated/VBN (/( RPMI-SE/NN and/CC HT1080/NN cells/NNS )/) ./.
P11032876A05
Finally/RB ,/, transfection/NN of/IN p38AGF/NN ,/, which/WDT exhibits/VBZ a/DT mutated/JJ activation/NN loop/NN ,/, inhibited/VBD cAMP-mediated/JJ neuronal/JJ differentiation/NN ./.
P11032891A03
The/DT regulation/NN of/IN COX/NN expression/NN in/IN neuronal/JJ cells/NNS is/VBZ only/RB partly/RB understood/VBN and/CC has/VBZ been/VBN mainly/RB linked/VBN to/TO synaptic/JJ activity/NN ./.
P11035106A05
Pseudosubstrate-specific/JJ peptides/NNS with/IN attached/JJ myristic/JJ acid/NN are/VBP cell/NN permeable/JJ and/CC can/MD be/VBP used/VBN to/TO block/VB the/DT activity/NN of/IN specific/JJ PKC/NN isoforms/NNS in/FW vivo/FW ./.
P11040101A10
Together/RB ,/, these/DT results/NNS indicate/VBP that/IN IL-1/NN beta/NN induces/VBZ VEGF/NN gene/NN expression/NN at/IN both/DT transcriptional/JJ and/CC post-transcriptional/JJ levels/NNS ,/, and/CC IL-1/NN beta/NN evokes/VBZ p38/NN MAPK/NN and/CC JNK/NN signalings/NNS ,/, which/WDT in/IN turn/NN stimulate/VBP the/DT transcription/NN of/IN the/DT VEGF/NN gene/NN through/IN Sp1-binding/JJ sites/NNS ./.
P11040243A11
These/DT data/NNS suggest/VBP that/IN the/DT activation/NN of/IN Ras/NN and/CC CYP450/NN contributes/VBZ to/TO the/DT development/NN of/IN Ang/NN II-dependent/JJ hypertension/NN and/CC associated/JJ vascular/JJ pathology/NN ./.
P11041451A10
Moreover/RB ,/, Gs/NN or/CC Gi/NN //SYM Go/NN proteins/NNS do/VBP not/RB appear/VBP to/TO participate/VB in/IN p42/NN //SYM p44/NN MAPK/NN activation/NN ./.
P11044439A06
Finally/RB ,/, we/PRP investigated/VBD the/DT molecular/JJ mechanism/NN of/IN JSAP1/NN 's/POS inhibitory/JJ function/NN and/CC showed/VBD that/IN JSAP1/NN prevents/VBZ MEK1/NN phosphorylation/NN and/CC activation/NN by/IN Raf-1/NN ,/, resulting/VBG in/IN the/DT suppression/NN of/IN the/DT activation/NN of/IN ERK/NN ./.
P11048642A04
The/DT ras/NN transformed/JJ cells/NNS formed/VBD numerous/JJ spikes/NNS at/IN the/DT edges/NNS of/IN cells/NNS and/CC showed/VBD loss/NN of/IN contact/NN inhibition/NN ./.
P11050008A02
An/DT improved/JJ understanding/NN of/IN the/DT mechanisms/NNS of/IN malarial/JJ clearance/NN may/MD facilitate/VBP the/DT development/NN of/IN new/JJ therapeutic/JJ interventions/NNS ./.
P11050045A01
Persistent/JJ hepatitis/NN C/NN virus/NN (/( HCV/NN )/) infection/NN is/VBZ associated/VBN with/IN the/DT development/NN of/IN human/NN hepatocellular/JJ carcinoma/NN (/( HCC/NN )/) ,/, although/IN the/DT mechanism/NN of/IN HCV-related/JJ hepatocarcinogenesis/NN remains/VBZ unclear/JJ ./.
P11053245A06
In/IN contrast/NN to/TO ischemia/NN ,/, brief/JJ ,/, lethal-simulated/JJ ischemia/NN activated/VBD only/RB p38/NN (/( 2.8/CD +/-/SYM 0.45/CD vs./CC basal/JJ ,/, P/NN </SYM 0.01/CD )/) ,/, which/WDT was/VBD attenuated/VBN by/IN expression/NN of/IN active/JJ PKC-delta/NN or/CC by/IN preconditioning/NN (/( 0.48/CD +/-/SYM 0.1/CD vs./CC ischemia/NN ,/, P/NN </SYM 0.01/CD )/) ./.
P11053253A07
Other/JJ potential/JJ targets/NNS of/IN ceramide/NN in/IN the/DT control/NN of/IN cell/NN fate/NN ,/, namely/RB ,/, c-Jun/NN amino-terminal/JJ kinase/NN ,/, p38/NN mitogen-activated/JJ protein/NN kinase/NN ,/, and/CC protein/NN kinase/NN B/NN ,/, were/VBD not/RB significantly/RB affected/VBN in/IN astrocytes/NNS exposed/VBN to/TO palmitate/NN ./.
P11053415A01
The/DT intensity/NN and/CC duration/NN of/IN an/DT inflammatory/JJ response/NN depends/VBZ on/IN the/DT balance/NN of/IN factors/NNS that/WDT favor/VBP perpetuation/NN versus/CC resolution/NN ./.
P11057029A07
Their/PRP$ pro-apoptotic/JJ effect/NN ,/, however/WRB ,/, was/VBD neither/CC mimicked/VBN nor/CC modified/VBN by/IN an/DT additional/JJ inhibition/NN of/IN MEK/NN //SYM ERK/NN kinase/NN by/IN 50/CD microM/NN PD/NN 98059/CD ,/, resulting/VBG in/IN an/DT 80/CD %/SYM inhibition/NN of/IN its/PRP$ initial/JJ activity/NN ./.
P11057428A08
The/DT contribution/NN of/IN ERK/NN to/TO cell/NN growth/NN was/VBD supported/VBN by/IN the/DT observation/NN that/IN addition/NN of/IN PD98059/NN ,/, a/DT specific/JJ inhibitor/NN of/IN MAPK/NN kinase/NN ,/, significantly/RB attenuated/VBN the/DT increase/NN in/IN endothelial/JJ cell/NN numbers/NNS induced/VBN by/IN HGF/NN ,/, in/IN a/DT dose-dependent/JJ manner/NN ./.
P11058801A07
These/DT findings/NNS indicate/VBP that/IN JNK/NN and/CC p38/NN MAPK/NN pathways/NNS may/MD play/VBP important/JJ roles/NNS in/IN neuronal/JJ death/NN during/IN brain/NN ischemia/NN ./.
P11062705A10
Genetic/JJ and/CC pharmacologic/JJ inhibition/NN of/IN ERK1/NN activity/NN was/VBD sufficient/JJ to/TO reproduce/VB the/DT effects/NNS of/IN ATF-2/NN on/IN cell/NN cycle/NN progression/NN and/CC proliferation/NN ./.
P11069059A07
Collectively/RB ,/, these/DT results/NNS suggest/VBP that/IN the/DT p38/NN MAPK/NN pathway/NN is/VBZ stimulated/VBN during/IN the/DT development/NN of/IN NK/NN cell-mediated/JJ cytotoxicity/NN and/CC that/IN efficient/JJ killing/NN is/VBZ influenced/VBN by/IN both/CC p38-dependent/JJ and/CC p38-independent/JJ pathways/NNS ./.
P11069918A09
This/DT work/NN also/RB suggests/VBZ that/IN whereas/IN MAPKs/NNS utilize/VBP docking/JJ interactions/NNS to/TO bind/VB substrates/NNS ,/, they/PRP can/MD be/VBP weak/JJ and/CC transient/JJ in/IN nature/NN ,/, providing/VBG just/RB enough/DT binding/JJ energy/NN to/TO promote/VB the/DT phosphorylation/NN of/IN a/DT specific/JJ substrate/NN ./.
P11071904A08
This/DT sequence/NN of/IN events/NNS provides/VBZ a/DT model/NN for/IN efficient/JJ cell/NN scattering/NN by/IN SF/NN //SYM HGF/NN at/IN low/JJ cell/NN density/NN ./.
P11071910A09
Complete/JJ inhibition/NN of/IN the/DT MEK/NN //SYM ERK/NN pathway/NN causes/VBZ 50/CD %/SYM decrease/NN of/IN D2/NN expression/NN ./.
P11073940A07
Activation/NN of/IN BMK1/NN //SYM ERK5/NN by/IN epidermal/JJ growth/NN factor/NN and/CC H2O2/NN in/IN Cos7/NN and/CC HEK293/NN cells/NNS was/VBD completely/RB blocked/VBN by/IN a/DT kinase-inactive/JJ MEKK3/NN (/( MEKK3kin/NN (/( -/SYM )/) )/) ,/, whereas/IN MEKK2kin/NN (/( -/SYM )/) had/VBD no/DT effect/NN ./.
P11074940A01
Stress/NN responses/NNS induced/VBN in/IN fibroblasts/NNS by/IN cryopreservation/NN were/VBD compared/VBN in/IN suspension/NN or/CC three-dimensional/JJ cultures/NNS at/IN various/JJ times/NNS up/IN to/TO 5/CD days/NNS of/IN recovery/NN ./.
P11076965A10
In/IN addition/NN ,/, we/PRP show/VBP that/IN the/DT polyamine/NN biosynthetic/JJ enzymes/NNS require/VBP c-Jun/NN activation/NN for/IN eliciting/NN their/PRP$ biological/JJ effects/NNS ./.
P11078444A02
In/IN this/DT article/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN osmotic/JJ shock/NN and/CC insulin/NN on/IN the/DT activation/NN of/IN the/DT mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) cascades/NNS in/IN differentiated/JJ 3T3-L1/NN adipocytes/NNS ./.
P11078444A13
Insulin/NN and/CC osmotic/JJ shock-stimulated/JJ glucose/NN transport/NN was/VBD not/RB inhibited/VBN by/IN any/DT inhibitor/NN at/IN concentrations/NNS that/WDT were/VBD shown/VBN to/TO block/VB p38/NN MAPK/NN activity/NN ./.
P11078445A06
In/FW vitro/FW insulin/NN treatment/NN (/( 1/CD nmol/NN //SYM l/NN over/IN 4/CD min/NN )/) and/CC electrically-induced/JJ contraction/NN of/IN isolated/JJ extensor/NN digitorum/NN longus/NN (/( EDL/NN )/) muscle/NN also/RB doubled/VBD the/DT kinase/NN activity/NN of/IN p38/NN MAPKalpha/NN and/CC p38/NN MAPKbeta/NN ./.
P11080183A08
A/DT cause-effect/NN relationship/NN between/IN agonist-dependent/JJ AA/NN release/NN and/CC stimulation/NN of/IN MAPKs/NNS ,/, but/CC not/RB the/DT opposite/NN ,/, was/VBD suggested/VBN by/IN activation/NN of/IN JNK/NN by/IN exogenous/JJ AA/NN and/CC by/IN the/DT observation/NN that/IN inhibition/NN of/IN MAPK/NN kinase/NN or/CC p38/NN MAPK/NN was/VBD inconsequential/JJ to/TO ET-1-induced/JJ AA/NN release/NN ./.
P11080191A02
Because/IN neuronal/JJ mechanisms/NNS controlling/VBG these/DT responses/NNS are/VBP not/RB known/VBN ,/, these/PRP were/VBD investigated/VBN in/IN human/NN neuroblastoma/NN SH-SY5Y/NN cells/NNS ./.
P11082122A08
In/IN contrast/NN ,/, SN50/NN failed/VBD to/TO affect/VB the/DT release/NN of/IN GM-CSF/NN from/IN the/DT same/JJ monocyte/NN cultures/NNS ./.
P11082292A04
We/PRP provide/VBP a/DT strong/JJ argument/NN indicating/VBG the/DT existence/NN of/IN a/DT direct/JJ correlation/NN between/IN JNK1/NN activation/NN and/CC cyclin/NN D2/NN stimulation/NN ./.
P11082445A05
Among/IN all/DT known/JJ PTX-insensitive/JJ G/NN proteins/NNS ,/, G/NN (/( z/NN )/) ,/, G/NN (/( 12/CD )/) ,/, G/NN (/( 14/CD )/) ,/, and/CC G/NN (/( 16/CD )/) seemed/VBD to/TO have/VB functional/JJ coupling/NN with/IN the/DT ORL/NN (/( 1/CD )/) receptor/NN in/IN terms/NNS of/IN JNK/NN activation/NN ./.
P11085325A09
Neurotoxicant-induced/JJ reductions/NNS in/IN striatal/JJ levels/NNS of/IN DA/NN and/CC tyrosine/NN hydroxylase/NN (/( TH/NN )/) paralleled/VBD the/DT temporal/JJ profile/NN of/IN GFAP/NN induction/NN ./.
P11087751A02
In/IN the/DT present/JJ study/NN ,/, we/PRP analyzed/VBD the/DT role/NN of/IN mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinases/NNS in/IN the/DT induction/NN of/IN TNF-alpha/NN by/IN glass/NN fibers/NNS ./.
P11089552A05
In/IN DCT/NN cells/NNS ,/, stimulation/NN of/IN calcium/NN entry/NN with/IN ionomycin/NN did/VBD not/RB activate/VBP ERK2/NN or/CC augment/VBP PTH-stimulated/JJ ERK2/NN activity/NN ,/, indicating/VBG that/IN MAPK/NN activation/NN lies/VBZ upstream/JJ of/IN calcium/NN entry/NN ./.
P11090594A03
Cyclic/JJ strain/NN induced/VBD activation/NN of/IN extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN ;/: 1.5-fold/NN )/) ,/, c-Jun/NN NH/NN (/( 2/CD )/) -terminal/JJ protein/NN kinase/NN (/( JNK/NN ;/: 1.9-fold/NN )/) ,/, and/CC p38/NN (/( 1./CD 5-fold/NN )/) with/IN a/DT peak/NN at/IN 30/CD min/NN ./.
P11093788A02
Tyrosine/NN kinase/NN inhibitors/NNS (/( genistein/NN or/CC tyrphostin/NN 23/CD )/) or/CC phosphatidylcholine-specific/JJ phospholipase/NN C/NN inhibitor/NN (/( D609/NN )/) attenuated/VBD IL-1beta-induced/JJ ICAM-1/NN expression/NN ./.
P11093794A07
Furthermore/RB ,/, we/PRP determined/VBD whether/IN the/DT RANK/NN engagement/NN of/IN JNK/NN signaling/JJ pathways/NNS could/MD lead/VBP to/TO the/DT activation/NN of/IN the/DT activator/NN protein/NN 1/CD (/( AP-1/NN )/) transcription/NN factor/NN ,/, one/CD of/IN the/DT potential/JJ downstream/JJ targets/NNS of/IN activated/JJ JNK/NN ./.
P11094337A06
In/IN one/CD case/NN ,/, we/PRP identified/VBD a/DT compact/JJ RNA/NN structural/JJ domain/NN responsible/JJ for/IN inhibition/NN ./.
P11095645A08
Overexpression/NN of/IN MAPK/NN phosphatase/NN CL/NN 100/CD prevented/VBD TGF-beta1/NN promoter/NN activation/NN by/IN high/JJ glucose/NN ,/, confirming/VBG the/DT involvement/NN of/IN the/DT MEK-ERK/NN pathway/NN in/IN response/NN to/TO high/JJ glucose/NN ./.
P11101507A01
Members/NNS of/IN the/DT mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) cascade/NN such/JJ as/IN extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) ,/, c-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) and/CC p38/NN are/VBP implicated/VBN as/IN important/JJ regulators/NNS of/IN cardiomyocyte/NN hypertrophic/JJ growth/NN in/IN culture/NN ./.
P11103805A03
However/WRB ,/, Bcl-2/NN phosphorylation/NN has/VBZ been/VBN reported/VBN to/TO occur/VB at/IN G2-M/NN in/IN nonapoptotic/JJ cells/NNS ,/, raising/VBG the/DT possibility/NN that/IN this/DT and/CC perhaps/RB other/DT signaling/JJ pathways/NNS altered/VBN by/IN microtubule/NN inhibitors/NNS reflect/VBP perturbations/NNS of/IN normal/JJ mitotic/JJ events/NNS ./.
P11104828A02
LL-Z1640-2/NN ,/, a/DT macrocyclic/JJ nonaketide/NN ,/, inhibited/VBD HgCl2-induced/JJ JNK/NN phosphorylation/NN at/IN 5-100/CD ng/NN //SYM ml/NN ./.
P11108246A01
Tumor/NN necrosis/NN factor-alpha/NN (/( TNFalpha/NN )/) induces/VBZ apoptosis/NN and/CC cell/NN growth/NN inhibition/NN in/IN primary/JJ rat/NN fetal/JJ brown/JJ adipocytes/NNS ./.
P11108246A13
These/DT results/NNS suggest/VBP that/IN p38MAPK/NN mediates/VBZ TNFalpha-induced/JJ apoptosis/NN and/CC cell/NN cycle/NN arrest/NN ,/, whereas/IN ERKs/NNS do/VBP the/DT opposite/NN ,/, and/CC JNKs/NNS play/VBP no/DT role/NN in/IN this/DT process/NN of/IN apoptosis/NN ./.
P11114188A05
ERK1/NN //SYM 2/CD are/VBP components/NNS of/IN the/DT Ras-mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) signal/NN transduction/NN pathway/NN ./.
P11118293A06
Finally/RB ,/, the/DT two/CD inhibitors/NNS suppressed/VBD [/( (/( 3/CD )/) H/NN ]/) thymidine/NN incorporation/NN into/IN DNA/NN in/IN MC3T3-E1/NN cells/NNS at/IN a/DT normal/JJ level/NN of/IN Ca/NN (/( 2+/CD )/) (/( o/NN )/) (/( 1.8/CD mM/NN )/) as/RB well/RB as/IN when/WRB stimulated/VBN by/IN high/JJ (/( 4.5/CD mM/NN )/) Ca/NN (/( 2+/CD )/) (/( o/NN )/) ,/, Gd/NN (/( 3+/CD )/) ,/, or/CC neomycin/NN ./.
P11121021A04
At/IN 3-6/CD h/NN ,/, the/DT activities/NNS of/IN ERK1/NN //SYM 2/CD ,/, JNK/NN ,/, Cdk5/NN ,/, and/CC GSK-3beta/NN toward/IN selective/JJ substrates/NNS were/VBD increased/VBN ;/: however/WRB ,/, only/RB JNK/NN ,/, Cdk5/NN ,/, and/CC GSK-3beta/NN but/CC not/RB ERK1/NN //SYM 2/CD were/VBD overactivated/VBN toward/IN purified/JJ bovine/JJ tau/NN ./.
P11121686A05
PTH-induced/JJ MAPK/NN phosphorylation/NN was/VBD effectively/RB suppressed/VBN by/IN the/DT tyrosine-kinase/NN inhibitors/NNS ,/, genistein/NN (/( 100microM/NN )/) and/CC herbimycin/NN (/( 2microM/NN )/) ./.
P11127202A04
SB203580/NN ,/, an/DT inhibitor/NN of/IN p38/NN MAP/NN kinase/NN ,/, markedly/RB enhanced/VBD the/DT bFGF-induced/JJ VEGF/NN release/NN ./.
P11133526A05
Fura/NN 2/CD ratiometry/NN was/VBD used/VBN to/TO assess/VB the/DT effect/NN of/IN urea/NN treatment/NN on/IN intracellular/JJ calcium/NN mobilization/NN ./.
P11134043A03
Here/RB we/PRP show/VBP that/IN secretion/NN of/IN tumor/NN necrosis/NN factor-alpha/NN induced/VBN by/IN Treponema/NN culture/NN supernatants/NNS and/CC extracted/JJ LTA/NN was/VBD paralleled/VBN by/IN an/DT LBP-dependent/JJ phosphorylation/NN of/IN mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) p42/NN and/CC p44/NN ,/, and/CC p38/NN ,/, as/RB well/RB as/IN the/DT stress-activated/JJ protein/NN kinases/NNS c-Jun/NN N-terminal/JJ kinases/NNS 1/CD and/CC 2/CD ./.
P11134332A06
The/DT activation/NN of/IN p38/NN by/IN Irak/NN requires/VBZ Irak/NN 's/POS kinase/NN activity/NN ./.
P11135575A05
We/PRP also/RB show/VBP that/IN there/EX are/VBP differences/NNS in/IN the/DT signaling/JJ thresholds/NNS of/IN the/DT three/CD mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) families/NNS ./.
P11139390A03
We/PRP have/VBP used/VBN well-characterized/JJ inhibitors/NNS for/IN proteins/NNS involved/VBN in/IN different/JJ signalling/JJ cascades/NNS to/TO assess/VB the/DT involvement/NN of/IN these/DT pathways/NNS on/IN the/DT transcriptional/JJ regulation/NN of/IN glucocorticoid-stimulated/JJ PF2K/NN //SYM Fru-2/NN ,/, 6-BPase/NN by/IN insulin/NN ./.
P11141234A09
The/DT activity/NN of/IN p38/NN was/VBD lowest/JJS immediately/RB after/IN isolation/NN ,/, increasing/VBG progressively/RB with/IN time/NN ./.
P11146006A02
Phosphorylation/NN of/IN APPthr/NN (/( 668/CD )/) is/VBZ believed/VBN to/TO regulate/VB APP/NN function/NN and/CC metabolism/NN ./.
P11156183A02
Recent/JJ studies/NNS of/IN GTP/NN extracts/NNS showed/VBD the/DT involvement/NN of/IN mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) in/IN the/DT regulation/NN of/IN Phase/NN II/CD enzymes/NNS gene/NN expression/NN and/CC induction/NN of/IN apoptosis/NN ./.
P11156183A13
As/IN the/DT most/RBS abundant/JJ catechin/NN in/IN GTP/NN extract/NN ,/, we/PRP found/VBD that/IN EGCG/NN potently/RB induced/VBD ARE-mediated/JJ gene/NN expression/NN ,/, activated/VBD MAP/NN kinase/NN pathway/NN ,/, stimulated/VBD caspase-3/NN activity/NN ,/, and/CC induced/VBD apoptosis/NN ./.
P11158304A08
Rac1/NN may/MD stimulate/VBP the/DT ERK/NN cascade/NN either/CC by/IN promoting/NN the/DT phosphorylation/NN of/IN c-Raf/NN or/CC by/IN increasing/NN MEK1/NN and/or/CC -2/CD association/NN with/IN c-Raf/NN to/TO facilitate/VB MEK1/NN and/or/CC -2/CD activation/NN ./.
P11159862A11
We/PRP also/RB observed/VBD that/IN activation/NN of/IN ERK/NN MAP/NN kinase/NN was/VBD required/VBN for/IN the/DT expression/NN of/IN c-fos/NN and/CC c-jun/NN mRNA/NN in/IN response/NN to/TO PGF2alpha/NN and/CC PMA/NN because/IN it/PRP was/VBD abrogated/VBN by/IN blocking/NN the/DT ERK/NN pathway/NN with/IN PD098059/NN ./.
P11160612A09
No/DT effects/NNS of/IN the/DT drug/NN were/VBD observed/VBN on/IN cerebral/JJ perfusion/NN ,/, hemodynamics/NNS ,/, or/CC body/NN temperature/NN ./.
P11160653A08
Western/NN Blot/NN analysis/NN and/CC subsequent/JJ densitometry/NN corroborated/VBD these/DT observations/NNS ./.
P11160861A04
Furthermore/RB ,/, we/PRP found/VBD that/IN the/DT full-length/NN MEKK1/NN was/VBD cleaved/VBN to/TO a/DT 91-kDa/NN carboxyl-terminal/JJ fragment/NN at/IN the/DT earlier/JJR time/NN of/IN apoptosis/NN induced/VBN by/IN microtubule-damaging/JJ agents/NNS ./.
P11161724A07
Therefore/RB ,/, the/DT early/JJ transient/JJ phase/NN of/IN ERK/NN activation/NN functioned/VBD in/IN signaling/NN chemotaxis/NN ;/: the/DT late/JJ sustained/JJ phase/NN of/IN ERK/NN activation/NN did/VBD not/RB seem/VBP to/TO have/VB an/DT essential/JJ role/NN ./.
P11162624A06
Furthermore/RB ,/, expression/NN of/IN a/DT dual/JJ specificity/NN phosphatase/NN capable/JJ of/IN inactivating/NN ERK/NN known/VBN as/IN mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN phosphatase-2/NN (/( MKP-2/NN )/) was/VBD elevated/VBN in/IN most/PRP of/IN the/DT pancreatic/JJ tumor/NN cell/NN lines/NNS and/CC correlated/VBN with/IN the/DT presence/NN of/IN active/JJ MAP/NN kinase/NN kinase/NN (/( MEK/NN )/) ./.
P11162898A11
Placental/JJ JEG-3/NN cells/NNS were/VBD treated/VBN with/IN (/( D-Ala/NN (/( 6/CD )/) )/) -GnRH/NN for/IN 24/CD h/NN ,/, and/CC betahCG/NN mRNA/NN level/NN was/VBD measured/VBN using/VBG Northern/NN blot/NN analysis/NN ./.
P11163183A02
LPS/NN stimulation/NN of/IN peritoneal/JJ macrophages/NNS from/IN these/DT mice/NNS did/VBD not/RB activate/VBP MEK1/NN ,/, ERK1/NN ,/, and/CC ERK2/NN but/CC did/VBD activate/VBP JNK/NN ,/, p38/NN MAPK/NN ,/, and/CC NF-kappaB/NN ./.
P11166122A11
That/IN 5-HT/NN (/( 7/CD )/) receptors/NNS couple/VBP to/TO activation/NN of/IN extracellular/JJ signal-regulated/JJ kinase/NN in/IN hippocampal/JJ neurons/NNS suggests/VBZ a/DT possible/JJ role/NN for/IN 5-HT/NN (/( 7/CD )/) receptors/NNS in/IN mediating/NN some/PRP of/IN the/DT actions/NNS of/IN antidepressants/NNS that/WDT increase/VBP 5-hydroxytryptamine/NN ./.
P11166517A08
These/DT results/NNS demonstrate/VBP that/IN chronic/JJ infusion/NN of/IN PCP/NN in/IN rats/NNS produces/VBZ a/DT differential/JJ and/CC brain/NN region-specific/JJ activation/NN of/IN MAP/NN kinases/NNS ,/, suggesting/VBG a/DT role/NN for/IN the/DT ERK/NN signaling/JJ pathway/NN in/IN PCP/NN abuse/NN and/CC perhaps/RB in/IN schizophrenia/NN ./.
P11169731A04
In/IN the/DT first/JJ phase/NN ,/, which/WDT lasts/VBZ 24-48/CD h/NN ,/, the/DT cells/NNS continued/VBD in/IN the/DT normal/JJ cell/NN cycle/NN while/IN expressing/VBG markers/NNS of/IN monocytic/JJ phenotype/NN ,/, such/JJ as/IN CD14/NN ./.
P11171562A09
Inhibition/NN of/IN the/DT ERK/NN pathway/NN markedly/RB reduced/VBD IFN-gamma/NN +/SYM LPS-induced/JJ tumor/NN necrosis/NN factor-alpha/NN protein/NN expression/NN ,/, providing/VBG a/DT possible/JJ mechanism/NN by/IN which/WDT ERK/NN augments/VBZ iNOS/NN expression/NN ./.
P11174007A09
This/DT finding/NN was/VBD confirmed/VBN by/IN immunocomplex/NN JNK/NN activity/NN assay/NN using/VBG ATF-2/NN as/IN substrate/NN ,/, which/WDT demonstrated/VBD a/DT significant/JJ increase/NN in/IN JNK/NN activity/NN in/IN the/DT left/JJ ventricle/NN of/IN PHR/NN as/IN compared/VBN to/TO PNR/NN (/( 6.4/CD +/-/SYM 1.5/CD vs./CC 2.5/CD +/-/SYM 0.5/CD OD/NN ;/: each/DT n/NN =/SYM 5/CD ;/: p/NN </SYM 0.05/CD )/) ./.
P11174068A09
The/DT use/NN of/IN these/DT compounds/NNS did/VBD not/RB significantly/RB alter/VBP the/DT inhibitory/JJ effects/NNS of/IN GF/NN 109203X/NN or/CC calphostin/NN C/NN ./.
P11175257A04
Analysis/NN of/IN PKC/NN isoform/NN expression/NN by/IN immunoblot/NN shows/VBZ that/IN TPA-induced/JJ downregulation/NN of/IN PKC/NN alpha/NN and/CC PKC/NN delta/NN is/VBZ delayed/VBN in/IN cells/NNS pre-treated/VBN with/IN calpeptin/NN ,/, and/CC that/IN this/PRP correlates/VBZ with/IN an/DT increase/NN of/IN these/DT isoforms/NNS in/IN the/DT membrane/NN fraction/NN of/IN cells/NNS ./.
P11179198A02
However/WRB ,/, additional/JJ factors/NNS appear/VBP to/TO modulate/VB the/DT exact/JJ timing/NN and/CC rate/NN of/IN NO-dependent/JJ apoptosis/NN ./.
P11179291A06
Inhibition/NN of/IN MAP/NN kinases/NNS with/IN PD98059/NN or/CC SB203580/NN did/VBD not/RB affect/VBP the/DT EPEC-induced/JJ decrease/NN in/IN transepithelial/JJ resistance/NN or/CC actin/NN accumulation/NN beneath/IN the/DT WT/NN bacteria/NN ,/, but/CC these/DT two/CD inhibitors/NNS significantly/RB decreased/VBD interleukin-8/NN (/( IL-8/NN )/) synthesis/NN ./.
P11179293A09
The/DT caspase/NN family/NN ,/, especially/RB caspase/NN 3/CD ,/, is/VBZ likely/RB to/TO play/VB an/DT important/JJ role/NN in/IN the/DT signal/NN transduction/NN for/IN iNOS-mediated/JJ NO/NN production/NN in/IN LPS-stimulated/JJ mouse/NN macrophages/NNS ./.
P11179444A07
Glutathione/NN ,/, a/DT neutral/JJ SMase/NN inhibitor/NN ,/, attenuated/VBD TNF-alpha-/NN or/CC SMase-induced/JJ activation/NN of/IN MAPKs/NNS ,/, COX-2/NN expression/NN ,/, and/CC COX-2/NN promoter/NN activity/NN ./.
P11181412A01
Transforming/JJ growth/NN factor-beta/NN (/( 1/CD )/) (/( TGF-beta/NN (/( 1/CD )/) )/) is/VBZ a/DT potent/JJ inducer/NN of/IN extracellular/JJ matrix/NN protein/NN synthesis/NN and/CC a/DT key/JJ mediator/NN of/IN renal/JJ fibrosis/NN ./.
P11181412A12
Thus/RB we/PRP show/VBP first/RB demonstration/NN of/IN p38/NN MAPK/NN activation/NN by/IN TGF-beta/NN (/( 1/CD )/) in/IN mesangial/JJ cells/NNS ,/, and/CC ,/, given/VBN the/DT rapid/JJ kinetics/NNS ,/, this/DT TGF-beta/NN (/( 1/CD )/) effect/NN is/VBZ likely/JJ a/DT direct/JJ one/PRP ./.
P11185956A06
Together/RB ,/, these/DT results/NNS suggest/VBP that/IN S1P/NN activates/VBZ the/DT EGF/NN receptor/NN through/IN a/DT PKC-dependent/JJ pathway/NN that/WDT links/VBZ Ras/NN signaling/NN to/TO the/DT activation/NN of/IN Erk-1/NN //SYM -2/CD in/IN Rat-2/NN cells/NNS ./.
P11204428A11
Moreover/RB ,/, the/DT adhesions/NNS of/IN alpha/NN (/( v/CD )/) beta3-cells/NNS to/TO type/NN I/CD collagen/NN and/CC fibronectin/NN were/VBD inhibited/VBN ,/, which/WDT was/VBD attributed/VBN to/TO decreased/JJ beta1-integrin/NN levels/NNS on/IN cell/NN surface/NN ./.
P11207214A06
PDBu/NN induced/VBD (/( P/NN </SYM 0.05/CD )/) activation/NN of/IN the/DT Raf-1/NN //SYM MEK-1/NN //SYM ERK-1/NN //SYM 2/CD pathway/NN ,/, which/WDT was/VBD obligatory/JJ for/IN the/DT expression/NN of/IN COX-2/NN and/CC secretion/NN of/IN PGF/NN but/CC was/VBD not/RB altered/VBN by/IN cotreatment/NN with/IN rbIFN-tau/NN ./.
P11211919A05
BAPTA-AM/NN and/CC GF/NN 109203X/NN did/VBD not/RB attenuate/VBP the/DT formation/NN of/IN F-actin/NN but/CC completely/RB inhibited/VBD the/DT activation/NN of/IN NADPH/NN oxidase/NN ./.
P11211936A05
Neither/CC the/DT RARalpha/NN nor/CC RXR/NN selective/JJ ligands/NNS alone/JJ induced/VBD expression/NN of/IN blr1/NN ,/, but/CC the/DT combination/NN of/IN the/DT two/CD ligands/NNS induced/VBD the/DT expression/NN of/IN blr1/NN to/TO the/DT same/JJ extent/NN as/IN RA/NN ./.
P11216996A06
RESULTS/NNS :/: The/DT ROS/NN levels/NNS in/IN ET-1-/CD or/CC PE-stimulated/JJ myocytes/NNS were/VBD maximally/RB increased/VBN at/IN 5/CD min/NN after/IN stimulation/NN ./.
P11222496A03
Using/VBG human/NN monocytes/NNS and/CC the/DT human/NN monocytic/JJ cell/NN line/NN THP1/NN ,/, we/PRP examined/VBD signal/NN transduction/NN events/NNS induced/VBN by/IN CD40/NN engagement/NN with/IN its/PRP$ ligand/NN ,/, CD154/NN ./.
P11222507A04
We/PRP show/VBP that/IN CD28/NN co-stimulation/NN restores/VBZ normal/JJ TCR-induced/JJ activation/NN of/IN Rac-1/NN and/CC p38/NN MAPK/NN in/IN NOD/NN T/NN cells/NNS ./.
P11226388A07
Furthermore/RB ,/, adenosine/NN A/NN (/( 1/CD )/) receptor-mediated/JJ increases/NNS in/IN p42/NN //SYM p44/NN MAPK/NN were/VBD sensitive/JJ to/TO the/DT MAPK/NN kinase/NN 1/CD inhibitor/NN PD/NN 98059/CD (/( 2'-amino-3'-methoxyflavone/NN )/) ,/, whereas/IN p38/NN MAPK/NN responses/NNS were/VBD blocked/VBN by/IN the/DT p38/NN MAPK/NN inhibitor/NN SB/NN 203580/CD (/( 4-/CD (/( 4-fluorophenyl/NN )/) -2-/CD (/( 4-methylsulfinylphenyl/NN )/) -5-/CD (/( 4-pyridyl/NN )/) 1H-imidazole/NN )/) ./.
P11228094A04
H2O2/NN treatment/NN induced/VBD apoptosis/NN in/IN H9c2/NN cells/NNS ,/, and/CC pretreatment/NN of/IN cells/NNS with/IN IGF-1/NN suppressed/VBD apoptotic/JJ cell/NN death/NN ./.
P11228545A09
We/PRP conclude/VBP that/IN posttranscriptional/JJ mechanisms/NNS play/VBP an/DT important/JJ role/NN in/IN the/DT regulation/NN of/IN COX-2/NN expression/NN during/IN carcinogenesis/NN ./.
P11230331A07
The/DT Ang/NN II-induced/JJ AT/NN (/( 1/CD )/) -R/NN mRNA/NN downregulation/NN was/VBD also/RB blocked/VBN by/IN PD98059/NN ,/, an/DT extracellular/JJ signal-regulated/JJ protein/NN kinase/NN (/( ERK/NN )/) kinase/NN inhibitor/NN ./.
P11231289A02
Activation/NN by/IN pI/NN :/: C/NN in/IN IFN/NN alpha-primed/JJ cells/NNS was/VBD delayed/VBN compared/VBN to/TO activation/NN with/IN interleukin-1/NN beta/NN ,/, and/CC this/DT delay/NN was/VBD followed/VBN by/IN high/JJ ,/, sustained/JJ activation/NN of/IN p38/NN MAPK/NN and/CC a/DT modest/JJ elevation/NN of/IN ERK/NN activation/NN ./.
P11232027A08
In/IN contrast/NN ,/, MAPK/NN activation/NN was/VBD not/RB significantly/RB affected/VBN by/IN pertussis/NN toxin/NN (/( 200/CD ng/NN //SYM mL/NN ;/: a/DT G/NN (/( i/NN )/) inhibitor/NN )/) pretreatment/NN ./.
P11233147A06
An/DT intracellular/JJ Ca2+/NN chelator/NN (/( BAPTA-AM/NN )/) inhibited/VBD H2O2-induced/JJ phosphorylation/NN of/IN SAPK/NN //SYM JNK/NN ,/, but/CC an/DT extracellular/JJ Ca2+/NN chelator/NN (/( EDTA/NN )/) or/CC a/DT Ca2+/NN entry/NN blocker/NN (/( NiCl2/NN )/) did/VBD not/RB ./.
P11234901A10
Combined/JJ inhibition/NN of/IN both/CC MAPK/NN and/CC IKK/NN pathways/NNS may/MD be/VBP needed/VBN for/IN suppression/NN of/IN the/DT signal/NN transduction/NN mechanism/NN (/( s/NNS )/) regulating/VBG VEGF/NN and/CC IL-8/NN secretion/NN and/CC angiogenesis/NN by/IN human/NN HNSCC/NN ./.
P11237743A07
This/PRP indicates/VBZ that/IN phorbol/NN ester-sensitive/JJ PKC/NN isoforms/NNS including/VBG PKCdelta/NN are/VBP involved/VBN in/IN MAPK/NN activation/NN ./.
P11238741A06
Surprisingly/RB ,/, overexpression/NN of/IN SPHK1/NN had/VBD no/DT effect/NN on/IN activation/NN of/IN two/CD known/JJ NGF-stimulated/JJ survival/NN pathways/NNS ,/, extracellular/JJ signal/NN regulated/JJ kinase/NN ERK/NN 1/CD //SYM 2/CD and/CC Akt/NN ./.
P11243567A03
However/WRB ,/, the/DT biochemical/JJ interactions/NNS of/IN the/DT ACh/NN system/NN with/IN the/DT immune/JJ system/NN have/VBP not/RB been/VBN elucidated/VBN in/IN detail/NN ./.
P11245462A02
Here/RB ,/, the/DT relationship/NN between/IN the/DT mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) response/NN and/CC apoptosis/NN in/IN ML-1/NN cells/NNS treated/VBN with/IN vinblastine/NN and/CC paclitaxel/NN was/VBD investigated/VBN ./.
P11245463A08
These/DT results/NNS suggest/VBP that/IN the/DT inhibition/NN of/IN ERK1/NN //SYM 2/CD phosphorylation/NN is/VBZ responsible/JJ for/IN at/IN least/JJS part/NN of/IN the/DT induction/NN of/IN programmed/JJ cell/NN death/NN by/IN sulindac/NN metabolites/NNS ./.
P11245653A03
Cardiomyocytes/NNS were/VBD exposed/VBN to/TO strain/NN (/( 4/CD %/SYM )/) during/IN either/CC the/DT first/JJ third/NN (/( systolic/JJ phase/NN )/) or/CC last/JJ third/NN (/( diastolic/JJ phase/NN )/) of/IN the/DT cardiac/JJ cycle/NN ./.
P11250939A08
VEGF/NN stimulated/VBD human/NN microvascular/JJ endothelial/JJ cells/NNS to/TO form/VB capillary/NN tubes/NNS ,/, which/WDT was/VBD significantly/RB inhibited/VBN by/IN expressing/NN dominant/JJ negative/JJ JNK-1/NN and/CC by/IN NP/NN ./.
P11252631A07
MEK3/NN ,/, an/DT activator/NN of/IN p38/NN kinase/NN ,/, was/VBD also/RB expressed/VBN in/IN the/DT outer/JJ layer/NN ./.
P11254551A03
Specific/JJ pharmacologic/JJ inhibition/NN of/IN the/DT extracellular-signal-regulated/JJ kinase/NN (/( ERK/NN )/) or/CC NF-kappaB/NN pathway/NN revealed/VBD that/IN both/PDT these/DT signaling/JJ cascades/NNS were/VBD required/VBN in/IN gamma/NN interferon/NN (/( IFN-gamma/NN )/) -ManLAM-induced/JJ iNOS/NN protein/NN and/CC NO2-/CD expression/NN in/IN mouse/NN macrophages/NNS ./.
P11254696A07
However/WRB ,/, analysis/NN of/IN the/DT dynamics/NNS of/IN ERK2/NN and/CC MEK/NN suggested/VBD that/IN both/PRP of/IN them/PRP rapidly/RB shuttle/VBP between/IN the/DT cytoplasm/NN and/CC the/DT nucleus/NN and/CC that/IN MEK/NN regulates/VBZ the/DT nuclear/JJ shuttling/NN of/IN ERK2/NN ,/, whereas/IN MEK/NN remains/VBZ mainly/RB in/IN the/DT cytoplasm/NN ./.
P11255226A10
These/DT results/NNS support/VBP our/PRP$ proposal/NN that/IN early/JJ castration-induced/JJ degeneration/NN and/CC constriction/NN of/IN the/DT vascular/JJ system/NN of/IN the/DT rat/NN ventral/JJ prostate/NN gland/NN leads/VBZ to/TO reduced/JJ oxygenation/NN of/IN prostatic/JJ epithelial/JJ cells/NNS and/CC the/DT activation/NN of/IN hypoxic/JJ cellular/JJ signaling/NN in/IN these/DT cells/NNS through/IN upregulation/NN of/IN HIF-1-alpha/NN expression/NN and/CC stimulation/NN of/IN the/DT JUN/NN kinase/NN signaling/JJ pathway/NN ./.
P11257452A05
Next/IN ,/, LPS/NN is/VBZ transferred/VBN to/TO the/DT transmembrane/JJ signaling/JJ receptor/NN toll-like/JJ receptor/NN 4/CD (/( TLR4/NN )/) and/CC its/PRP$ accessory/NN protein/NN MD2/NN ./.
P11262176A08
We/PRP examined/VBD the/DT activation/NN of/IN MAP/NN kinases/NNS during/IN hemin-induced/JJ differentiation/NN ./.
P11266467A04
We/PRP confirmed/VBD the/DT specificity/NN of/IN this/DT interaction/NN in/FW vitro/FW by/IN glutathione/NN S-transferase/NN pull-down/JJ assays/NNS and/CC by/IN coimmunoprecipitation/NN ,/, cosedimentation/NN on/IN glycerol/NN gradients/NNS ,/, and/CC colocalization/NN ./.
P11276120A09
On/IN the/DT other/JJ hand/NN ,/, the/DT c-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) and/CC p38/NN kinase/NN members/NNS of/IN the/DT MAPK/NN family/NN appear/VBP to/TO regulate/VB apoptotic/JJ events/NNS in/IN OL/NN ./.
P11278318A05
Inhibition/NN of/IN ERK/NN activity/NN enhanced/VBD gonadotropin-stimulated/JJ progesterone/NN production/NN ,/, which/WDT was/VBD correlated/VBN with/IN increased/JJ expression/NN of/IN the/DT steroidogenic/JJ acute/JJ regulatory/JJ protein/NN (/( StAR/NN )/) ,/, a/DT key/JJ regulator/NN of/IN progesterone/NN synthesis/NN ./.
P11278385A07
Therefore/RB ,/, these/DT results/NNS demonstrate/VBP that/IN the/DT sequential/JJ ERK/NN //SYM RSK1/NN //SYM NF-kappaB/NN pathway/NN mediates/VBZ PMA-stimulated/JJ megakaryocytic/JJ differentiation/NN of/IN K562/NN cells/NNS ./.
P11278392A04
IGF-I/NN induced/VBD a/DT rapid/JJ and/CC transient/JJ activation/NN of/IN JNK/NN that/WDT peaked/VBD at/IN 40/CD min/NN that/WDT was/VBD paralleled/VBN by/IN a/DT transient/JJ and/CC robust/JJ phosphorylation/NN of/IN c-Jun/NN ./.
P11278622A07
In/IN T/NN cells/NNS ,/, MEKK2/NN was/VBD found/VBN to/TO be/VB a/DT strong/JJ activator/NN of/IN JNK/NN but/CC not/RB of/IN extracellular/JJ signal-regulated/JJ kinase/NN MAPKs/NNS and/CC to/TO activate/VB JNK-dependent/JJ AP-1/NN reporter/NN gene/NN expression/NN ./.
P11278768A02
These/DT mechanisms/NNS most/RBS likely/RB prevent/VBP chondrocyte/NN dedifferentiation/NN to/TO fibroblast-like/JJ cells/NNS and/CC chondrocyte/NN death/NN ./.
P11278794A07
Closely/RB related/JJ protein/NN kinases/NNS (/( male/NN germ/NN cell-associated/JJ kinase/NN and/CC male/NN germ/NN cell-associated/JJ kinase-related/JJ kinase/NN )/) were/VBD also/RB found/VBN to/TO associate/VB with/IN HSP90/NN ,/, whereas/IN conventional/JJ mitogen-activated/JJ protein/NN kinases/NNS (/( extracellular/JJ signal-regulated/JJ kinase/NN ,/, p38/NN ,/, and/CC c-Jun/NN N-terminal/JJ kinase/NN //SYM stress-activated/JJ protein/NN kinase/NN )/) were/VBD not/RB associated/VBN with/IN HSP90/NN ./.
P11278848A07
To/TO understand/VB the/DT events/NNS upstream/JJ of/IN Sp1/NN activation/NN ,/, we/PRP investigated/VBD the/DT role/NN of/IN p38/NN and/CC extracellular/JJ signal-regulated/JJ kinase/NN mitogen-activated/JJ protein/NN kinases/NNS by/IN using/NN their/PRP$ specific/JJ inhibitors/NNS ./.
P11278851A09
Furthermore/RB ,/, inhibition/NN of/IN JNK/NN ,/, p38/NN MAPK/NN ,/, or/CC MEK/NN did/VBD not/RB alter/VBP PARP/NN cleavage/NN and/CC the/DT cell/NN death/NN induced/VBN by/IN paclitaxel/NN ./.
P11279118A02
In/IN this/DT study/NN ,/, we/PRP examined/VBD the/DT ability/NN of/IN TAO2/NN to/TO activate/VB stress-sensitive/JJ MAP/NN kinase/NN pathways/NNS in/IN cells/NNS and/CC the/DT relationship/NN between/IN activation/NN of/IN TAO2/NN and/CC potential/JJ downstream/JJ pathways/NNS ./.
P11279606A07
In/IN agreement/NN with/IN this/DT notion/NN ,/, transient/JJ expression/NN of/IN active/JJ MEK1/NN prevented/VBD apoptosis/NN in/IN serum-deprived/JJ condition/NN ./.
P11283019A09
Finally/RB ,/, p38-dependent/JJ phosphorylation/NN of/IN CDX3/NN was/VBD observed/VBN in/IN differentiating/JJ Caco-2/NN //SYM 15/CD cells/NNS ./.
P11287413A02
In/IN this/DT study/NN ,/, we/PRP have/VBP further/RB investigated/VBN the/DT signal/NN transduction/NN pathways/NNS responsible/JJ for/IN the/DT event/NN and/CC its/PRP$ role/NN in/IN HGF-induced/JJ cell/NN scattering/NN ./.
P11295367A03
Treatment/NN with/IN H2O2/NN (/( 100/CD microM/NN )/) ,/, superoxide/NN anion/NN (/( generated/VBN by/IN 1/CD mM/NN xanthine/NN and/CC 1/CD mU/NN //SYM ml/NN xanthine/NN oxidase/NN )/) ,/, menadione/NN ,/, and/CC phenazine/NN methosulfate/NN increased/VBD the/DT cell/NN proliferation/NN by/IN approximately/RB 50/CD %/SYM ./.
P11297525A07
Surprisingly/RB ,/, constitutive/JJ ERK1/NN //SYM 2/CD activation/NN is/VBZ MEK-independent/JJ ./.
P11298121A04
As/IN shown/VBN here/RB ,/, ERK/NN is/VBZ activated/VBN in/IN K562/NN and/CC COS-7/NN cells/NNS within/IN 10/CD min/NN of/IN sublytic/JJ immune/JJ attack/NN and/CC then/RB shows/VBZ a/DT decline/NN and/CC a/DT second/JJ peak/NN of/IN activation/NN at/IN 20/CD min/NN ./.
P11303787A03
The/DT effect/NN of/IN SB/NN 203580/CD on/IN nitric/JJ oxide/NN (/( NO/NN )/) -/: or/CC peroxynitrite-induced/JJ cell/NN death/NN is/VBZ not/RB known/VBN ./.
P11306108A04
Within/IN 15-30/CD min/NN after/IN HNE/NN treatment/NN ,/, c-Jun/NN N-terminal/JJ protein/NN kinase/NN (/( JNK/NN )/) was/VBD maximally/RB activated/VBN ,/, before/IN returning/NN to/TO control/NN level/NN after/IN 1/CD h/NN post-treatment/NN ./.
P11306514A07
In/IN contrast/NN ,/, overexpression/NN of/IN the/DT wild-type/NN kinases/NNS had/VBD a/DT slight/JJ proapoptotic/JJ effect/NN ./.
P11306698A03
Nuclear/JJ ARE/NN complex/NN was/VBD activated/VBN 1/CD to/TO 6/CD h/NN after/IN treatment/NN of/IN H4IIE/NN cells/NNS with/IN t-BHQ/NN ./.
P11306706A04
Here/RB ,/, we/PRP demonstrate/VBP that/IN mitogen-activated/JJ protein/NN kinase/NN kinase-1/NN (/( MEK-1/NN )/) inhibitor/NN PD98059/NN does/VBZ not/RB change/VBP either/CC the/DT stabilization/NN or/CC DNA/NN binding/JJ ability/NN of/IN HIF-1alpha/NN but/CC it/PRP inhibits/VBZ the/DT trans-activation/NN ability/NN of/IN HIF-1alpha/NN ,/, thereby/RB it/PRP reduces/VBZ the/DT hypoxia-induced/JJ transcription/NN of/IN both/CC an/DT endogenous/JJ target/NN gene/NN and/CC a/DT hypoxia-responsive/JJ reporter/NN gene/NN ./.
P11309236A08
We/PRP next/RB examined/VBD the/DT effect/NN of/IN AG1478/NN on/IN thrombin-induced/JJ DNA/NN synthesis/NN ./.
P11310789A01
UV-induced/JJ melanogenesis/NN is/VBZ a/DT well/RB known/JJ physiological/JJ response/NN of/IN human/NN skin/NN exposed/VBN to/TO solar/JJ radiation/NN ;/: however/WRB ,/, the/DT signaling/JJ molecules/NNS involved/VBN in/IN the/DT stimulation/NN of/IN melanogenesis/NN in/IN melanocytes/NNS following/VBG UV/NN exposure/NN remain/VBP unclear/JJ ./.
P11310854A01
Phosphorylation/NN of/IN extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) in/IN response/NN to/TO arachidonic/JJ acid/NN (/( AA/NN )/) was/VBD rapid/JJ and/CC transient/JJ ,/, peaking/VBG at/IN 1/CD min/NN and/CC disappearing/VBG after/IN 3/CD min/NN ,/, and/CC it/PRP was/VBD accompanied/VBN by/IN an/DT increase/NN in/IN ERK/NN activity/NN in/IN rat/NN neutrophils/NNS ./.
P11311983A02
However/WRB ,/, our/PRP$ knowledge/NN of/IN the/DT class/NN of/IN glutamate/NN receptor/NN and/CC the/DT intracellular/JJ pathways/NNS involved/VBN derives/VBZ totally/RB from/IN studies/NNS on/IN embryonic/JJ neurons/NNS ,/, where/WRB the/DT mechanisms/NNS are/VBP likely/RB to/TO be/VB totally/RB different/JJ from/IN those/PRP operating/VBG in/IN mature/JJ neurons/NNS ./.
P11316261A08
Furthermore/RB ,/, in/IN the/DT presence/NN of/IN U0126/NN there/EX was/VBD no/DT aldosterone-induced/JJ increase/NN of/IN steady-state/NN pH/NN ./.
P11316733A08
In/IN contrast/NN to/TO the/DT effect/NN of/IN tumor/NN necrosis/NN factor-alpha/NN on/IN NF-kappaB/NN activation/NN ,/, Western/NN blot/NN analyses/NNS demonstrated/VBD that/IN IGF-I/NN had/VBD no/DT effect/NN on/IN IkappaB/NN phosphorylation/NN and/CC degradation/NN or/CC nuclear/JJ translocation/NN and/CC DNA/NN binding/NN of/IN NF-kappaB/NN ./.
P11319753A08
Furthermore/RB ,/, the/DT strong/JJ correlation/NN between/IN inhibition/NN of/IN kinase/NN activity/NN and/CC IL-1/NN and/CC TNF-stimulated/JJ biological/JJ responses/NNS indicates/VBZ that/IN selective/JJ inhibition/NN of/IN the/DT p38/NN MAPK/NN pathway/NN may/MD have/VBP therapeutic/JJ utility/NN in/IN joint/NN diseases/NNS such/JJ as/IN rheumatoid/JJ arthritis/NN (/( RA/NN )/) ./.
P11322385A06
MAPK/NN blockade/NN by/IN the/DT specific/JJ MEK1/NN inhibitor/NN (/( PD98059/NN )/) decreased/VBD the/DT ability/NN of/IN sodium/NN arsenite/NN to/TO increase/VB HSP70/NN gene/NN expression/NN in/IN a/DT dose-dependent/JJ manner/NN along/JJ with/IN dephosphorylation/NN of/IN ERK1/NN //SYM 2/CD proteins/NNS ./.
P11323408A05
SpD/NN binds/VBZ to/TO the/DT ligand-binding/JJ site/NN of/IN the/DT bombesin/NN //SYM gastrin-releasing/JJ peptide/NN receptor/NN and/CC blocks/VBZ the/DT bombesin-stimulated/JJ increase/NN in/IN [/( Ca2+/NN ]/) i/NN within/IN the/DT same/JJ concentration/NN range/NN that/WDT causes/VBZ sustained/JJ activation/NN of/IN c-Jun/NN N-terminal/JJ kinase/NN and/CC extracellular/JJ signal-regulated/JJ protein/NN kinase/NN (/( ERK/NN )/) ./.
P11325811A04
Both/DT groups/NNS were/VBD treated/VBN either/CC with/IN SB202190/NN (/( inhibitor/NN of/IN p38/NN MAP/NN kinase/NN )/) ,/, PD98059/NN (/( inhibitor/NN of/IN extracellular-signal-regulated/JJ kinase/NN [/( ERK/NN ]/) pathway/NN )/) ,/, Ro-31-7549/NN (/( protein/NN kinase/NN C/NN [/( PKC/NN ]/) inhibitor/NN )/) ,/, LY/NN 294002/CD (/( a/DT phosphatidylinositol/NN 3-kinase/NN [/( PI/NN 3-kinase/NN ]/) inhibitor/NN )/) or/CC vehicle/NN ./.
P11327629A09
Angiotensin/NN II/CD increased/VBD c-fos/NN mRNA/NN expression/NN in/IN SHR/NN and/CC had/VBD a/DT small/JJ stimulatory/JJ effect/NN in/IN WKY/NN ./.
P11327635A02
Adrenomedullin/NN has/VBZ recently/RB been/VBN found/VBN to/TO enhance/VB proliferation/NN of/IN cultured/JJ rat/NN vascular/JJ smooth/JJ muscle/NN cells/NNS and/CC zona/NN glomerulosa/NN cells/NNS ./.
P11328854A03
Both/CC p38/NN MAPK/NN and/CC its/PRP$ upstream/JJ activator/NN MAPK/NN kinase-6/NN (/( MKK6/NN )/) were/VBD found/VBN to/TO be/VB chronically/RB activated/VBN during/IN the/DT luteal/JJ maturation/NN phase/NN ,/, with/IN activation/NN detected/VBN by/IN 24/CD h/NN post/IN hCG/NN and/CC maintained/VBN through/IN 4/CD days/NNS post/IN hCG/NN ./.
P11331278A07
The/DT expression/NN levels/NNS of/IN these/DT kinases/NNS were/VBD unaltered/JJ ./.
P11341985A09
AP-1/NN and/CC HSF/NN show/VBP opposite/JJ patterns/NNS of/IN response/NN to/TO HS/NN in/IN the/DT presence/NN of/IN proteasome/NN inhibitors/NNS or/CC reducing/JJ agents/NNS ./.
P11348889A01
Plasminogen/NN activator/NN inhibitor/NN type-1/NN (/( PAI-1/NN )/) plays/VBZ an/DT integral/JJ role/NN not/RB only/RB in/IN the/DT regulation/NN of/IN fibrinolytic/JJ activity/NN but/CC also/RB in/IN the/DT pathogenesis/NN of/IN atherosclerosis/NN and/CC hypertension/NN ./.
P11350764A01
Extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) phosphorylate/VBP caldesmon/NN in/FW vivo/FW ,/, but/CC the/DT function/NN of/IN caldesmon/NN phosphorylation/NN in/IN smooth/JJ muscle/NN physiology/NN is/VBZ controversial/JJ ./.
P11350812A01
To/TO examine/VB signaling/JJ mechanisms/NNS relevant/JJ to/TO cAMP/NN //SYM protein/NN kinase/NN A/NN (/( PKA/NN )/) -dependent/JJ endothelial/JJ cell/NN barrier/NN regulation/NN ,/, we/PRP investigated/VBD the/DT impact/NN of/IN the/DT cAMP/NN //SYM PKA/NN inhibitors/NNS Rp/NN diastereomer/NN of/IN adenosine/NN 3/CD '/SYM ,/, 5'-cyclic/JJ monophosphorothioate/NN (/( Rp-cAMPS/NN )/) and/CC PKA/NN inhibitor/NN (/( PKI/NN )/) on/IN bovine/JJ pulmonary/JJ artery/NN and/CC bovine/JJ lung/NN microvascular/JJ endothelial/JJ cell/NN cytoskeleton/NN reorganization/NN ./.
P11359446A10
These/DT results/NNS suggest/VBP that/IN DPPC/NN ,/, the/DT major/JJ component/NN of/IN pulmonary/JJ surfactant/NN ,/, may/MD play/VBP a/DT role/NN in/IN modulating/NN leucocyte/NN inflammatory/JJ responses/NNS in/IN the/DT lung/NN ./.
P11359772A08
Serum-stimulated/JJ c-Fos/NN expression/NN is/VBZ dependent/JJ on/IN MAPK/NN //SYM Erk/NN activity/NN because/IN the/DT MEK/NN inhibitor/NN PD98059/NN suppresses/VBZ Erk/NN activity/NN and/CC c-Fos/NN expression/NN ./.
P11360180A09
These/DT data/NNS are/VBP consistent/JJ with/IN a/DT model/NN where/WRB thrombin/NN induces/VBZ ERK/NN activation/NN via/IN both/CC PKC-dependent/JJ and/CC independent/JJ pathways/NNS ,/, whereas/IN p38/NN MAPK/NN activation/NN requires/VBZ only/RB PTKs/NNS ./.
P11360301A10
The/DT activating/JJ factor/NN was/VBD shown/VBN to/TO have/VB a/DT native/JJ size/NN of/IN 50-100/CD kD/NN and/CC did/VBD not/RB signal/VBP through/IN the/DT classical/JJ EGF/NN receptor/NN ./.
P11367542A02
Although/IN IL-1/NN signaling/NN is/VBZ known/VBN to/TO involve/VB PI3-kinase/NN ,/, p38/NN mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN and/CC extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) ,/, the/DT crosstalk/NN of/IN these/DT kinases/NNS on/IN the/DT IL-1-mediated/JJ signal/NN transduction/NN is/VBZ not/RB clear/JJ ./.
P11372759A04
The/DT kinetics/NNS of/IN activation/NN of/IN Erk1/NN and/CC Erk2/NN were/VBD examined/VBN during/IN erythroid/NN and/CC megakaryocytic/JJ differentiation/NN of/IN UT-7/NN //SYM GM/NN cells/NNS ./.
P11375350A10
High/JJ D-glucose/NN treatment/NN induced/VBD MEKK1/NN cleavage/NN ,/, whereas/IN caspase/NN inhibitors/NNS significantly/RB attenuated/VBD the/DT cleavage/NN ./.
P11376873A02
To/TO determine/VB whether/IN TGF-beta/NN (/( 1/CD )/) interferes/VBZ directly/RB with/IN TPO-induced/JJ signal/NN transduction/NN in/IN hematopoietic/JJ cells/NNS ,/, we/PRP compared/VBD the/DT regulatory/JJ effects/NNS in/IN the/DT TPO-responsive/JJ cell/NN lines/NNS Mo-7e/NN and/CC HEL/NN ./.
P11377386A06
IFN-gamma/NN induced/VBD the/DT phosphorylation/NN of/IN signal/NN transducer/NN and/CC activator/NN of/IN transcription/NN 1/CD ./.
P11381075A01
PURPOSE/NN :/: To/TO determine/VB the/DT signal/NN mediators/NNS involved/VBN in/IN glycated/JJ human/NN serum/NN albumin/NN (/( GHSA/NN )/) stimulation/NN of/IN interleukin/NN (/( IL/NN )/) -8/CD and/CC monocyte/NN chemotactic/JJ protein/NN (/( MCP/NN )/) -1/CD secretion/NN in/IN human/NN retinal/JJ pigment/NN epithelium/NN (/( hRPE/NN )/) cells/NNS ./.
P11382751A09
The/DT specific/JJ inhibition/NN of/IN either/CC ERK/NN or/CC p38/NN (/( MAPK/NN )/) attenuated/VBD the/DT IL-1/NN beta-/NN or/CC LIF-stimulated/JJ ANF/NN expression/NN by/IN up/IN to/TO 70/CD %/SYM ./.
P11387337A09
Both/CC in/FW vitro/FW and/CC in/FW vivo/FW ,/, wild/JJ type/NN MKP-2/NN effectively/RB inactivated/VBD ERK2/NN whereas/IN MKP-2/NN mutants/NNS incapable/JJ of/IN binding/NN to/TO ERK/NN //SYM p38/NN did/VBD not/RB ./.
P11388701A05
We/PRP found/VBD that/IN thrombin/NN induced/VBD time-/NN and/CC dose-dependent/JJ activation/NN of/IN p38/NN MAPK/NN ./.
P11389977A04
Both/CC the/DT TP/NN agonist/NN U46619/NN and/CC 8-epiPGF/NN (/( 2alpha/NN )/) elicited/VBD time/NN and/CC concentration/NN dependent/JJ activation/NN of/IN the/DT extracellular/JJ signal/NN regulated/JJ kinase/NN (/( ERK/NN )/) s/NNS and/CC c-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) s/NNS in/IN ULTR/NN cells/NNS ./.
P11390374A06
Specifically/RB ,/, fucoidan/NN stimulates/VBZ activity/NN of/IN p21-activated/JJ kinase/NN (/( PAK/NN )/) and/CC of/IN the/DT MAPKs/NNS extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) ,/, c-Jun/NN NH/NN (/( 2/CD )/) -terminal/JJ kinase/NN (/( JNK/NN )/) ,/, and/CC p38/NN ./.
P11399523A03
NO/NN may/MD be/VBP the/DT mediator/NN of/IN the/DT cytotoxic/JJ effect/NN of/IN IL-1/NN beta/NN in/IN rat/NN islets/NNS and/CC beta-cell/NN lines/NNS ./.
P11399647A05
In/IN contrast/NN ,/, HGF/NN was/VBD unable/JJ to/TO reverse/VB the/DT loss/NN of/IN adhesion/NN of/IN cells/NNS exposed/VBN to/TO 99/CD %/SYM ATP/NN depletion/NN ./.
P11400118A08
Phosphorylated/JJ ERK1/NN //SYM 2/CD MAP/NN kinase/NN is/VBZ thus/RB potentially/RB prognostic/JJ for/IN prediction/NN of/IN response/NN to/TO anti-hormonal/JJ agents/NNS and/CC survival/NN ,/, data/NNS providing/VBG further/JJ evidence/NN that/IN ERK1/NN //SYM 2/CD MAP/NN kinase/NN plays/VBZ a/DT role/NN in/IN circumvention/NN of/IN anti-hormonal/JJ response/NN in/IN breast/NN cancer/NN ./.
P11401397A01
Retinoic/JJ acid/NN (/( RA/NN )/) ,/, a/DT potent/JJ teratogen/NN ,/, produces/VBZ a/DT characteristic/JJ set/NN of/IN embryonic/JJ cardiovascular/JJ malformations/NNS similar/JJ to/TO those/PRP observed/VBN in/IN neural/JJ crest/NN ablated/JJ avians/NNS ./.
P11401420A03
The/DT role/NN of/IN mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) activation/NN in/IN the/DT early/JJ intracellular/JJ signal/NN transduction/NN involved/VBN in/IN iNOS/NN and/CC IL-6/NN transcription/NN in/IN the/DT combined/JJ agents-stimulated/JJ osteoblasts/NNS has/VBZ been/VBN investigated/VBN ./.
P11401854A04
In/IN this/DT study/NN ,/, we/PRP report/VBP on/IN the/DT interactions/NNS between/IN the/DT TGF-beta/NN and/CC MAP/NN kinase/NN signaling/JJ pathways/NNS in/IN isolated/JJ rat/NN pancreatic/JJ acinar/JJ cells/NNS ./.
P11401859A04
Ionomycin/NN also/RB activated/VBD (/( 2/CD microM/NN )/) and/CC primed/VBD (/( 20-200/CD nM/NN )/) the/DT PMN/NN oxidase/NN ./.
P11408609A11
Together/RB ,/, these/DT findings/NNS suggest/VBP that/IN subsequent/JJ exposure/NN of/IN paclitaxel-treated/JJ U937/NN cells/NNS to/TO MEK/NN //SYM MAPK/NN inhibitors/NNS induces/VBZ perturbations/NNS in/IN signaling/JJ pathways/NNS ,/, particularly/RB the/DT p42/NN //SYM 44/CD MAPK/NN and/CC p38/NN MAPK/NN cascades/NNS ,/, that/WDT lower/VBP the/DT threshold/NN for/IN mitochondrial/JJ injury/NN and/CC induction/NN of/IN cell/NN death/NN ./.
P11408617A05
Selectively/RB blocking/NN mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) pathways/NNS by/IN overexpression/NN of/IN dominant-negative/JJ mutants/NNS of/IN kinases/NNS attenuated/VBD the/DT AP-1/NN activation/NN by/IN PMA/NN and/CC UVC/NN ./.
P11415463A03
The/DT inhibition/NN of/IN MAPK/NN activity/NN induced/VBD a/DT dose-dependent/JJ growth/NN arrest/NN in/IN G/NN (/( 0/CD )/) //SYM G/NN (/( 1/CD )/) phase/NN ./.
P11422444A07
The/DT c2-ceramide/NN treatment/NN also/RB increases/VBZ levels/NNS of/IN c-jun/NN ,/, c-fos/NN and/CC p53/NN mRNA/NN in/IN primary/JJ cortical/JJ neuron/NN cultures/NNS ,/, but/CC this/PRP is/VBZ independent/JJ of/IN p38/NN activation/NN ./.
P11423664A03
We/PRP show/VBP that/IN two/CD different/JJ inhibitors/NNS of/IN the/DT ERK/NN pathway/NN suppress/VBP the/DT induction/NN of/IN two/CD forms/NNS of/IN long-term/NN potentiation/NN (/( LTP/NN )/) in/IN rat/NN cortical/JJ slices/NNS and/CC that/IN their/PRP$ intracortical/JJ administration/NN to/TO monocularly/RB deprived/JJ rats/NNS prevents/VBZ the/DT shift/NN in/IN ocular/JJ dominance/NN towards/IN the/DT nondeprived/JJ eye/NN ./.
P11423976A06
Proliferation/NN and/CC survival/NN of/IN cancer/NN cells/NNS has/VBZ been/VBN linked/VBN in/FW vivo/FW to/TO enhanced/JJ expression/NN of/IN angiogenic/JJ growth/NN factors/NNS ./.
P11423998A01
Introduction/NN :/: We/PRP report/VBP the/DT results/NNS of/IN a/DT study/NN investigating/VBG signaling/JJ proteins/NNS in/IN 26/CD cases/NNS of/IN primary/JJ acute/JJ myelogenous/JJ leukemia/NN ./.
P11435219A10
However/WRB ,/, phosphorylation/NN of/IN PLD/NN by/IN p38/NN failed/VBD to/TO affect/VB PLD/NN activity/NN in/FW vitro/FW ./.
P11438570A02
It/PRP has/VBZ been/VBN shown/VBN previously/RB that/IN the/DT induction/NN of/IN apoptosis/NN in/IN these/DT neurons/NNS at/IN NGF/NN withdrawal/NN requires/VBZ both/CC the/DT activity/NN of/IN the/DT small/JJ GTP-binding/JJ protein/NN Cdc42/NN and/CC the/DT activation/NN of/IN the/DT c-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) pathway/NN ./.
P11438574A02
Protein/NN kinase/NN C/NN (/( PKC/NN )/) is/VBZ known/VBN to/TO increase/VB non-amyloidogenic/JJ alpha-secretase/NN cleavage/NN of/IN APP/NN ,/, producing/VBG secreted/JJ APP/NN (/( sAPPalpha/NN )/) ,/, and/CC glycogen/NN synthase/NN kinase/NN (/( GSK/NN )/) -3beta/NN is/VBZ known/VBN to/TO increase/VB tau/NN phosphorylation/NN ./.
P11443053A03
A/DT redox-cycling/JJ agent/NN ,/, phenazine/NN methosulfate/NN ,/, was/VBD found/VBN to/TO both/CC upregulate/VBP TNF-alpha/NN (/( 5.8/CD +/-/SYM 1.0/CD fold/NN ;/: P/NN =/SYM 0.01/CD )/) and/CC increase/VBP the/DT phosphorylation/NN state/NN of/IN p42/NN //SYM 44/CD MAPK/NN (/( 3.1/CD +/-/SYM 0.2/CD fold/NN ;/: P/NN =/SYM 0.01/CD )/) in/IN PMA-differentiated/JJ U-937/NN cells/NNS ./.
P11448861A05
It/PRP did/VBD not/RB appear/VBP that/IN stimulation/NN of/IN NKCC/NN activity/NN was/VBD a/DT reflection/NN of/IN increased/JJ Na/NN (/( +/SYM )/) -K/NN (/( +/SYM )/) -ATPase/NN activity/NN because/IN insulin/NN treatment/NN did/VBD not/RB stimulate/VBP NKCC/NN activity/NN ,/, despite/IN insulin/NN 's/POS well-known/JJ stimulation/NN of/IN Na/NN (/( +/SYM )/) -K/NN (/( +/SYM )/) -ATPase/NN activity/NN ./.
P11453646A05
These/DT findings/NNS suggest/VBP that/IN Rac/NN is/VBZ activated/VBN by/IN a/DT mechanism/NN that/WDT is/VBZ at/IN least/JJS partly/RB dependent/JJ on/IN PI3K/NN in/IN TNFalpha/NN stimulated/JJ cells/NNS and/CC plays/VBZ a/DT critical/JJ role/NN in/IN activation/NN of/IN the/DT Erk/NN signaling/JJ pathway/NN ./.
P11454854A07
These/DT cells/NNS also/RB had/VBD increased/JJ phosphorylation/NN of/IN native/JJ c-Jun/NN ,/, suggesting/VBG that/IN both/CC c-Jun/NN NH/NN (/( 2/CD )/) -terminal/JJ kinase/NN and/CC p38/NN MAP/NN kinases/NNS phosphorylate/VBP c-Jun/NN ./.
P11454948A06
Inhibition/NN of/IN Akt/NN activation/NN required/VBD almost/RB complete/JJ inhibition/NN of/IN ERK/NN ./.
P11455016A09
Our/PRP$ data/NNS confirmed/VBD additivity/NN in/IN those/DT cells/NNS lines/NNS that/WDT undergo/VBP paclitaxel-induced/JJ ERK/NN activation/NN ,/, and/CC antagonism/NN in/IN cells/NNS with/IN low/JJ ERK/NN activity/NN ,/, suggesting/VBG that/IN in/IN tumors/NNS with/IN high/JJ ERK/NN activity/NN ,/, there/EX may/MD be/VBP an/DT application/NN for/IN this/DT strategy/NN in/IN therapy/NN ./.
P11455028A03
The/DT activation/NN of/IN MAPKs/NNS ,/, especially/RB the/DT extracellular-regulated/JJ protein/NN kinase/NN subfamily/NN ,/, seems/VBZ to/TO play/VB a/DT causal/JJ role/NN in/IN death/NN of/IN renal/JJ proximal/JJ tubular/JJ epithelial/JJ cells/NNS (/( LLC-PK1/NN )/) induced/VBN by/IN reactive/JJ oxygen/NN species/NNS (/( ROS/NN )/) ./.
P11457751A08
Simvastatin/NN reduced/VBD LV/NN mass/NN by/IN 37/CD %/SYM ,/, interventricular/JJ septal/JJ thickness/NN by/IN 21/CD %/SYM ,/, and/CC posterior/JJ wall/NN thickness/NN by/IN 13/CD %/SYM ./.
P11461121A10
The/DT appearance/NN of/IN the/DT fragmented/JJ chromatin/NN visualized/VBN by/IN DAPI/NN staining/NN ,/, and/CC DNA/NN fragments/NNS seen/VBN on/IN an/DT agarose/NN gel/NN ,/, coincided/VBD with/IN the/DT decrease/NN in/IN ERK1/NN //SYM 2/CD activation/NN and/CC concomitant/JJ increase/NN of/IN the/DT level/NN of/IN active/JJ p38/NN MAPK/NN ./.
P11464287A06
In/IN contrast/NN ,/, MCF-7/NN cells/NNS expressing/VBG constitutively/RB activated/JJ MEK/NN show/VBP a/DT significant/JJ increase/NN in/IN MAPK/NN activity/NN and/CC cell/NN migration/NN ,/, but/CC this/PRP failed/VBD to/TO enhance/VB in/FW vitro/FW invasion/NN ./.
P11466386A06
The/DT induction/NN of/IN COX-2/NN was/VBD blocked/VBN by/IN the/DT p38/NN MAP/NN kinase/NN inhibitor/NN SB202190/NN ,/, even/RB when/WRB added/VBN 12-16/CD h/NN after/IN stimulation/NN with/IN Ag/NN when/WRB p38/NN MAP/NN kinase/NN activity/NN had/VBD returned/VBN to/TO near/RB basal/JJ ,/, but/CC still/RB minimally/RB elevated/VBN ,/, levels/NNS ./.
P11468147A02
The/DT present/JJ study/NN examines/VBZ the/DT involvement/NN of/IN different/JJ intracellular/JJ signaling/JJ pathways/NNS and/CC their/PRP$ physiopathologic/JJ consequences/NNS following/VBG the/DT CD4-independent/JJ interaction/NN between/IN CXCR4/NN or/CC CCR5/NN and/CC gp120/NN in/IN different/JJ cell/NN types/NNS :/: primary/JJ T/NN cells/NNS ,/, CD4/NN (/( -/SYM )/) //SYM CXCR4/NN (/( +/SYM )/) //SYM CCR5/NN (/( +/SYM )/) T/NN cells/NNS ,/, or/CC glioma/NN cells/NNS ./.
P11468529A07
FR167653/NN significantly/RB suppressed/VBD serum/NN ALT/NN and/CC LDH/NN levels/NNS and/CC improved/VBD liver/NN tissue/NN blood/NN flow/NN after/IN transplantation/NN ./.
P11472310A03
This/DT review/NN will/MD provide/VBP insight/NN on/IN potential/JJ intracellular/JJ signalling/JJ mechanisms/NNS by/IN which/WDT muscle/NN contraction/NN //SYM exercise/NN leads/VBZ to/TO changes/NNS in/IN gene/NN expression/NN ./.
P11487550A07
TUDC-induced/JJ stimulation/NN of/IN TC/NN excretion/NN was/VBD accompanied/VBN by/IN a/DT p38/NN (/( MAPK/NN )/) -dependent/JJ insertion/NN of/IN subcanalicular/JJ immunoreactive/JJ Bsep/NN into/IN the/DT canalicular/JJ membrane/NN ./.
P11498525A10
In/IN summary/NN ,/, we/PRP have/VBP shown/VBN the/DT histamine/NN H/NN (/( 1/CD )/) receptor/NN activates/VBZ p42/NN //SYM p44/NN MAPK/NN and/CC p38/NN MAPK/NN signalling/JJ pathways/NNS in/IN DDT/NN (/( 1/CD )/) MF-2/NN smooth/JJ muscle/NN cells/NNS ./.
P11504702A05
However/WRB ,/, inhibition/NN of/IN either/CC ERK/NN or/CC p38/NN MAPK/NN did/VBD not/RB affect/VBP acrolein-dependent/JJ inhibition/NN of/IN apoptosis/NN ./.
P11504709A03
PMA/NN and/CC TPO/NN were/VBD able/JJ to/TO modulate/VB GPIX/NN expression/NN at/IN mRNA/NN and/CC protein/NN levels/NNS ./.
P11509022A07
The/DT anisomycin/NN effect/NN was/VBD enhanced/VBN in/IN the/DT presence/NN of/IN 100/CD mM/NN ethanol/NN ./.
P11518563A01
Administration/NN of/IN bacterial/JJ lipopolysaccharide/NN (/( LPS/NN )/) to/TO laboratory/NN animals/NNS and/CC cultured/JJ macrophages/NNS is/VBZ known/VBN to/TO induce/VB the/DT production/NN of/IN nitric/JJ oxide/NN (/( NO/NN )/) from/IN inducible/JJ nitric/JJ oxide/NN synthase/NN (/( iNOS/NN )/) ./.
P11524243A02
PGE1/NN induced/VBD the/DT phosphorylation/NN of/IN both/CC p44/NN //SYM p42/NN mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN and/CC p38/NN MAP/NN kinase/NN ./.
P11525649A04
We/PRP now/RB directly/RB confirm/VBP this/DT prediction/NN by/IN showing/NN that/IN oncogenic/JJ p21/NN induces/VBZ activating/JJ phosphorylation/NN of/IN JNK/NN (/( JNK-P/NN )/) and/CC of/IN ERK/NN (/( MAP/NN kinase/NN )/) (/( MAPK-P/NN )/) ,/, whose/WDT levels/NNS correlate/VBP with/IN oocyte/NN maturation/NN ./.
P11525903A01
Mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) play/VBP a/DT critical/JJ role/NN in/IN the/DT regulation/NN of/IN cell/NN proliferation/NN ,/, differentiation/NN and/CC apoptosis/NN ./.
P11527089A05
Incubation/NN of/IN HREC/NN in/IN serum-free/JJ medium/NN caused/VBD a/DT time-dependent/JJ increase/NN in/IN c-Jun/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) activity/NN ,/, and/CC continuous/JJ culture/NN of/IN HREC/NN in/IN the/DT presence/NN of/IN IGF-I/NN or/CC vascular/JJ endothelial/JJ growth/NN factor/NN (/( VEGF/NN )/) prevented/VBD JNK/NN activation/NN and/CC arrested/VBD apoptosis/NN ./.
P11527418A01
It/PRP has/VBZ been/VBN shown/VBN that/IN thyroid/NN hormone/NN stimulates/VBZ the/DT activity/NN of/IN alkaline/JJ phosphatase/NN ,/, a/DT marker/NN of/IN mature/JJ osteoblast/NN phenotype/NN ,/, in/IN osteoblasts/NNS ./.
P11527419A01
Cannabinoids/NNS affect/VBP prostaglandin/NN (/( PG/NN )/) formation/NN in/IN the/DT central/JJ nervous/JJ system/NN through/IN as/RB yet/RB unidentified/JJ mechanisms/NNS ./.
P11527648A09
CONCLUSIONS/NNS :/: These/DT data/NNS demonstrate/VBP a/DT nearly/RB complete/JJ requirement/NN of/IN endogenous/JJ norepinephrine/NN and/CC epinephrine/NN for/IN the/DT induction/NN of/IN in/FW vivo/FW pressure-overload/NN cardiac/JJ hypertrophy/NN and/CC for/IN the/DT activation/NN of/IN hypertrophic/JJ signaling/JJ pathways/NNS ./.
P11543732A06
Activation/NN of/IN mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) and/CC the/DT redox-sensitive/JJ transcription/NN factors/NNS ,/, nuclear/JJ factor-kappaB/NN (/( NF-kappaB/NN )/) and/CC activator/NN protein/NN 1/CD (/( AP-1/NN )/) ,/, are/VBP key/JJ events/NNS in/IN the/DT signal/NN transduction/NN pathways/NNS mediating/VBG TNF-alpha/NN induction/NN ./.
P11544323A05
Using/VBG highly/RB specific/JJ inhibitors/NNS of/IN p38/NN (/( SB203580/NN )/) and/CC MAP/NN kinase/NN kinase-1/NN (/( PD98059/NN )/) ,/, we/PRP found/VBD that/IN activation/NN of/IN the/DT extracellular/JJ signal-regulated/JJ kinase/NN pathway/NN ,/, but/CC not/RB of/IN p38/NN ,/, was/VBD essential/JJ for/IN the/DT M./NN avium-induced/JJ TNF-alpha/NN formation/NN ./.
P11549715A03
This/DT stimulation/NN resulted/VBD in/IN a/DT transient/JJ phosphorylation/NN of/IN p42/NN MAPK/NN ,/, and/CC the/DT resulting/JJ LTP/NN was/VBD MAPK/NN dependent/JJ ./.
P11553284A05
However/WRB ,/, blockade/NN of/IN dopaminergic/JJ (/( DA/NN )/) D1/NN receptors/NNS by/IN administration/NN of/IN SCH/NN 23390/CD ,/, prior/RB to/TO THC/NN ,/, totally/RB prevents/VBZ ERK/NN activation/NN in/IN the/DT striatum/NN ,/, thus/RB demonstrating/VBG a/DT critical/JJ involvement/NN of/IN DA/NN systems/NNS in/IN THC-induced/JJ ERK/NN activation/NN ./.
P11553563A01
Enteropathogenic/JJ Escherichia/NN coli/NN (/( EPEC/NN )/) is/VBZ an/DT extracellular/JJ bacterial/JJ pathogen/NN that/WDT infects/VBZ the/DT human/NN intestinal/JJ epithelium/NN and/CC is/VBZ a/DT major/JJ cause/NN of/IN infantile/JJ diarrhea/NN in/IN developing/JJ countries/NNS ./.
P11559033A06
G/NN (/( 2/CD )/) //SYM M/NN was/VBD the/DT most/RBS sensitive/JJ cell/NN cycle/NN phase/NN to/TO Cd/NN for/IN the/DT induction/NN of/IN ERK/NN and/CC p38/NN MAPK/NN activities/NNS ,/, cytotoxicity/NN ,/, apoptosis/NN ,/, micronucleus/NN ,/, and/CC intracellular/JJ peroxide/NN ;/: despite/IN that/IN similar/JJ Cd/NN accumulation/NN was/VBD observed/VBN in/IN G/NN (/( 1/CD )/) -/: ,/, S-/NN ,/, and/CC G/NN (/( 2/CD )/) //SYM M-cells/NNS ./.
P11560859A02
Epidemiological/JJ studies/NNS indicate/VBP that/IN estrogen/NN replacement/NN therapy/NN is/VBZ cardioprotective/JJ ;/: the/DT mechanisms/NNS involved/VBN in/IN this/DT process/NN ,/, however/WRB ,/, are/VBP poorly/RB understood/VBN ./.
P11560928A09
These/DT results/NNS suggest/VBP that/IN transient/JJ activation/NN of/IN ILK/NN is/VBZ required/VBN for/IN neurite/NN outgrowth/NN in/IN serum-starved/JJ N1E-115/NN cells/NNS on/IN laminin/NN ./.
P11561064A01
Genistein/NN is/VBZ a/DT potent/JJ plant-derived/JJ isoflavone/NN displaying/VBG estrogenic/JJ activity/NN at/IN low/JJ (/( nanomolar/JJ )/) concentrations/NNS and/CC antiproliferative/JJ and/CC antiangiogenic/JJ properties/NNS at/IN higher/JJR concentrations/NNS (/( above/IN 10-50/CD microM/NN )/) ./.
P11562426A01
Angiotensin/NN II/CD (/( Ang/NN II/CD )/) induces/VBZ vascular/JJ smooth/JJ muscle/NN cell/NN (/( VSMC/NN )/) hypertrophy/NN ,/, which/WDT results/VBZ in/IN various/JJ cardiovascular/JJ diseases/NNS ./.
P11564659A07
4./CD The/DT UTP-induced/JJ enhancement/NN of/IN the/DT growth/NN of/IN C6/NN cells/NNS is/VBZ due/JJ to/TO activation/NN of/IN MAPK/NN by/IN a/DT PPADS/NN sensitive/JJ nucleotide/NN receptor/NN ./.
P11570006A03
However/WRB ,/, during/IN the/DT last/JJ six/CD to/TO seven/CD years/NNS this/DT view/NN has/VBZ been/VBN challenged/VBN by/IN several/JJ studies/NNS demonstrating/VBG that/IN a/DT significant/JJ number/NN of/IN myocytes/NNS undergo/VBP apoptosis/NN in/IN myocardial/JJ infarction/NN ,/, heart/NN failure/NN ,/, myocarditis/NN ,/, arrhythmogen/NN right/JJ ventricular/JJ dysplasia/NN ,/, and/CC immune/JJ rejection/NN after/IN cardiac/JJ transplantation/NN ,/, as/RB well/RB as/IN in/IN other/JJ conditions/NNS of/IN stress/NN ./.
P11570814A07
The/DT potential/NN of/IN SNP/NN toxicity/NN directly/RB from/IN NO/NN was/VBD supported/VBN by/IN our/PRP$ finding/NN that/IN the/DT NO/NN scavenger/NN carboxy-PTIO/NN prevented/VBD cell/NN death/NN ./.
P11571231A06
These/DT findings/NNS suggest/VBP that/IN the/DT activation/NN of/IN p38/NN kinase/NN may/MD play/VBP important/JJ roles/NNS in/IN the/DT signal/NN transduction/NN mechanisms/NNS of/IN hydroxyurea/NN leading/NN to/TO erythroid/NN differentiation/NN ./.
P11571286A07
In/IN contrast/NN ,/, inner/JJ retina/NN //SYM glia/NN possess/VBP alternative/JJ ,/, cell/NN type/NN ,/, and/CC growth/NN factor-specific/JJ MEK-independent/JJ ERK1/NN //SYM 2/CD activation/NN pathways/NNS ./.
P11573595A02
The/DT effects/NNS of/IN propofol/NN on/IN the/DT function/NN and/CC intracellular/JJ signal/NN transduction/NN systems/NNS of/IN neutrophils/NNS is/VBZ controversial/JJ ./.
P11574421A07
Bax/NN quantity/NN also/RB increased/VBD ./.
P11577023A02
Thrombin/NN exerts/VBZ profound/JJ effects/NNS on/IN endothelial/JJ function/NN ./.
P11577023A14
These/DT effects/NNS of/IN thrombin/NN may/MD be/VBP important/JJ for/IN endothelial/JJ dysfunction/NN in/IN cardiovascular/JJ disease/NN ,/, particularly/RB during/IN acute/JJ coronary/JJ episodes/NNS ./.
P11577087A01
The/DT expression/NN of/IN enzymes/NNS involved/VBN in/IN fatty/JJ acid/NN beta-oxidation/NN (/( FAO/NN )/) ,/, the/DT principal/JJ source/NN of/IN energy/NN production/NN in/IN the/DT adult/NN mammalian/JJ heart/NN ,/, is/VBZ controlled/VBN at/IN the/DT transcriptional/JJ level/NN via/IN the/DT nuclear/JJ receptor/NN peroxisome/NN proliferator-activated/JJ receptor/NN alpha/NN (/( PPARalpha/NN )/) ./.
P11579095A01
The/DT estrogen/NN receptors/NNS (/( ERs/NNS )/) are/VBP ligand-inducible/JJ transcription/NN factors/NNS that/WDT play/VBP key/JJ roles/NNS in/IN the/DT control/NN of/IN growth/NN and/CC differentiation/NN in/IN reproductive/JJ tissues/NNS ./.
P11585923A04
A/DT similar/JJ inhibition/NN of/IN the/DT Ras-MAPK/NN pathway/NN was/VBD observed/VBN on/IN stimulation/NN of/IN endogenous/JJ EphB2/NN in/IN COS-1/NN cells/NNS ./.
P11588033A01
During/IN the/DT cell/NN transformation/NN processes/NNS leading/VBG to/TO erythroleukemia/NN ,/, erythroid/NN progenitors/NNS often/RB become/VBP erythropoietin/NN (/( Epo/NN )/) -independent/JJ for/IN their/PRP$ proliferation/NN ./.
P11590318A05
METHODOLOGY/NN AND/CC RESULTS/NNS :/: We/PRP established/VBD an/DT in/FW vitro/FW model/NN for/IN ECM-induced/JJ differentiation/NN of/IN poorly/RB differentiated/JJ pancreatic/JJ carcinoma/NN cells/NNS and/CC found/VBD that/IN a/DT specific/JJ pattern/NN of/IN ECM/NN proteins/NNS resembling/VBG basal/JJ laminas/NN (/( matrigel/NN )/) induces/VBZ differentiation/NN of/IN the/DT PaTu-II/NN pancreatic/JJ carcinoma/NN cell/NN line/NN to/TO a/DT ductal/JJ phenotype/NN ./.
P11591707A11
Transcriptional/JJ activity/NN of/IN Egr-1/NN protein/NN was/VBD enhanced/VBN by/IN GnRH/NN treatment/NN ./.
P11592793A04
They/PRP were/VBD treated/VBN with/IN menadione/NN (/( an/DT intracellular/JJ generator/NN of/IN O/NN (/( -2/CD )/) )/) and/or/CC platelet-derived/JJ growth/NN factor/NN homodimer/NN BB/NN (/( PDGF/NN )/) ./.
P11595733A05
Activation/NN of/IN Akt/NN by/IN raloxifene/NN reached/VBD a/DT plateau/NN at/IN 15-30/CD min/NN and/CC declined/VBD thereafter/RB ,/, a/DT similar/JJ time/NN frame/NN to/TO that/PRP of/IN Akt/NN activation/NN by/IN 17beta-estradiol/NN ./.
P11595756A03
NO/NN donors/NNS could/MD induce/VBP the/DT neurite/NN outgrowth/NN dose-dependently/RB in/IN the/DT cells/NNS ./.
P11597764A09
Since/IN cleaved/JJ caspase-3/NN is/VBZ not/RB expressed/VBN by/IN dying/JJ cells/NNS in/IN the/DT present/JJ paradigm/NN ,/, JNK/NN (/( P/NN )/) ,/, p38/NN (/( P/NN )/) and/CC c-Jun/NN (/( P/NN )/) expression/NN is/VBZ not/RB associated/VBN with/IN caspase-3/NN activation/NN ./.
P11597988A12
Collectively/RB ,/, these/DT data/NNS indicated/VBD that/IN Ang/NN II/CD stimulated/VBD ROS/NN production/NN via/IN the/DT AT1/NN receptor/NN and/CC NADH/NN //SYM NADPH/NN oxidase/NN ,/, and/CC that/IN these/DT ROS/NN mediated/VBD activation/NN of/IN MAPKs/NNS ,/, which/WDT culminated/VBD in/IN IL-6/NN gene/NN expression/NN through/IN a/DT CRE-dependent/JJ ,/, but/CC not/RB NF-kappaB-dependent/JJ ,/, pathway/NN in/IN cardiac/JJ fibroblasts/NNS ./.
P11598011A01
The/DT oncogenic/JJ latent/JJ membrane/NN protein/NN 1/CD (/( LMP1/NN )/) of/IN the/DT Epstein-Barr/NN virus/NN recruits/VBZ tumor/NN necrosis/NN factor-receptor/NN (/( TNFR/NN )/) -associated/JJ factors/NNS (/( TRAFs/NNS )/) ,/, the/DT TNFR-associated/JJ death/NN domain/NN protein/NN (/( TRADD/NN )/) and/CC JAK3/NN to/TO induce/VB intracellular/JJ signaling/JJ pathways/NNS ./.
P11598045A11
ERK1/NN //SYM 2/CD ,/, while/IN not/RB involved/VBN in/IN P./NN gingivalis/NN invasion/NN of/IN GECs/NNS ,/, may/MD be/VBP downregulated/VBN by/IN internalized/JJ P./NN gingivalis/NN ./.
P11600417A05
H/NN (/( 2/CD )/) O/NN (/( 2/CD )/) (/( 50/CD microM/NN )/) caused/VBD transient/JJ activation/NN of/IN ERK1/NN //SYM 2/CD and/CC p38/NN MAP/NN kinase/NN that/WDT was/VBD detected/VBN as/RB early/RB as/IN 5/CD min/NN ,/, was/VBD maximal/JJ at/IN 20/CD min/NN (/( 9.6/CD +/-/SYM 1.2-/CD and/CC 9.0/CD +/-/SYM 1.6-fold/NN ,/, respectively/RB ,/, vs./CC control/NN )/) ,/, and/CC returned/VBD to/TO baseline/NN at/IN 60/CD min/NN ./.
P11600497A07
Furthermore/RB ,/, we/PRP found/VBD that/IN the/DT expression/NN of/IN FADD/NN and/CC caspase-8/NN was/VBD significantly/RB reduced/VBN in/IN serum-starved/JJ cells/NNS ,/, whereas/IN the/DT level/NN of/IN cFLIP/NN remained/VBD unchanged/JJ ./.
P11602182A05
At/IN the/DT commitment/NN time/NN for/IN inducing/NN cell/NN death/NN ,/, TT-232/NN decreased/VBD EGFR-tyrosine/NN phosphorylation/NN and/CC prevented/VBD epidermial/JJ growth/NN factor/NN (/( EGF/NN )/) -induced/JJ events/NNS like/IN cRaf-1/NN and/CC ERK2/NN activation/NN ./.
P11603565A01
The/DT aim/NN of/IN this/DT experiment/NN was/VBD to/TO examine/VB the/DT regulation/NN of/IN p38/NN mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN by/IN platelet-derived/JJ growth/NN factor/NN (/( PDGF/NN )/) -BB/NN and/CC its/PRP$ biological/JJ effects/NNS on/IN rat/NN cultured/JJ vascular/JJ smooth/JJ muscle/NN cells/NNS (/( VSMCs/NNS )/) ./.
P11604491A01
Trophic/JJ factor/NN withdrawal/NN induces/VBZ cell/NN death/NN by/IN mechanisms/NNS that/WDT are/VBP incompletely/RB understood/VBN ./.
P11606371A05
In/IN addition/NN ,/, we/PRP show/VBP that/IN the/DT inhibition/NN of/IN HER-2/NN //SYM neu/NN signaling/NN with/IN AG825/NN triggers/VBZ an/DT imbalance/NN between/IN extracellular/JJ signal-regulated/JJ kinase/NN 1/CD //SYM 2/CD and/CC p38/NN mitogen-activated/JJ protein/NN kinase/NN activation/NN ,/, which/WDT leads/VBZ to/TO p38-dependent/JJ apoptosis/NN ./.
P11606383A08
Inhibiting/NN the/DT ERKs/NNS 1/CD &/CC 2/CD or/CC Akt/NN pathways/NNS with/IN specific/JJ chemical/JJ inhibitors/NNS (/( PD98059/NN or/CC LY294002/NN ,/, respectively/RB )/) did/VBD not/RB affect/VBP the/DT extent/NN of/IN apoptosis/NN induced/VBN by/IN SDG/NN or/CC p-XSC/NN (/( with/IN the/DT exception/NN of/IN LY294002/NN ,/, which/WDT actually/RB enhanced/VBD the/DT level/NN of/IN induction/NN of/IN apoptosis/NN by/IN SDG/NN )/) ./.
P11606583A02
However/WRB ,/, it/PRP is/VBZ unclear/JJ how/WRB elevated/JJ endogenous/JJ p38/NN MAPK/NN activity/NN is/VBZ maintained/VBN in/IN invasive/JJ breast/NN cancer/NN cells/NNS ./.
P11640950A05
However/WRB ,/, in/IN non-demented/JJ cases/NNS lacking/VBG any/DT sign/NN of/IN pathology/NN (/( Braak/NN stage/NN 0/CD )/) ,/, either/CC ERK/NN alone/JJ or/CC JNK/NN //SYM SAPK/NN alone/JJ can/MD be/VBP activated/VBN ./.
P11641266A05
Activation/NN of/IN AP-1/NN with/IN a/DT c-Jun/NN amino-terminal/JJ kinase/NN (/( JNK/NN )/) activator/NN (/( Ro318220/NN ,/, 10/CD microM/NN )/) provoked/VBD apoptosis/NN in/IN 18.7/CD +/-/SYM 1.2/CD %/SYM cardiomyocytes/NNS ,/, which/WDT was/VBD again/RB blocked/VBN by/IN intracellular/JJ scavenging/NN of/IN AP-1/NN ./.
P11641267A08
Our/PRP$ data/NNS indicate/VBP that/IN p90RSK/NN downstream/JJ of/IN ERK1/NN //SYM 2/CD is/VBZ the/DT molecular/JJ target/NN for/IN ROS/NN generated/VBN through/IN stimulation/NN of/IN purinergic/JJ receptors/NNS by/IN ATP/NN ./.
P11667949A08
Time/NN course/NN experiments/NNS (/( 5-HT/NN 10/CD (/( -5/CD )/) M/NN ;/: 5/CD min/NN ,/, 15/CD min/NN ,/, 30/CD min/NN and/CC 60/CD min/NN )/) showed/VBD no/DT significant/JJ activation/NN of/IN JNK/NN after/IN incubation/NN with/IN 5-HT/NN at/IN any/DT time/NN point/NN ./.
P11677248A10
PP2/NN ,/, a/DT Src/NN family/NN kinase/NN inhibitor/NN ,/, or/CC cytochalasin/NN D/NN ,/, which/WDT selectively/RB disrupts/VBZ the/DT network/NN of/IN actin/NN filaments/NNS ,/, inhibited/VBD both/CC FAK/NN phosphorylation/NN and/CC NO/NN production/NN induced/VBN by/IN FN-f/NN ,/, but/CC the/DT phosphatidylinositol/NN 3-kinase/NN inhibitor/NN wortmannin/NN had/VBD no/DT effect/NN ./.
P11678615A02
Three/CD major/JJ mitogen-activation/NN protein/NN kinases/NNS (/( MAPKs/NNS )/) ,/, extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) ,/, c-JUN/NN N-terminal/JJ kinase/NN (/( JNK/NN )/) and/CC p38/NN ,/, have/VBP been/VBN shown/VBN to/TO regulate/VB apoptosis/NN ./.
P11678615A14
Conversely/RB ,/, neither/CC SB202190/NN nor/CC PD98059/NN altered/VBD Cr/NN (/( VI/CD )/) -induced/JJ cytotoxicity/NN ./.
P11679966A11
Despite/IN similar/JJ activators/NNS of/IN TAK1/NN //SYM JNK/NN and/CC p38/NN ,/, their/PRP$ functions/NNS in/IN HSCs/NNS are/VBP distinct/JJ and/CC opposed/VBN ./.
P11682454A01
1./CD Although/IN accumulating/JJ studies/NNS have/VBP identified/VBN I/NN kappa/NN B/NN kinase/NN (/( IKK/NN )/) to/TO be/VB essential/JJ for/IN controlling/NN NF-kappa/NN B/NN activity/NN in/IN response/NN to/TO several/JJ cytokines/NNS ,/, the/DT upstream/JJ kinases/NNS that/WDT control/VBP IKK/NN activity/NN are/VBP still/RB not/RB completely/RB known/VBN ./.
P11682454A12
While/IN PKC/NN and/CC ERK/NN participate/VBP in/IN IKK/NN activation/NN by/IN LPS/NN and/CC UTP/NN ,/, the/DT phosphatidylinositide-phospholipase/NN C-dependent/JJ activation/NN of/IN CaMK/NN plays/VBZ a/DT major/JJ role/NN in/IN UTP/NN potentiation/NN of/IN the/DT LPS/NN response/NN ./.
P11683179A03
In/IN the/DT LMD/NN ,/, the/DT growing/JJ embryonic/JJ sex/NN tract/NN ,/, the/DT amount/NN of/IN JNK/NN increased/VBD from/IN the/DT 8th/JJ to/TO 10th/JJ embryonic/JJ day/NN and/CC reached/VBD its/PRP$ highest/NN at/IN the/DT 12th/JJ to/TO 18th/JJ day/NN ./.
P11689560A07
The/DT stimulation/NN of/IN apoptosis/NN by/IN ERK/NN inhibition/NN was/VBD accompanied/VBN by/IN increased/JJ p53/NN accumulation/NN and/CC caspase-3/NN activity/NN ,/, whereas/IN the/DT inhibitory/JJ effect/NN of/IN p38/NN kinase/NN blockade/NN was/VBD associated/VBN with/IN reduced/JJ p53/NN accumulation/NN and/CC caspase-3/NN activity/NN ./.
P11690563A01
The/DT mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) family/NN members/NNS have/VBP been/VBN implicated/VBN in/IN cell/NN survival/NN ./.
P11692108A03
METHODS/NNS :/: The/DT levels/NNS of/IN gene/NN expression/NN and/CC protein/NN production/NN for/IN IL-6/NN and/CC IL-8/NN in/IN IL-17-treated/JJ cells/NNS ,/, in/IN the/DT presence/NN or/CC absence/NN of/IN MAP/NN kinase/NN inhibitors/NNS ,/, were/VBD analyzed/VBN by/IN RT-PCR/NN and/CC ELISA/NN ,/, respectively/RB ,/, and/CC activation/NN of/IN MAP/NN kinases/NNS was/VBD determined/VBN by/IN Western/NN blot/NN analyses/NNS ./.
P11694531A02
UV/NN also/RB induces/VBZ the/DT activation/NN of/IN another/DT MAPK/NN member/NN ,/, extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) ,/, which/WDT is/VBZ typically/RB involved/VBN in/IN a/DT growth-signaling/JJ cascade/NN ./.
P11697858A03
Ceramide/NN also/RB inhibited/VBD production/NN of/IN PGD/NN (/( 2/CD )/) and/CC an/DT increase/NN in/IN the/DT activity/NN of/IN cytosolic/JJ phospholipase/NN A/NN (/( 2/CD )/) (/( cPLA/NN (/( 2/CD )/) )/) ,/, whereas/IN it/PRP did/VBD not/RB influence/VBP the/DT tyrosine/NN phosphorylation/NN of/IN major/JJ cellular/JJ proteins/NNS in/IN response/NN to/TO antigen/NN ./.
P11698257A08
We/PRP conclude/VBP that/IN hypertonic/JJ activation/NN of/IN Na/NN (/( +/SYM )/) //SYM H/NN (/( +/SYM )/) exchange/NN in/IN Xenopus/NN oocytes/NNS requires/VBZ Cl/NN (/( -/SYM )/) and/CC is/VBZ mediated/VBN by/IN activation/NN of/IN JNK/NN ./.
P11699878A04
Administration/NN of/IN SB203580/NN led/VBD to/TO a/DT 63.4/CD %/SYM reduction/NN in/IN the/DT extent/NN of/IN inflammatory/JJ involvement/NN ,/, the/DT level/NN of/IN ET-1/NN fell/VBP by/IN a/DT 42/CD %/SYM and/CC TNF-alpha/NN declined/VBD by/IN a/DT 52.3/CD %/SYM ,/, whereas/IN PD98059/NN elicited/VBD a/DT 21.2/CD %/SYM reduction/NN in/IN the/DT extent/NN of/IN inflammatory/JJ involvement/NN and/CC a/DT 22.7/CD %/SYM decrease/NN in/IN TNF-alpha/NN ,/, but/CC had/VBD no/DT effect/NN on/IN the/DT LPS-induced/JJ increase/NN in/IN ET-1/NN ./.
P11701758A10
Whereas/IN the/DT effect/NN of/IN Z-VAD-FMK/NN on/IN cell/NN survival/NN was/VBD transient/JJ ,/, the/DT effect/NN of/IN MEK/NN inhibitors/NNS was/VBD long-lasting/JJ ./.
P11704547A01
The/DT mechanisms/NNS responsible/JJ for/IN the/DT divergent/JJ physiological/JJ responses/NNS of/IN endothelial/JJ cells/NNS to/TO vascular/JJ endothelial/JJ growth/NN factor/NN (/( VEGF/NN )/) are/VBP incompletely/RB understood/VBN ./.
P11707695A08
The/DT transcription/NN factor/NN Ets-1/NN mediates/VBZ matrix/NN metalloproteinase/NN induction/NN required/VBN for/IN tissue/NN invasion/NN by/IN VSMC/NN ./.
P11709424A03
IL-1/NN beta/NN stimulated/VBD biphasic/JJ ERK/NN activation/NN in/IN vascular/JJ smooth/JJ muscle/NN (/( VSM/NN )/) cells/NNS ,/, a/DT transient/JJ activation/NN that/WDT reached/VBD a/DT maximum/NN at/IN 15/CD min/NN and/CC declined/VBD to/TO baseline/NN levels/NNS within/IN 1/CD h/NN ,/, and/CC a/DT second/JJ phase/NN of/IN sustained/JJ ERK/NN activation/NN lasting/VBG up/IN to/TO 8/CD h/NN ./.
P11709707A04
The/DT expression/NN of/IN matrix/NN metalloproteinases/NNS MMP-1/NN and/CC MMP-9/NN ,/, which/WDT have/VBP RRE/NN in/IN their/PRP$ promoters/NNS ,/, were/VBD reduced/VBN by/IN treatment/NN with/IN malolactomycin/NN D/NN at/IN the/DT translational/JJ and/CC transcriptional/JJ levels/NNS ./.
P11714824A08
A/DT similar/JJ inhibition/NN was/VBD observed/VBN with/IN 20/CD mg/NN //SYM kg/NN of/IN a/DT second/JJ p38/NN inhibitor/NN SB203580/NN (/( 67/CD %/SYM ,/, p/NN </SYM 0.05/CD )/) ./.
P11716483A10
These/DT results/NNS indicated/VBD that/IN ERK/NN activation/NN negatively/RB regulated/VBD Smad7/NN transcription/NN possibly/RB by/IN inhibiting/NN translocation/NN of/IN Smad/NN complex/NN to/TO nuclei/NNS ./.
P11719557A08
TGF-beta1/NN concentrations/NNS of/IN 1-2/CD ng/NN //SYM ml/NN were/VBD significantly/RB promigratory/JJ ,/, whereas/IN lower/JJR levels/NNS (/( 0.2-0.6/CD ng/NN //SYM ml/NN )/) were/VBD ineffective/JJ and/CC final/JJ concentrations/NNS >/SYM or/CC =5/CD ng/NN //SYM ml/NN inhibited/VBD T2/NN cell/NN motility/NN ./.
P11724348A07
These/DT results/NNS suggest/VBP that/IN activation/NN of/IN the/DT Raf-1/NN //SYM ERK/NN module/NN of/IN the/DT MAP/NN kinase/NN pathway/NN play/VBP an/DT important/JJ role/NN in/IN PNETs/NNS ./.
P11731435A04
We/PRP analyzed/VBD the/DT death/NN signaling/JJ pathways/NNS activated/VBN by/IN these/DT molecules/NNS ./.
P11731569A03
This/DT Ca2+/NN signalling/NN was/VBD critical/JJ for/IN the/DT normal/JJ regulatory/JJ volume/NN decrease/NN (/( RVD/NN )/) response/NN ./.
P11732999A06
Western/NN blot/NN analysis/NN showed/VBD that/IN phosphorylation/NN of/IN ERK/NN was/VBD induced/VBN from/IN 30/CD to/TO 60/CD min/NN and/CC phosphorylation/NN of/IN p38/NN MAPK/NN from/IN 10/CD to/TO 15/CD min/NN after/IN the/DT addition/NN of/IN CTGF/NN //SYM Hcs24/NN in/IN confluence/NN HCS-2/NN //SYM 8/CD cells/NNS ./.
P11733514A02
We/PRP employed/VBD a/DT neurofilament/NN light/JJ chain/NN (/( NFLC/NN )/) promoter-luciferase/NN (/( NFLC-Luc/NN )/) reporter/NN to/TO define/VB the/DT role/NN of/IN the/DT ERKs/NNS as/RB well/RB as/IN additional/JJ MAPK/NN pathways/NNS in/IN NGF/NN induction/NN of/IN this/DT neural/JJ specific/JJ gene/NN ./.
P11734304A03
Mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) signaling/JJ cascades/NNS trigger/VBP stimulus-specific/JJ responses/NNS in/IN cells/NNS with/IN ERK/NN being/NN associated/VBN with/IN proliferation/NN and/CC differentiation/NN ,/, and/CC JNK/NN //SYM SAPK/NN and/CC p38/NN mediating/NN stress/NN and/CC apoptotic/JJ responses/NNS ./.
P11734574A03
We/PRP stimulated/VBD the/DT MAP/NN kinase/NN pathway/NN with/IN anti-CD3/NN antibodies/NNS and/CC phorbol/NN 12-myristate/NN 13-acetate/NN (/( PMA/NN )/) ,/, which/WDT act/VBP upstream/JJ of/IN the/DT MAP/NN kinase/NN (/( MAPK/NN )/) //SYM ERK/NN kinase/NN (/( MEK/NN )/) as/IN U0126/NN ,/, an/DT MEK/NN inhibitor/NN ,/, abolished/VBD the/DT actions/NNS of/IN these/DT two/CD agents/NNS on/IN MAP/NN kinase/NN activation/NN ./.
P11736793A02
Recent/JJ evidence/NN indicates/VBZ the/DT presence/NN of/IN p21/NN Ras/NN and/CC the/DT phosphorylation/NN of/IN ERK1/NN and/CC ERK2/NN ,/, suggesting/VBG the/DT occurrence/NN of/IN the/DT Ras/NN //SYM ERK/NN cascade/NN in/IN mammalian/JJ spermatozoa/NNS ./.
P11739023A03
We/PRP have/VBP examined/VBN the/DT possibility/NN that/IN mitogen/NN activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) may/MD play/VBP a/DT role/NN in/IN mediating/NN the/DT effects/NNS of/IN PACAP/NN on/IN alpha/NN T3-1/NN gonadotrophs/NNS ./.
P11741321A06
We/PRP also/RB show/VBP that/IN each/DT c-FLIP/NN variant/NN is/VBZ regulated/VBN by/IN a/DT distinct/JJ molecular/JJ mechanism/NN at/IN the/DT transcriptional/JJ level/NN ;/: c-FLIP/NN (/( L/NN )/) is/VBZ induced/VBN by/IN Erk/NN ,/, whereas/IN c-FLIP/NN (/( S/NN )/) ,/, through/IN the/DT JNK/NN activation/NN ,/, is/VBZ like/IN an/DT autocrine/JJ regulatory/JJ loop/NN ./.
P11744731A04
In/IN contrast/NN to/TO PKC/NN alpha/NN ,/, ERK/NN activity/NN increased/VBD 15-fold/NN during/IN dedifferentiation/NN ./.
P11746384A06
Five/CD hours/NNS after/IN stimulation/NN ,/, neuronal/JJ retina/NN cells/NNS had/VBD an/DT apoptotic-like/JJ nuclear/JJ morphology/NN ./.
P11748143A02
To/TO determine/VB if/IN these/DT cellular/JJ events/NNS are/VBP regulated/VBN by/IN the/DT same/JJ signalling/JJ pathways/NNS ,/, we/PRP examined/VBD the/DT role/NN of/IN mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) signalling/NN in/IN FGF-induced/JJ lens/NN cell/NN proliferation/NN and/CC differentiation/NN ./.
P11750912A04
U0126/NN ,/, however/WRB ,/, did/VBD not/RB significantly/RB affect/VBP KCl-evoked/JJ glutamate/NN release/NN at/IN concentrations/NNS shown/VBN to/TO inhibit/VB ERK/NN activity/NN ./.
P11750919A11
We/PRP conclude/VBP that/IN distinct/JJ receptors/NNS TNFR1/NN and/CC TNFR2/NN are/VBP expressed/VBN on/IN cultured/JJ DRG/NN neurones/NNS and/CC that/IN they/PRP are/VBP functionally/RB linked/VBD to/TO intracellular/JJ Ca2+/NN mobilisation/NN ,/, a/DT response/NN that/WDT may/MD involve/VBP sphingolipid/NN signalling/NN ./.
P11751459A01
Bryostatin/NN 1/CD (/( bryo/NN 1/CD )/) is/VBZ known/VBN to/TO induce/VB the/DT differentiation/NN and/CC cell/NN cycle/NN arrest/NN of/IN human/NN lymphoid/JJ leukemia/NN cells/NNS in/FW vitro/FW ./.
P11751459A13
Our/PRP$ analysis/NN also/RB shows/VBZ that/IN CD11c/NN 's/POS gene/NN promoter/NN activity/NN is/VBZ augmented/VBN by/IN bryo/NN 1/CD ./.
P11751895A03
The/DT mRNA/NN up-regulation/NN was/VBD seen/VBN at/IN 3/CD h/NN in/IN response/NN to/TO MIF/NN (/( 10/CD microg/NN //SYM ml/NN )/) ,/, reached/VBD the/DT maximum/NN level/NN at/IN 6-12/CD h/NN ,/, and/CC returned/VBD to/TO the/DT basal/JJ level/NN at/IN 36/CD h/NN ./.
P11751976A06
However/WRB ,/, hBD-2/NN induction/NN by/IN F./NN nucleatum/NN was/VBD not/RB blocked/VBN by/IN pretreatment/NN with/IN two/CD NF-kappaB/NN inhibitors/NNS ,/, pyrrolidine/NN dithiocarbamate/NN and/CC the/DT proteasome/NN inhibitor/NN ,/, MG132/NN ./.
P11752055A08
While/IN both/CC ET-1/NN and/CC PDGF/NN displayed/VBD a/DT proliferative/JJ effect/NN on/IN SC/NN ,/, treatment/NN with/IN PDGF/NN did/VBD not/RB affect/VBP the/DT morphology/NN of/IN these/DT cells/NNS to/TO a/DT significant/JJ extent/NN ./.
P11752101A09
Therefore/RB ,/, alpha/NN (/( 1B/NN )/) -/: and/CC alpha/NN (/( 1D/NN )/) -ARs/NNS mediated/VBD similar/JJ growth/NN responses/NNS but/CC differ/VBP with/IN respect/NN to/TO the/DT MAPK/NN family/NN member/NN involved/VBN and/CC the/DT requirement/NN for/IN agonist/NN ./.
P11756172A07
These/DT results/NNS strongly/RB indicate/VBP that/IN OxPAPC-induced/JJ TF/NN expression/NN is/VBZ independent/JJ of/IN the/DT classical/JJ NF-kappa/NN B/NN pathway/NN ./.
P11771655A07
The/DT ability/NN of/IN exogenously/RB added/JJ BMP-2/NN ,/, BMP-4/NN ,/, or/CC BMP-7/NN to/TO stimulate/VB osteocalcin/NN (/( OCN/NN )/) and/CC bone/NN sialoprotein/NN (/( BSP/NN )/) mRNAs/NNS or/CC OCN/NN promoter/NN activity/NN was/VBD synergistically/RB increased/VBN in/IN cells/NNS that/WDT were/VBD actively/RB synthesizing/VBG an/DT ECM/NN (/( i.e./IN ,/, were/VBD grown/VBN in/IN the/DT presence/NN of/IN AA/NN )/) ./.
P11781373A04
To/TO further/RB define/VB the/DT role/NN Bam32/NN plays/VBZ in/IN B/NN cells/NNS ,/, we/PRP generated/VBD Bam32-deficient/JJ DT40/NN cells/NNS ./.
P11782348A12
No/DT change/NN in/IN nuclear/JJ factor-kappaB/NN binding/JJ activity/NN was/VBD found/VBN ,/, however/WRB ./.
P11786558A04
Oxidative/JJ stress-induced/JJ apoptosis/NN was/VBD abrogated/VBN by/IN dominant/JJ negative/JJ stress-activated/JJ protein/NN kinase/NN //SYM extracellular/JJ signal-regulated/JJ kinase/NN kinase-1/NN (/( SEK1/NN )/) -mediated/JJ inhibition/NN of/IN the/DT JNK/NN pathway/NN ,/, whereas/IN activation/NN of/IN the/DT JNK/NN pathway/NN by/IN constitutively/RB active/JJ SEK1/NN was/VBD sufficient/JJ to/TO cause/VB apoptosis/NN ./.
P11788789A02
Therefore/RB these/DT kinases/NNS have/VBP been/VBN designated/VBN suitable/JJ targets/NNS for/IN anti-inflammatory/JJ therapy/NN ./.
P11790788A08
Thus/RB ,/, CRH/NN promotes/VBZ PC12/NN apoptosis/NN via/IN the/DT CRH/NN type/NN 1/CD receptor/NN ,/, which/WDT induces/VBZ Fas/NN ligand/NN production/NN via/IN activation/NN of/IN p38/NN ./.
P11795313A08
We/PRP hypothesized/VBD that/IN fluid/NN shear/NN stress/NN modulates/VBZ TNF/NN effects/NNS on/IN EC/NN by/IN inhibiting/NN TNF-mediated/JJ activation/NN of/IN MAP/NN kinases/NNS ./.
P11796002A05
The/DT effect/NN of/IN MAP/NN kinase/NN inhibitors/NNS was/VBD tested/VBN using/VBG a/DT tissue/NN culture/NN model/NN ,/, the/DT fibroblast-populated/JJ collagen/NN lattice/NN (/( FPCL/NN )/) contraction/NN assay/NN ,/, and/CC a/DT rat/NN full-thickness/NN skin/NN defect/NN model/NN of/IN wound/NN healing/NN ./.
P11796505A03
Subsequently/RB ,/, IGF-I/NN switches/VBZ to/TO stimulating/NN differentiation/NN of/IN these/DT cells/NNS ./.
P11796722A08
Staurosporine/NN and/CC Go6983/NN ,/, inhibitors/NNS for/IN PKC/NN ,/, also/RB inhibited/VBD the/DT induction/NN of/IN Prx/NN I/CD ,/, suggesting/VBG that/IN protein/NN kinase/NN Cdelta/NN is/VBZ required/VBN for/IN the/DT induction/NN by/IN arsenate/NN ./.
P11796740A05
H/NN (/( 2/CD )/) O/NN (/( 2/CD )/) -induced/JJ phosphorylation/NN of/IN ERK1/NN //SYM 2/CD ,/, Akt/NN //SYM PKB/NN or/CC JNK/NN were/VBD unaffected/VBN by/IN the/DT NMDA/NN channel/NN blocker/NN MK801/NN ./.
P11796750A08
These/DT findings/NNS suggest/VBP that/IN a/DT cell-survival/NN program/NN involving/VBG phospho-activation/NN of/IN MEK1/NN //SYM 2/CD and/CC ERK1/NN //SYM 2/CD and/CC inactivation/NN of/IN Bad/NN is/VBZ mobilized/VBN in/IN hypoxic/JJ neurons/NNS ,/, and/CC may/MD help/VBP to/TO regulate/VB neuronal/JJ fate/NN following/VBG hypoxic-ischemic/JJ injury/NN ./.
P11799073A09
Incubation/NN of/IN VSMCs/NNS with/IN the/DT antioxidant/NN N-acetylcysteine/NN suppressed/VBD GSA-elicited/JJ mRNA/NN induction/NN of/IN MCP-1/NN and/CC IL-6/NN ./.
P11799150A09
These/DT results/NNS demonstrate/VBP the/DT importance/NN of/IN signaling/NN via/IN ERK/NN and/CC p38/NN in/IN the/DT early/JJ host/NN response/NN to/TO adenovirus/NN vectors/NNS and/CC will/MD permit/VBP the/DT development/NN of/IN novel/JJ strategies/NNS to/TO improve/VB the/DT safety/NN and/CC efficacy/NN of/IN these/DT agents/NNS in/IN human/NN gene/NN therapy/NN ./.
P11802792A05
To/TO investigate/VB the/DT role/NN of/IN ERK/NN activation/NN ,/, co-treatment/NN of/IN RA/NN with/IN PD98059/NN ,/, a/DT specific/JJ inhibitor/NN of/IN the/DT ERK/NN signalling/JJ pathway/NN ,/, prevented/VBD both/CC adipocyte/NN formation/NN and/CC expression/NN of/IN the/DT adipogenic/JJ markers/NNS ,/, adipocyte/NN lipid-binding/JJ protein/NN and/CC peroxisome-proliferator-activated/JJ receptor/NN gamma/NN ./.
P11806247A06
Treatment/NN of/IN hVSMCs/NNS with/IN IL-1/NN beta/NN induced/VBD VEGF/NN expression/NN in/IN a/DT time-/NN and/CC concentration-dependent/JJ manner/NN and/CC increased/VBD both/CC the/DT VEGF/NN promoter/NN activity/NN and/CC the/DT mRNA/NN half-life/NN ./.
P11810403A05
Phosphorylated/JJ SAPK/NN //SYM JNK/NN (/( SAPK/NN //SYM JNK-P/NN )/) expression/NN occurs/VBZ in/IN cortical/JJ neurons/NNS with/IN neurofibrillary/JJ tangles/NNS in/IN the/DT common/JJ form/NN of/IN DLB/NN ./.
P11817656A08
Calcineurin/NN (/( or/CC protein/NN phosphatase/NN 2B/NN )/) is/VBZ activated/VBN by/IN increases/NNS in/IN [/( Ca2+i/NN ]/) through/IN the/DT [/( Ca2+/NN ]/) -sensing/JJ protein/NN ,/, calmodulin/NN ./.
P11821017A11
These/DT results/NNS indicate/VBP that/IN (/( 1/CD )/) the/DT endothelin-1-induced/JJ mitogenic/JJ response/NN involves/VBZ both/CC ERK1/NN //SYM 2-dependent/JJ and/CC -independent/JJ mechanisms/NNS ,/, (/( 2/CD )/) ERK1/NN //SYM 2/CD activation/NN by/IN endothelin-1/NN involves/VBZ an/DT extracellular/JJ Ca2+/NN influx-dependent/JJ cascade/NN as/RB well/RB as/IN an/DT extracellular/JJ Ca2+/NN influx-independent/JJ cascade/NN ,/, (/( 3/CD )/) because/IN endothelin-1-induced/JJ mitogenesis/NN is/VBZ completely/RB dependent/JJ on/IN extracellular/JJ Ca2+/NN influx/NN ,/, extracellular/JJ Ca2+/NN influx/NN also/RB plays/VBZ an/DT important/JJ role/NN in/IN mitogenic/JJ pathways/NNS downstream/JJ of/IN ERK1/NN //SYM 2/CD ,/, (/( 4/CD )/) extracellular/JJ Ca2+/NN influx/NN through/IN NSCC-1/NN and/CC NSCC-2/NN has/VBZ an/DT important/JJ role/NN in/IN the/DT extracellular/JJ Ca2+/NN influx-dependent/JJ component/NN of/IN ERK1/NN //SYM 2-dependent/JJ mitogenesis/NN ,/, (/( 5/CD )/) extracellular/JJ Ca2+/NN influx/NN through/IN NSCC-2/NN has/VBZ an/DT important/JJ role/NN in/IN ERK1/NN //SYM 2-independent/JJ mitogenesis/NN ,/, and/CC (/( 6/CD )/) Ca2+/NN influx/NN through/IN each/DT Ca2+/NN channel/NN may/MD play/VBP a/DT distinct/JJ role/NN in/IN intracellular/JJ mitogenic/JJ cascades/NNS ./.
P11823472A03
We/PRP report/VBP that/IN inhibition/NN of/IN mitogen-activated/JJ protein/NN kinase/NN //SYM extracellular/JJ signal-regulated/JJ kinase/NN kinase/NN (/( MEK/NN )/) -1/CD //SYM 2/CD blocked/VBD BCR-induced/JJ activation/NN of/IN extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) ./.
P11827704A04
OxLDL/NN ,/, but/CC not/RB LDL/NN ,/, increased/VBD CXCR2/NN mRNA/NN determined/VBN by/IN RT-PCR/NN in/IN both/DT cells/NNS ./.
P11830491A11
Together/RB ,/, these/DT results/NNS reveal/VBP Gab2/NN as/IN a/DT limiting/JJ signaling/JJ component/NN for/IN Erk/NN MAP/NN kinase/NN activation/NN and/CC terminal/JJ differentiation/NN of/IN K562/NN CML/NN cells/NNS ./.
P11832348A07
Treatment/NN of/IN the/DT p53/NN -/-/SYM VSMC/NN with/IN S-nitroso-N-acetylpenicillamine/NN resulted/VBD in/IN a/DT marked/JJ activation/NN of/IN p38/NN MAPK/NN and/CC ,/, to/TO a/DT lesser/JJR extent/NN ,/, of/IN c-Jun/NN NH/NN (/( 2/CD )/) -terminal/JJ kinase/NN ,/, mitogen-activated/JJ protein/NN kinase/NN kinase/NN (/( MEK/NN )/) 1/CD //SYM 2/CD ,/, and/CC p42/NN //SYM 44/CD (/( extracellular/JJ signal-regulated/JJ kinase/NN ,/, ERK/NN )/) ./.
P11841790A08
The/DT activation/NN of/IN MAP/NN kinases/NNS by/IN H/NN (/( 2/CD )/) O/NN (/( 2/CD )/) and/CC NSAIDs/NNS was/VBD suppressed/VBN by/IN quinone/NN reductase/NN inhibitors/NNS ,/, suggesting/VBG that/IN "/`` redox/NN cycling/NN "/'' was/VBD involved/VBN in/IN the/DT activation/NN mechanisms/NNS of/IN MAP/NN kinases/NNS by/IN H/NN (/( 2/CD )/) O/NN (/( 2/CD )/) and/CC NSAIDs/NNS ./.
P11846446A07
Furthermore/RB ,/, PDGF/NN alpha-/NN ,/, but/CC not/RB PDGF/NN beta-receptor/NN protein/NN levels/NNS were/VBD reduced/VBN by/IN type/NN II/CD TGF-beta/NN receptor/NN overexpression/NN ./.
P11846786A02
We/PRP studied/VBD the/DT involvement/NN of/IN the/DT mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) pathway/NN in/IN regulating/NN ChAT/NN expression/NN in/IN a/DT murine/JJ septal/JJ cell/NN line/NN ./.
P11849444A06
Apoptosis/NN was/VBD detected/VBN by/IN the/DT TUNEL/NN method/NN ./.
P11850208A07
These/DT results/NNS indicated/VBD that/IN MAPK/NN plays/VBZ an/DT important/JJ role/NN in/IN aromatase/NN activation/NN at/IN the/DT post-transcriptional/JJ level/NN ./.
P11852102A03
Pretreatment/NN with/IN antioxidants/NNS such/JJ as/IN glutathione/NN or/CC estrogen/NN attenuated/VBD TRAIL/NN //SYM Apo2L-induced/JJ apoptosis/NN through/IN a/DT reduction/NN of/IN ROS/NN generation/NN and/CC diminished/JJ p38/NN MAP/NN kinase/NN and/CC caspase/NN activation/NN ./.
P11853544A01
Chondrocyte/NN dedifferentiation/NN has/VBZ been/VBN noted/VBN in/IN osteoarthritic/JJ cartilage/NN ,/, but/CC the/DT contribution/NN of/IN this/DT phenomenon/NN is/VBZ poorly/RB understood/VBN ./.
P11854195A04
Therefore/RB ,/, polarized/JJ human/NN T84/NN intestinal/JJ epithelial/JJ cells/NNS were/VBD infected/VBN from/IN the/DT basolateral/JJ surface/NN with/IN either/CC wild-type/NN S./NN flexneri/NN or/CC one/CD of/IN its/PRP$ isogenic/JJ LPS-defective/JJ strains/NNS with/IN mutations/NNS in/IN either/CC rfc/NN ,/, rfaL/NN ,/, or/CC galU/NN ./.
P11856743A10
JIP-1/NN specifically/RB scaffolds/VBZ JNK/NN ,/, MKK7/NN ,/, and/CC members/NNS of/IN the/DT mixed-lineage/NN kinase/NN (/( MLK/NN )/) family/NN ,/, implicating/VBG these/DT kinases/NNS upstream/JJ of/IN JNK/NN in/IN the/DT apoptotic/JJ pathway/NN induced/VBN by/IN PBOX-6/NN in/IN K562/NN cells/NNS ./.
P11857775A02
Irradiation/NN of/IN HLE/NN cells/NNS with/IN ultraviolet/JJ B/NN and/CC ultraviolet/JJ C/NN radiation/NN activates/VBZ the/DT stress-response/NN MAPK/NN proteins/NNS ,/, p38/NN and/CC c-Jun/NN NH/NN (/( 2/CD )/) -terminal/JJ kinase/NN (/( JNK/NN )/) ,/, in/IN a/DT dose-/NN and/CC time-dependent/JJ manner/NN ,/, while/IN the/DT extracellular-regulated/JJ signal/NN kinase/NN (/( ERK/NN 44/CD //SYM 42/CD )/) cascade/NN was/VBD not/RB altered/VBN by/IN UVR/NN exposure/NN ./.
P11861527A10
Cotransfection/NN of/IN the/DT LHbeta-promoter/NN and/CC the/DT constitutively/RB active/JJ CDC42/NN stimulated/VBD basal/JJ and/CC GnRH-A-induced/JJ LHbeta-CAT/NN activity/NN ./.
P11867267A03
However/WRB ,/, antiproliferative/JJ mechanisms/NNS of/IN estrogen/NN were/VBD not/RB well/RB elucidated/VBN yet/RB ./.
P11867622A07
Coexpression/NN of/IN wild/JJ type/NN JNK/NN with/IN CYP/NN 2C9/NN attenuated/VBD the/DT CYP/NN 2C9-induced/JJ increase/NN in/IN cyclin/NN D1/NN expression/NN and/CC abolished/VBD the/DT CYP/NN 2C9-induced/JJ proliferation/NN response/NN ./.
P11878930A01
Hepatitis/NN C/NN virus/NN (/( HCV/NN )/) core/NN protein/NN is/VBZ a/DT multifunctional/JJ protein/NN interacting/VBG with/IN cellular/JJ and/CC viral/JJ proteins/NNS and/CC promoters/NNS ./.
P11880263A04
Furthermore/RB ,/, we/PRP demonstrate/VBP that/IN pretreatment/NN with/IN KN-93/NN or/CC a/DT CaM/NN kinase/NN II/CD inhibitor/NN peptide/NN inhibits/VBZ Ca/NN (/( 2+/CD )/) -dependent/JJ PYK2/NN activation/NN and/CC EGF/NN receptor/NN tyrosine/NN phosphorylation/NN in/IN response/NN to/TO ionomycin/NN ,/, ATP/NN ,/, and/CC platelet-derived/JJ growth/NN factor/NN but/CC has/VBZ no/DT effect/NN on/IN phorbol/NN 12/CD ,/, 13-dibutyrate-/NN or/CC EGF-induced/JJ responses/NNS ./.
P11882602A02
Although/IN HB-EGF/NN has/VBZ been/VBN shown/VBN to/TO stimulate/VB mitogenesis/NN and/CC chemotaxis/NN of/IN vascular/JJ smooth/JJ muscle/NN cells/NNS (/( VSMC/NN )/) ,/, its/PRP$ signaling/JJ mechanism/NN remains/VBZ undefined/JJ ./.
P11884386A04
We/PRP show/VBP that/IN aggregation/NN and/CC Me/NN (/( 2/CD )/) SO/NN treatment/NN ,/, which/WDT trigger/VBP the/DT differentiation/NN response/NN ,/, result/VBP in/IN sustained/JJ activation/NN of/IN JNK1/NN ,/, p38/NN ,/, and/CC ERK1/NN //SYM 2/CD MAPKs/NNS and/CC acquisition/NN of/IN AP-1/NN DNA/NN binding/JJ activity/NN ./.
P11884562A06
Infection/NN by/IN UV-irradiated/JJ ,/, inactivated/JJ virus/NN capable/JJ of/IN receptor/NN binding/NN and/CC endocytosis/NN triggered/VBD early/JJ ERK1/NN //SYM 2/CD activation/NN ,/, but/CC was/VBD insufficient/JJ to/TO trigger/VB late/JJ ERK1/NN //SYM 2/CD activation/NN ./.
P11886455A05
A/DT MAPK/NN //SYM ERK/NN kinase/NN inhibitor/NN ,/, PD098059/NN ,/, decreased/VBD the/DT basal/JJ levels/NNS of/IN phospho-ERK1/NN //SYM 2/CD and/CC prevented/VBD the/DT increase/NN in/IN ERK1/NN //SYM 2/CD phosphorylation/NN induced/VBN by/IN depolarization/NN ./.
P11886529A09
This/DT study/NN provides/VBZ evidence/NN that/IN the/DT p38-MAPK/NN //SYM SAPK/NN pathway/NN is/VBZ necessary/JJ ,/, but/CC insufficient/JJ ,/, for/IN mediating/NN human/NN keratinocyte/NN migration/NN on/IN collagen/NN ./.
P11888212A03
We/PRP addressed/VBD this/DT point/NN in/IN primary/JJ cultures/NNS of/IN Sertoli/NN cells/NNS experimentally/RB maintained/VBN in/IN suspension/NN ,/, considering/VBG that/IN follicle-stimulating/JJ hormone/NN (/( FSH/NN )/) activates/VBZ ERK1/NN ,/, 2/CD in/IN attached/JJ Sertoli/NN cells/NNS by/IN acting/NN through/IN a/DT GPCR/NN ./.
P11891438A07
These/DT findings/NNS suggest/VBP that/IN ERK/NN and/CC JNK/NN but/CC not/RB p38/NN cascades/NNS may/MD be/VBP closely/RB involved/VBN in/IN signal/NN transduction/NN in/IN the/DT rat/NN hippocampus/NN after/IN traumatic/JJ brain/NN injury/NN ./.
P11895866A11
Together/RB ,/, the/DT data/NNS suggest/VBP that/IN an/DT inhibition/NN of/IN ERK1/NN //SYM 2/CD activation/NN and/CC an/DT increased/JJ activation/NN of/IN JNK1/NN //SYM 2/CD and/CC p38/NN by/IN silibinin/NN could/MD be/VBP possible/JJ underlying/JJ molecular/JJ events/NNS involved/VBN in/IN inhibition/NN of/IN proliferation/NN and/CC induction/NN of/IN apoptosis/NN in/IN A431/NN cells/NNS ./.
P11909638A08
Retinoic/JJ acid/NN enhanced/VBD the/DT TGF-beta-induced/JJ increase/NN of/IN mRNA/NN for/IN HSP27/NN ./.
P11918731A06
PCNA/NN staining/NN and/CC TUNEL/NN assay/NN were/VBD performed/VBN on/IN kidney/NN sections/NNS ./.
P11919515A03
Treatment/NN with/IN PD98059/NN ,/, which/WDT inhibits/VBZ MAPK/NN //SYM ERK/NN 1/CD //SYM 2/CD ,/, the/DT upstream/JJ activator/NN of/IN ERK/NN ,/, significantly/RB increased/VBD cell/NN survival/NN in/FW vitro/FW ./.
P11923227A04
To/TO evaluate/VB the/DT ERK/NN mRNA/NN expression/NN level/NN ,/, semiquantitative/JJ reverse/JJ transcription-polymerase/NN chain/NN reaction/NN (/( RT-PCR/NN )/) was/VBD performed/VBN ./.
P11948398A04
Because/IN catalytically/RB active/JJ PKD/NN associates/VBZ with/IN JNK/NN we/PRP determined/VBD whether/IN it/PRP could/MD phosphorylate/VBP the/DT c-Jun/NN N-terminus/NN as/IN a/DT potential/JJ mechanism/NN by/IN which/WDT it/PRP suppresses/VBZ c-Jun/NN Ser/NN 63/CD phosphorylation/NN when/WRB it/PRP complexes/VBZ with/IN JNK/NN ./.
P11953456A01
In/IN this/DT report/NN we/PRP describe/VBP our/PRP$ studies/NNS on/IN intracellular/JJ signals/NNS that/WDT mediate/VBP neurite/NN outgrowth/NN and/CC long-term/NN survival/NN of/IN cerebellar/JJ granule/NN cells/NNS ./.
P11956171A01
Treatment/NN of/IN osteoblastic/JJ cells/NNS with/IN PTH/NN initiates/VBZ dual/JJ signaling/JJ cascades/NNS resulting/VBG in/IN activation/NN of/IN both/CC PKA/NN and/CC PKC/NN ./.
P11969294A03
Here/RB we/PRP show/VBP that/IN this/DT block/NN of/IN G/NN (/( 1/CD )/) progression/NN is/VBZ not/RB simply/RB a/DT consequence/NN of/IN inhibition/NN of/IN the/DT MAPK/NN //SYM Erk/NN pathway/NN but/CC instead/RB it/PRP reveals/VBZ the/DT existence/NN of/IN a/DT discrete/JJ CSK-sensitive/JJ checkpoint/NN ./.
P11971021A05
In/IN contrast/NN ,/, CpG/NN DNA-mediated/JJ ERK/NN activation/NN was/VBD shown/VBN to/TO suppress/VB IL-12/NN production/NN ,/, but/CC to/TO be/VB essential/JJ for/IN the/DT CpG/NN DNA-induced/JJ IL-10/NN production/NN ./.
P11979370A03
To/TO compare/VB the/DT results/NNS obtained/VBN in/IN the/DT 3/CD specimens/NNS ,/, the/DT average/NN percentages/NNS of/IN both/DT epithelial/JJ and/CC stromal/JJ immunostained/JJ cells/NNS were/VBD calculated/VBN on/IN immunostained/JJ sections/NNS ./.
P11986211A09
Inhibitors/NNS were/VBD used/VBN to/TO identify/VB the/DT causal/JJ relationship/NN between/IN signaling/JJ pathways/NNS and/CC PPF/NN ./.
P11991680A03
Among/IN the/DT best-characterized/JJ pathways/NNS regulating/VBG cell/NN survival/NN and/CC cell/NN death/NN are/VBP those/PRP mediated/VBN by/IN the/DT mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) family/NN ./.
P11991731A06
Immunolocalization/NN in/IN cultured/JJ cardiac/JJ myocytes/NNS followed/VBN by/IN confocal/JJ microscopy/NN showed/VBD punctate/JJ ,/, non-nuclear/JJ SAPK3/NN staining/NN ./.
P11997322A08
These/DT findings/NNS identify/VBP a/DT novel/JJ action/NN of/IN ERK/NN to/TO inhibit/VB Na/NN (/( +/SYM )/) //SYM H/NN (/( +/SYM )/) exchange/NN activity/NN and/CC establish/VBP a/DT role/NN for/IN MAP/NN kinase/NN pathways/NNS in/IN the/DT acute/JJ regulation/NN of/IN Na/NN (/( +/SYM )/) //SYM H/NN (/( +/SYM )/) exchange/NN activity/NN and/CC transepithelial/JJ acid/NN secretion/NN in/IN renal/JJ tubules/NNS ./.
P12000769A06
Consistently/RB ,/, we/PRP detected/VBD higher/JJR levels/NNS of/IN activated/JJ Ras/NN in/IN MEFs/NNS lacking/VBG pRB/NN ./.
P12008117A05
Neither/CC genomic/JJ DNA/NN fragmentation/NN nor/CC poly/JJ (/( ADP-ribose/NN )/) polymerase/NN cleavage/NN was/VBD observed/VBN during/IN SAAD-induced/JJ cell/NN death/NN ./.
P12012331A03
This/DT hypothesis/NN was/VBD addressed/VBN by/IN directly/RB visualizing/NN the/DT migration/NN of/IN cultured/JJ human/NN HMFs/NNS into/IN a/DT wound/NN ./.
P12019309A01
Despite/IN the/DT characterization/NN of/IN neuroprotection/NN by/IN transforming/JJ growth/NN factor-beta1/NN (/( TGF-beta1/NN )/) ,/, the/DT signaling/JJ pathway/NN mediating/VBG its/PRP$ protective/JJ effect/NN is/VBZ unclear/JJ ./.
P12020969A03
In/IN the/DT present/JJ study/NN ,/, we/PRP have/VBP addressed/VBN the/DT role/NN of/IN the/DT MAP-kinase/NN pathway/NN in/IN the/DT signaling/JJ events/NNS leading/VBG to/TO the/DT induction/NN of/IN these/DT genes/NNS ./.
P12023682A12
Vascular/JJ structure/NN was/VBD unaltered/VBN by/IN PD98059/NN ./.
P12024021A04
IB2/NN //SYM JIP2/NN is/VBZ a/DT scaffold/NN for/IN the/DT p38/NN mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN cascade/NN because/IN it/PRP binds/VBZ to/TO the/DT Rac/NN target/NN MLK3/NN ,/, the/DT MAP/NN kinase/NN kinase/NN MKK3/NN ,/, and/CC the/DT p38/NN MAP/NN kinase/NN ./.
P12028436A14
IL-1beta/NN was/VBD unable/JJ to/TO activate/VB the/DT COX-2/NN promoter/NN when/WRB the/DT AP-1-like/JJ site/NN was/VBD mutated/VBN ./.
P12029621A02
During/IN TGF-beta1-induced/JJ apoptosis/NN ,/, 3/CD mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinases/NNS (/( extracellular/JJ signal-regulated/JJ kinase/NN [/( ERK/NN ]/) ,/, c-Jun/NN N-terminal/JJ kinase/NN [/( JNK/NN ]/) ,/, and/CC p38/NN kinase/NN )/) showed/VBD simultaneously/RB sustained/JJ activation/NN in/IN FaO/NN rat/NN hepatoma/NN cells/NNS ./.
P12031710A04
METHODS/NNS :/: Balloon/NN angioplasty/NN was/VBD performed/VBN on/IN 38/CD coronary/JJ arteries/NNS from/IN 23/CD large/JJ white/JJ pigs/NNS ./.
P12032150A03
HGF/NN stimulation/NN of/IN the/DT cells/NNS induces/VBZ not/RB only/RB a/DT rapid/JJ ,/, marked/JJ ,/, and/CC sustained/JJ activation/NN and/CC rapid/JJ nuclear/JJ accumulation/NN of/IN ERK1/NN //SYM 2/CD ,/, but/CC also/RB a/DT prolonged/JJ nuclear/JJ retention/NN of/IN the/DT activated/JJ ERK1/NN //SYM 2/CD ./.
P12032367A07
Burn/NN trauma/NN activated/VBD p38/NN MAPK/NN ,/, JNK/NN ,/, and/CC NF-kappaB/NN ,/, and/CC this/DT stress/NN response/NN was/VBD blocked/VBN by/IN either/CC prazosin/NN or/CC propranolol/NN ./.
P12032835A01
We/PRP had/VBD previously/RB shown/VBN that/IN murine/JJ macrophages/NNS expressing/VBG v-Fes/NN ,/, the/DT oncogenically/RB activated/JJ counterpart/NN of/IN the/DT c-Fes/NN cytoplasmic/JJ tyrosine/NN kinase/NN ,/, proliferate/VBP independently/RB of/IN Macrophage/NN Colony-Stimulating/JJ Factor/NN (/( MCSF/NN )/) and/CC that/IN the/DT Extracellular/JJ signal-Regulated/JJ Kinase/NN (/( ERK/NN )/) pathway/NN mediates/VBZ the/DT mitogenic/JJ effect/NN of/IN v-Fes/NN ./.
P12034375A03
Berberine-induced/JJ IL-12/NN p40/NN production/NN and/CC activation/NN of/IN p38/NN mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) in/IN dose-dependent/JJ manners/NNS ,/, which/WDT were/VBD significantly/RB inhibited/VBN by/IN p38/NN MAPK/NN inhibitors/NNS and/CC yohimbine/NN ,/, indicating/VBG that/IN p38/NN MAPK/NN and/CC alpha/NN (/( 2/CD )/) -adrenergic/JJ receptor/NN were/VBD involved/VBN in/IN the/DT induction/NN of/IN IL-12/NN p40/NN production/NN in/IN mouse/NN macrophages/NNS by/IN berberine/NN ./.
P12034736A05
The/DT mitochondrial/JJ pathway/NN is/VBZ involved/VBN in/IN the/DT synergistic/JJ induction/NN of/IN apoptosis/NN by/IN Bis/NN VIII/CD and/CC TRA-8/NN ./.
P12042096A07
Western/NN blots/NNS showed/VBD that/IN phosphorylated/JJ extracellular/JJ signal/NN regulated/JJ kinase/NN (/( ERK1/NN //SYM 2/CD )/) and/CC p38/NN were/VBD rapidly/RB upregulated/VBN in/IN co-cultures/NNS after/IN mechanical/JJ injury/NN ./.
P12049654A03
While/IN cells/NNS transfected/VBN with/IN the/DT signalling-competent/JJ long/JJ form/NN of/IN the/DT leptin/NN receptor/NN (/( ObRb/NN )/) have/VBP been/VBN used/VBN to/TO study/VB leptin/NN signalling/NN ,/, these/PRP are/VBP likely/RB to/TO be/VB of/IN limited/JJ use/NN in/IN studying/NN STAT3/NN Ser727/NN phosphorylation/NN due/JJ to/TO the/DT importance/NN of/IN cell/NN background/NN in/IN determining/NN the/DT nature/NN of/IN the/DT response/NN ./.
P12051697A02
We/PRP investigated/VBD the/DT role/NN of/IN extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) and/CC p38/NN mitogen/NN activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) in/IN the/DT disturbances/NNS in/IN gastric/JJ mucin/NN synthesis/NN and/CC apoptotic/JJ processes/NNS evoked/VBN by/IN H./NN pylori/NN lipopolysaccharide/NN (/( LPS/NN )/) ./.
P12051955A05
These/DT effects/NNS were/VBD investigated/VBN in/IN relationship/NN to/TO the/DT activation/NN of/IN p38/NN mitogen/NN activated/JJ protein/NN kinase/NN (/( p38/NN MAPK/NN )/) and/CC c-jun/NN amino-terminal/JJ kinase/NN (/( JNK/NN )/) by/IN arachidonic/JJ acid/NN in/IN these/DT cell/NN lines/NNS ./.
P12057008A06
ATP/NN and/CC BzATP/NN also/RB increased/VBD the/DT tyrosine/NN phosphorylation/NN and/CC activity/NN of/IN PKCdelta/NN ,/, and/CC these/DT stimuli/NNS also/RB increased/VBD extracellular/JJ signal-regulated/JJ protein/NN kinase/NN (/( ERK/NN )/) 1/CD //SYM 2/CD activity/NN in/IN a/DT PKC-dependent/JJ manner/NN ./.
P12058028A06
TGF-beta1/NN treatment/NN increased/VBD the/DT half-life/NN of/IN p21/NN by/IN 3-4-fold/NN ./.
P12060490A03
The/DT p42/NN //SYM 44/CD MAPK/NN activation/NN was/VBD determined/VBN by/IN studying/NN the/DT expression/NN of/IN the/DT phosphorylated/JJ p42/NN //SYM 44/CD MAPK/NN (/( Thr202/NN //SYM Tyr204/NN )/) in/IN the/DT MCP-1-treated/JJ macrophages/NNS ./.
P12072413A08
The/DT effect/NN of/IN 1alpha/NN ,/, 25-/CD (/( OH/NN )/) (/( 2/CD )/) D/NN (/( 3/CD )/) required/VBD phospholipase/NN C/NN ,/, and/CC the/DT effect/NN of/IN 24R/NN ,/, 25-/CD (/( OH/NN )/) (/( 2/CD )/) D/NN (/( 3/CD )/) required/VBD phospholipase/NN D/NN ./.
P12077118A07
In/IN addition/NN ,/, co-transfections/NNS with/IN mutants/NNS of/IN Ras/NN ,/, Raf/NN ,/, and/CC MEK/NN showed/VBD that/IN the/DT induction/NN of/IN MUC2/NN promoter/NN activity/NN by/IN PMA/NN required/VBD these/DT three/CD signaling/JJ proteins/NNS ./.
P12082101A09
The/DT overexpression/NN of/IN MEK1/NN enhanced/VBD substantially/RB junD/NN expression/NN in/IN response/NN to/TO UV/NN or/CC TPA/NN ./.
P12091247A02
We/PRP have/VBP recently/RB shown/VBN that/IN phorbol/NN 13-myristate/NN 12-acetate/NN (/( PMA/NN )/) -stimulated/JJ SPRR1B/NN transcription/NN in/IN Clara-like/JJ H441/NN cells/NNS is/VBZ mainly/RB mediated/VBN by/IN activator/NN protein-1/NN (/( AP-1/NN )/) and/CC c-Jun/NN N-terminal/JJ kinase-1/NN (/( JNK1/NN )/) ./.
P12091480A03
Yet/RB ,/, the/DT role/NN of/IN ERK/NN activation/NN prior/RB to/TO seizure/NN has/VBZ not/RB been/VBN evaluated/VBN ./.
P12097372A05
The/DT ability/NN of/IN apoptotic/JJ cells/NNS to/TO promote/VB survival/NN and/CC inhibit/VB proliferation/NN appears/VBZ to/TO be/VB the/DT result/NN of/IN simultaneous/JJ activation/NN of/IN Akt/NN and/CC inhibition/NN of/IN the/DT mitogen-activated/JJ protein/NN kinases/NNS extracellular/JJ signal-regulated/JJ kinase/NN (/( ERK/NN )/) 1/CD and/CC ERK2/NN (/( ERK1/NN //SYM 2/CD )/) ./.
P12105223A06
Co-transfection/NN of/IN a/DT JNK/NN expression/NN plasmid/NN inhibited/VBD RXR/NN :/: RAR-mediated/JJ activation/NN of/IN the/DT Ntcp/NN promoter/NN ,/, while/IN a/DT dominant/JJ negative/JJ JNK/NN expression/NN plasmid/NN completely/RB blocked/VBD IL-1/NN beta-mediated/JJ suppression/NN ./.
P12111821A11
Moreover/RB ,/, the/DT PC12-N1/NN cells/NNS may/MD be/VBP used/VBN as/IN a/DT model/NN for/IN investigating/NN molecular/JJ signaling/JJ mechanisms/NNS underlying/VBG neuronal/JJ differentiation/NN and/CC axonal/JJ outgrowth/NN ./.
P12114201A08
Inhibition/NN of/IN integrin/NN signaling/NN ,/, with/IN EDTA/NN or/CC RGD/NN peptides/NNS ,/, decreased/VBD LPS-induced/JJ MAP/NN kinase/NN activity/NN ./.
P12131776A07
The/DT activation/NN of/IN mitogen-activated/JJ protein/NN kinases/NNS was/VBD assessed/VBN by/IN Western/NN blotting/NN with/IN use/NN of/IN antiphosphospecific/JJ antibodies/NNS ./.
P12133965A07
However/WRB ,/, this/PRP was/VBD completely/RB blocked/VBN by/IN combinations/NNS of/IN the/DT inhibitors/NNS ,/, including/VBG PD98059-SB203580/NN ,/, PD98059-CAPE/NN ,/, or/CC SB203580-CAPE/NN combinations/NNS ,/, in/IN both/CC LPS-/NN and/CC GBS-stimulated/JJ monocytes/NNS ./.
P12137564A05
The/DT mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) //SYM extracellular/JJ signal-regulated/JJ protein/NN kinase/NN (/( ERK/NN )/) was/VBD rapidly/RB activated/VBN after/IN 30/CD min/NN ,/, strongly/RB inhibited/VBN after/IN 5/CD h/NN of/IN continuous/JJ ischaemia/NN and/CC reactivated/VBN 3/CD times/NNS more/RB than/IN control/NN during/IN reoxygenation/NN ./.
P12138187A07
Consistently/RB ,/, Mekk2/NN (/( -/-/SYM )/) thymocytes/NNS were/VBD more/RB susceptible/JJ than/IN wild-type/NN thymocytes/NNS to/TO anti-CD3/NN MAb-induced/JJ cell/NN death/NN ./.
P12143037A07
In/FW vitro/FW ,/, 17/CD beta/NN estradiol-induced/JJ proliferation/NN of/IN isolated/JJ normal/JJ cholangiocyte/NN was/VBD associated/VBN with/IN increased/JJ (/( P/NN </SYM .01/CD )/) protein/NN expression/NN of/IN p-ERK1/NN //SYM 2/CD ,/, Src/NN ,/, and/CC Shc/NN ./.
P12145102A06
4/CD :/: Inhibition/NN by/IN ebselen/NN of/IN H/NN (/( 2/CD )/) O/NN (/( 2/CD )/) -induced/JJ hydroxyl/NN radical/NN generation/NN in/IN PC12/NN cells/NNS was/VBD observed/VBN using/VBG electron/NN paramagnetic/JJ resonance/NN measurements/NNS ./.
P12151271A06
Hypothermia/NN activated/VBD the/DT NF-kappaB/NN complex/NN ,/, ERK/NN 1/CD //SYM 2/CD and/CC p38/NN MAPK/NN pathway/NN ./.
P12160213A08
These/DT results/NNS indicate/VBP that/IN MK/NN exerts/VBZ its/PRP$ neuroprotective/JJ actions/NNS mainly/RB via/IN ERK/NN activation/NN ./.
P12161424A01
STAT6/NN functions/VBZ as/IN a/DT critical/JJ mediator/NN of/IN IL-4-stimulated/JJ gene/NN activation/NN ,/, and/CC the/DT function/NN of/IN STAT6/NN is/VBZ regulated/VBN by/IN both/CC tyrosine/NN and/CC serine/NN kinase/NN activities/NNS ./.
P12172379A03
The/DT increased/JJ levels/NNS of/IN glutamate/NN receptors/NNS ,/, synaptic/JJ proteins/NNS ,/, and/CC glycolytic/JJ enzyme/NN were/VBD used/VBN to/TO track/VB maturation/NN ./.
P12174383A07
RESULTS/NNS :/: Activity/NN of/IN p38/NN MAPK/NN in/IN control/NN organs/NNS decreased/VBD in/IN the/DT course/NN of/IN ischemia/NN and/CC reperfusion/NN by/IN 85/CD %/SYM ,/, whereas/IN ANP/NN increased/VBD p38/NN activity/NN by/IN up/IN to/TO 30-fold/NN ./.
P12176128A02
Our/PRP$ hypothesis/NN is/VBZ that/IN Fas/NN stimulation/NN not/RB only/RB activates/VBZ pro-apoptotic/JJ signals/NNS but/CC also/RB may/MD inhibit/VBP some/PRP of/IN them/PRP ,/, and/CC this/DT inhibition/NN is/VBZ blocked/VBN by/IN AD/NN ./.
P12181443A02
We/PRP show/VBP for/IN the/DT first/JJ time/NN ,/, with/IN the/DT use/NN of/IN both/CC pharmacological/JJ and/CC genetic/JJ inhibitors/NNS ,/, that/IN the/DT kinase/NN activity/NN and/CC S473/NN phosphorylation/NN of/IN Akt/NN induced/VBN by/IN LPA/NN and/CC S1P/NN requires/VBZ both/CC mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN kinase/NN (/( MEK/NN )/) and/CC p38/NN MAP/NN kinase/NN ,/, and/CC MEK/NN is/VBZ likely/RB to/TO be/VB upstream/JJ of/IN p38/NN ,/, in/IN HEY/NN ovarian/JJ cancer/NN cells/NNS ./.
P12183528A09
Site-directed/JJ mutagenesis/NN of/IN the/DT NF-kappaB/NN binding/JJ sites/NNS at/IN positions/NNS -2640/CD to/TO -2632/CD ,/, -2612/CD to/TO -2603/CD in/IN the/DT enhancer/NN region/NN ,/, or/CC the/DT AP-1/NN biding/JJ site/NN at/IN position/NN -2276/CD to/TO -2270/CD decreased/VBD the/DT inducible/JJ activity/NN of/IN the/DT promoter/NN ./.
P12186863A08
Neutrophil/NN exposure/NN to/TO the/DT Ser/NN //SYM Thr/NN phosphatase/NN inhibitors/NNS okadaic/JJ acid/NN and/CC calyculin/NN A/NN induced/VBD JNK/NN activation/NN ./.
P12186945A11
This/PRP indicates/VBZ that/IN ,/, unlike/IN the/DT transient/JJ JNK/NN activation/NN that/WDT occurs/VBZ in/IN the/DT TPA-mediated/JJ myogenic/JJ process/NN ,/, long-lasting/JJ JNK/NN activation/NN supports/VBZ the/DT growth-arrest/NN state/NN but/CC antagonises/VBZ p38-mediated/JJ myosin/NN expression/NN ./.
P12187125A04
Changes/NNS in/IN diameter/NN were/VBD recorded/VBN under/IN physiological/JJ levels/NNS of/IN flow/NN (/( 90/CD microl/NN //SYM min/NN )/) and/CC pressure/NN (/( 50/CD mm/NN Hg/NN )/) ./.
P12187281A03
MATERIALS/NNS AND/CC METHODS/NNS :/: Eight-week-old/JJ Wistar/NN rats/NNS underwent/VBD bilateral/JJ vasectomy/NN and/CC the/DT testes/NNS were/VBD harvested/VBN 1/CD to/TO 9/CD days/NNS after/IN vasectomy/NN ./.
P12187281A14
In/IN contrast/NN to/TO the/DT delayed/JJ phase/NN up/IN to/TO 24/CD weeks/NNS after/IN vasectomy/NN ,/, we/PRP observed/VBD hyperdynamic/JJ cellular/JJ turnover/NN ,/, spermatocyte/NN loss/NN through/IN apoptosis/NN and/CC enhanced/JJ germ/NN cell/NN proliferation/NN transiently/RB at/IN the/DT early/JJ phase/NN after/IN vasectomy/NN ./.
P12193381A06
Quantitative/JJ analysis/NN of/IN the/DT genomic/JJ DNA/NN showed/VBD a/DT >/SYM 5-fold/NN increase/NN (/( P/NN </SYM 0.05/CD )/) in/IN the/DT low/JJ molecular/JJ weight/NN DNA/NN fragments/NNS by/IN 18/CD h/NN postinjection/NN ./.
P12193714A04
In/IN this/DT study/NN ,/, we/PRP report/VBP that/IN unlike/IN CD28/NN ,/, ligation/NN of/IN CD30/NN on/IN normal/JJ effector/NN T/NN cells/NNS induces/VBZ IL-13/NN production/NN in/IN the/DT absence/NN of/IN concurrent/JJ TCR/NN engagement/NN ./.
P12193730A07
Conversely/RB ,/, H/NN (/( 2/CD )/) O/NN (/( 2/CD )/) activated/VBD JNK/NN ,/, whereas/IN exogenously/RB added/JJ AA/NN stimulated/VBD both/CC superoxide/NN production/NN and/CC JNK/NN activity/NN ./.
P12197778A01
Sphingosine-1-phosphate/NN (/( S-1-P/NN )/) has/VBZ been/VBN identified/VBN as/IN an/DT extracellular/JJ mediator/NN and/CC an/DT intracellular/JJ second/JJ messenger/NN that/WDT may/MD modulate/VBP cell/NN motility/NN ,/, adhesion/NN ,/, proliferation/NN ,/, and/CC differentiation/NN and/CC cancer/NN cell/NN invasion/NN ./.
P12197778A13
However/WRB ,/, pretreatment/NN with/IN 10/CD microM/NN SB202190/NN or/CC SB203580/NN (/( putative/JJ p38/NN inhibitors/NNS )/) attenuated/VBD the/DT stimulation/NN of/IN proliferation/NN by/IN S-1-P/NN ./.
P12202534A02
Mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) are/VBP involved/VBN in/IN the/DT control/NN of/IN cell/NN proliferation/NN ./.
P12204895A05
Eotaxin/NN (/( 1-100/CD nM/NN )/) induced/VBD tyrosine/NN //SYM threonine/NN phosphorylation/NN and/CC activation/NN of/IN extracellular/JJ regulated/JJ kinase/NN (/( ERK/NN )/) 1/CD //SYM 2/CD and/CC p38/NN in/IN NCI-H/NN (/( 292/CD )/) cells/NNS and/CC normal/JJ human/NN bronchial/JJ epithelial/JJ cells/NNS ./.
P12206715A01
We/PRP investigated/VBD intracellular/JJ signalling/JJ pathways/NNS for/IN apoptosis/NN induced/VBN by/IN epigallocatechin-3-gallate/NN (/( EGCG/NN )/) as/IN compared/VBN with/IN those/PRP induced/VBN by/IN a/DT toxic/JJ chemical/JJ substance/NN (/( etoposide/NN ,/, VP16/NN )/) or/CC the/DT death/NN receptor/NN ligand/NN [/( tumour/NN necrosis/NN factor/NN (/( TNF/NN )/) ]/) ./.
P12207652A01
Mitogen-activated/JJ protein/NN kinases/NNS (/( MAPKs/NNS )/) appear/VBP to/TO be/VB ubiquitously/RB involved/VBN in/IN signal/NN transduction/NN during/IN eukaryotic/JJ responses/NNS to/TO extracellular/JJ stimuli/NNS ./.
P12208742A02
Exposure/NN of/IN WB-F344/NN rat/NN liver/NN epithelial/JJ cells/NNS to/TO menadione/NN (/( 50-100/CD micro/JJ M/NN )/) led/VBD to/TO a/DT 50-75/CD %/SYM decrease/NN in/IN GJIC/NN ./.
P12208955A03
Our/PRP$ model/NN is/VBZ composed/VBN of/IN a/DT differentiated/JJ hepatocyte/NN (/( AML12/NN )/) 3pX-1/NN cell/NN line/NN that/WDT undergoes/VBZ pX-dependent/JJ transformation/NN and/CC a/DT dedifferentiated/JJ hepatocyte/NN (/( AML12/NN )/) 4pX-1/NN cell/NN line/NN that/WDT does/VBZ not/RB exhibit/VBP transformation/NN by/IN pX/NN ./.
P12209089A11
CONCLUSION/NN :/: These/DT results/NNS demonstrate/VBP that/IN p38/NN MAPK/NN is/VBZ required/VBN for/IN CD40-mediated/JJ class/NN switching/NN to/TO IgE/NN ./.
P12213569A02
Most/PRP ,/, if/CC not/RB all/PRP ,/, the/DT biological/JJ effects/NNS of/IN TCDD/NN are/VBP mediated/VBN by/IN the/DT activation/NN of/IN AHR/NN ,/, which/WDT is/VBZ a/DT ligand-activated/JJ transcription/NN factor/NN required/VBN for/IN ligand-induced/JJ expression/NN of/IN several/JJ detoxification/NN genes/NNS ,/, including/VBG those/PRP encoding/VBG for/IN cytochrome/NN P450/NN enzymes/NNS CYP1A1/NN ,/, CYP1A2/NN ,/, and/CC CYP1B1/NN ./.
P12218097A11
Our/PRP$ previous/JJ results/NNS indicate/VBP that/IN MAPK/NN //SYM ERK/NN protects/VBZ recently/RB activated/JJ T/NN cells/NNS from/IN Fas/NN receptor-mediated/JJ apoptosis/NN during/IN the/DT initial/JJ phase/NN of/IN an/DT immune/JJ response/NN before/IN the/DT activation-induced/JJ cell/NN death/NN takes/VBZ place/NN ./.
P12219008A01
BACKGROUND/NN :/: Vascular/JJ endothelial/JJ cell/NN apoptosis/NN is/VBZ central/JJ in/IN atherosclerosis/NN and/CC intimal/JJ hyperplasia/NN ./.
P12219008A13
Because/IN TGF-beta1/NN is/VBZ upregulated/VBN in/IN vascular/JJ remodeling/NN ,/, p38/NN (/( MAPK/NN )/) is/VBZ a/DT potential/JJ target/NN to/TO prevent/VB endothelial/JJ cell/NN apoptosis/NN during/IN this/DT process/NN ./.
P12219035A09
RESULTS/NNS :/: LPS/NN caused/VBD an/DT early/JJ activation/NN in/IN all/DT members/NNS of/IN the/DT MAPK/NN family/NN ,/, whereas/IN antecedent/JJ shock/NN both/CC delayed/VBD and/CC attenuated/VBD the/DT LPS/NN induction/NN ./.
P12220646A05
Overexpression/NN of/IN inactive/JJ mutant/JJ Elk-1/NN enhanced/VBD differentiation/NN ./.
P12220664A07
Ornithine/NN decarboxylase/NN activity/NN decreased/VBD after/IN etoposide/NN ,/, indicating/VBG that/IN DFMO/NN exerts/VBZ its/PRP$ effect/NN by/IN depleting/NN cellular/JJ polyamines/NNS before/IN induction/NN of/IN apoptosis/NN ./.
P12225289A06
Nevertheless/RB ,/, ATF3/NN does/VBZ not/RB serve/VBP as/IN a/DT JNK/NN substrate/NN in/FW vitro/FW or/CC in/FW vivo/FW ./.
P12225365A01
We/PRP examined/VBD the/DT role/NN of/IN cell/NN surface/NN clustering/NN of/IN beta2-integrin/NN caused/VBN by/IN protein/NN kinase/NN C/NN (/( PKC/NN )/) -activated-cPLA2/NN in/IN adhesion/NN of/IN eosinophilic/JJ AML14.3D10/NN (/( AML/NN )/) cells/NNS ./.
P12225365A13
Our/PRP$ data/NNS indicate/VBP that/IN PMA/NN causes/VBZ AML/NN cell/NN adhesion/NN through/IN beta2-integrin/NN by/IN PKC/NN activation/NN of/IN cPLA2/NN ./.
P12225959A01
Lung/NN ischemia-reperfusion/NN (/( I-R/NN )/) is/VBZ an/DT important/JJ model/NN of/IN oxidant-mediated/JJ acute/JJ lung/NN and/CC vascular/JJ injury/NN ./.
P12225989A09
PD-98059/NN ,/, an/DT inhibitor/NN of/IN phosphorylation/NN of/IN ERK1/NN //SYM 2/CD ,/, caused/VBD a/DT marked/JJ inhibition/NN of/IN HSP60-induced/JJ COX-2/NN and/CC NOS-2/NN expression/NN ./.
P12226747A06
Kinase/NN assays/NNS show/VBP that/IN Menin/NN overexpression/NN does/VBZ not/RB interfere/VBP with/IN activation/NN of/IN either/CC ERK2/NN or/CC JNK1/NN ,/, suggesting/VBG that/IN Menin/NN acts/VBZ at/IN a/DT level/NN downstream/JJ of/IN MAPK/NN activation/NN ./.
P12237315A06
In/IN addition/NN ,/, immunoblot/NN analysis/NN revealed/VBD that/IN phosphorylation/NN of/IN ERK/NN was/VBD increased/VBN by/IN treatment/NN with/IN the/DT p38/NN inhibitors/NNS ,/, whereas/IN the/DT MEK/NN inhibitors/NNS increased/VBD phosphorylation/NN of/IN p38/NN ,/, which/WDT implies/VBZ a/DT seesaw-like/JJ balance/NN between/IN ERK/NN and/CC p38/NN phosphorylation/NN ./.
P12297293A03
Phosphorylation/NN of/IN p38/NN MAPK/NN was/VBD decreased/VBN in/IN response/NN to/TO TNF-alpha/NN ,/, and/CC the/DT specific/JJ p38/NN MAPK/NN inhibitor/NN SB203580/NN mimicked/VBD the/DT effect/NN of/IN TNF-alpha/NN on/IN col1a1/NN mRNA/NN levels/NNS ./.
P12297830A10
Betaine/NN supplementation/NN in/IN the/DT drinking/JJ water/NN significantly/RB ameliorated/VBD in/FW vivo/FW hepatocyte/NN apoptosis/NN following/VBG bile/NN duct/NN ligation/NN ./.
P12354421A07
We/PRP used/VBD enzyme-linked/JJ immunosorbent/JJ assay/NN (/( ELISA/NN )/) and/CC fluorescence-activated/JJ cell/NN sorting/NN (/( FACS/NN )/) for/IN detecting/NN the/DT induction/NN of/IN ICAM-1/NN on/IN HDMEC/NN ./.
P12354565A07
Other/JJ 5-HT/NN (/( 1A/NN )/) receptor/NN agonists/NNS (/( buspirone/NN ,/, gepirone/NN and/CC ipsapirone/NN )/) also/RB reduced/VBD phospho-Erk1/NN //SYM 2/CD levels/NNS in/IN hippocampus/NN ./.
P12355484A09
Inhibitors/NNS of/IN mitogen-activated/JJ protein/NN kinase/NN kinase/NN ,/, p38/NN ,/, and/CC JNK/NN were/VBD each/PRP able/JJ to/TO inhibit/VB increased/JJ MMP-13/NN production/NN ,/, while/IN the/DT interleukin-1/NN receptor/NN antagonist/NN (/( IL-1Ra/NN )/) protein/NN did/VBD not/RB ./.
P12356731A03
IEX-1/NN was/VBD isolated/VBN by/IN phosphorylation/NN screening/NN with/IN active/JJ ERK2/NN and/CC found/VBN subsequently/RB phosphorylated/VBN in/FW vivo/FW upon/IN ERK/NN activation/NN ./.
P12359764A06
We/PRP have/VBP examined/VBN the/DT response/NN of/IN the/DT extracellular/JJ signal-regulated/JJ kinase/NN ERK1/NN //SYM 2/CD in/IN PDT-resistant/JJ (/( LFS087/NN )/) and/CC PDT-sensitive/JJ (/( GM38A/NN )/) cells/NNS after/IN Photofrin-mediated/JJ PDT/NN ./.
P12372814A06
We/PRP also/RB demonstrate/VBP that/IN upstream/JJ tyrosine/NN kinase/NN activity/NN is/VBZ involved/VBN in/IN the/DT mechanotransduction/NN pathway/NN leading/VBG to/TO stretch-induced/JJ MAPK/NN activation/NN and/CC c-fos/NN mRNA/NN expression/NN ./.
P12377734A10
CONCLUSIONS/NNS :/: Treatment/NN with/IN 17betaE/NN has/VBZ a/DT dual/JJ beneficial/JJ effect/NN :/: the/DT improvement/NN of/IN vascular/JJ healing/NN and/CC the/DT prevention/NN of/IN restenosis/NN after/IN angioplasty/NN ./.
P12377986A11
These/DT data/NNS provide/VBP insight/NN into/IN possible/JJ general/JJ mechanisms/NNS by/IN which/WDT VT/NN and/CC other/JJ trichlothecenes/NNS upregulate/VBP proinflammatory/JJ genes/NNS and/CC impart/VBP immunotoxicity/NN ./.
P12391145A02
Here/RB ,/, evidence/NN is/VBZ presented/VBN for/IN VEGF/NN stimulation/NN of/IN sphingosine/NN kinase/NN (/( SPK/NN )/) that/WDT affects/VBZ not/RB only/RB endothelial/JJ cell/NN signaling/NN but/CC also/RB tumor/NN cells/NNS expressing/VBG VEGF/NN receptors/NNS ./.
P12392577A01
In/IN this/DT study/NN it/PRP was/VBD shown/VBN that/IN growth/NN factor/NN receptors/NNS (/( GFR/NN )/) play/VBP a/DT crucial/JJ role/NN in/IN early/JJ embryogenesis/NN of/IN the/DT echinoderms/NNS Hemicentrotus/NN pulcherrimus/NN and/CC Clypeaster/NN japonicus/NN by/IN transmitting/NN signals/NNS to/TO the/DT mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) pathway/NN ./.
P12393099A01
Activation/NN of/IN vascular/JJ endothelial/JJ cells/NNS (/( ECs/NNS )/) plays/VBZ an/DT important/JJ pathogenic/JJ role/NN in/IN the/DT development/NN of/IN atherosclerosis/NN ./.
P12393706A04
Partial/JJ inhibition/NN of/IN p38/NN MAPK/NN impaired/VBD CD4/NN (/( -/SYM )/) CD8/NN (/( -/SYM )/) thymocyte/NN development/NN and/CC T-cell/NN proliferation/NN ,/, but/CC not/RB positive/JJ selection/NN ./.
P12397020A11
CO/NN may/MD act/VBP as/IN an/DT important/JJ mediator/NN of/IN remodeling/NN of/IN human/NN airways/NNS in/IN asthma/NN via/IN its/PRP$ ability/NN to/TO regulate/VB cell/NN growth/NN of/IN airway/NN smooth/JJ muscle/NN cells/NNS ./.
P12406026A10
Preincubation/NN with/IN SB202190/NN (/( 20/CD micro/JJ M/NN )/) ,/, a/DT specific/JJ inhibitor/NN of/IN p38/NN MAPK/NN ,/, significantly/RB decreased/VBD the/DT oxLDL-induced/JJ VEGF/NN mRNA/NN expression/NN by/IN 40/CD %/SYM ./.
P12410564A04
These/DT differing/JJ sensitivities/NNS at/IN low/JJ concentrations/NNS correlated/VBD well/RB with/IN the/DT level/NN of/IN constitutive/JJ activation/NN of/IN nuclear/JJ factor/NN kappa/NN B/NN (/( NFkappaB/NN )/) in/IN the/DT individual/JJ cell/NN lines/NNS ./.
P12417265A06
ET-1/NN (/( 1-31/CD )/) in/IN addition/NN to/TO ET-1/NN increased/VBD the/DT generation/NN of/IN cellular/JJ reactive/JJ oxygen/NN species/NNS (/( ROS/NN )/) in/IN RASMC/NN ./.
P12421945A08
Herein/RB ,/, we/PRP show/VBP that/IN CD44/NN expression/NN induced/VBN by/IN the/DT LPS-mediated/JJ pathway/NN predominantly/RB involved/VBD JNK/NN activation/NN ./.
P12425799A04
Then/RB the/DT 542nm/NN absorption/NN value/NN was/VBD measured/VBN and/CC the/DT growth/NN curve/NN was/VBD drawn/VBN ./.
P12450322A04
MAPK/NN activities/NNS were/VBD determined/VBN by/IN Western/NN immunoblotting/NN using/VBG specific/JJ antibodies/NNS to/TO their/PRP$ activated/JJ phosphorylated/JJ forms/NNS ./.
P12477734A10
In/IN contrast/NN ,/, forced/JJ MAPK/NN activation/NN diminished/VBD p27/NN expression/NN and/CC markedly/RB augmented/VBD femoral/JJ artery/NN SMC/NN proliferation/NN and/CC migration/NN ./.
